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the four-leaf-clover is a symbol for luck, but is the arterial input function measurement of 
Dynamic Susceptibility Contrast MrI also a matter of luck? Models for an optimal location for 
arterial input function measurements, as presented in this thesis, show for both the magnitude 
and the phase of the Mr signal a four-leaf-clover pattern. Is this just a coincidence or are we 
always lucky? 
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Chapter 1: general introduction
the human body is a wonderful creation and it is worth investigating its beauty. the order 
and complexity of life and living beings is surprising, especially the robust unity of all the 
complicated systems involved in sustaining and creating life. this thesis focuses on the human 
brain. More specifically, it focuses on the measurement of blood supply to brain tissue (or brain-
perfusion) with Magnetic resonance Imaging (MrI). 
An MrI scanner is a unity of complicated electrical systems, software and physical principles 
that allow an investigator to study the inside of the human body, especially soft tissue. MrI 
can make a series of images each with different diagnostic information that helps the physi-
cian in determining the condition of patients. Furthermore, post processing of a single image 
or a series of images can reveal additional (diagnostic) information, such as brain activation, 
functional brain connections, structural brain connections or hemodynamic properties. One 
of the intriguing facts of MrI is that, in general, the signal for image formation is based on free 
water molecules, one of life’s most essential molecules, whereas each specific MrI technique 
reflects completely different aspects of the functioning of the brain. 
In the human body, water can diffuse freely over the membranes but nutrients have to be 
supplied by the blood stream. blood must flow slowly (like in the capillaries) to allow exchange 
of nutrients. Measuring the blood supply to brain tissue (and thereby indirectly the nutrients 
supply) is relevant in multiple clinical conditions. An example is measurement of blood supply 
in a brain tumor in order to asses its (degree of ) malignancy. Another example is assessing the 
extent of tissue at risk following an ischemic stroke. In both conditions, flow measurements 
have important therapeutic consequences.
this thesis focuses on assessing blood supply to brain tissue using MrI. Chapter 2 is a review 
on measurements of blood supply to brain tissue and describes two techniques for measuring 
brain perfusion with MrI. One technique uses a contrast agent to measure the perfusion, the 
other employs water in the arteries as a label to measure the cerebral blood flow. the other 
chapters of this thesis focus on perfusion measurements with dynamic susceptibility contrast 
(DSC-) MrI, which uses gadolinium-based contrast agents and dynamic t2
(*) weighted images.
For DSC-MrI (or bolus tracking MrI) a series of images is acquired during the passage of a 
bolus contrast agent through the brain up to the point that the contrast agent is equally mixed 






change) measured in tissue holds the hemodynamic information and the cerebral blood flow 
and volume can be determined when the input of the microvasculature is a delta (or Dirac) 
function. Contrast agent is injected in the antecubital vein as a short bolus. Subsequently, the 
bolus travels through the right side of the heart, the lungs circulation, and the left side of the 
heart. After the second passage through the heart, the bolus contrast agent enters the oxygen 
rich arterial stream that supplies the body with oxygen and nutrients. When the bolus reaches 
the brain-feeding arteries the bolus no longer has a clearly defined beginning and end due 
to the dispersion in the heart and lungs, and consequently the shape of the concentration 
profile is no longer the same as at its injection site. For this reason, a reference or calibration 
measurement close to the brain tissue is required to enable quantification of perfusion. the 
measurement of the change in concentration contrast agent in a brain-feeding artery is called 
an arterial input function (AIF) measurement.
A special focus of this thesis lies on how to measure a correct AIF. A correct shape of the AIF 
is crucial for absolute or even relative perfusion values. A correct peak-height is necessary for 
absolute perfusion quantification, but an erroneous peak-height in combination with a correct 
shape of the AIF can still produce correct relative values for cerebral blood flow and volume. 
therefore, the first objective should be to measure the correct shape of the AIF, whereas the 
measurement of the peak-height of the AIF should be considered of secondary importance. 
Partial volume effects are known to corrupt the shape of the AIF measurement, and a relevant 
question is: where to select an AIF with a correct shape? Another relevant question is: can an 
AIF with correct shape also be selected automatically? 
We used numerical simulations, modeling physical principles present in AIF measurements, 
to determine the optimal location for correct AIF measurements near two of the main brain-
feeding arteries, the left and right middle cerebral artery. these manual AIF measurements can 
be performed using the magnitude of the Mr signal, which is described in chapter 3, as well 
as using the phase of the Mr signal (see Chapter 4). Phase-based AIF measurements have a 
number of potential advantages compared to the magnitude-based AIF measurements. both 
chapters focus on manual AIF selection within the acquired dataset.
Several research groups have proposed automatic AIF selection procedures, however if the 
selection criteria do not prevent the inclusion of incorrect AIF measurements the results are 
not reliable. An additional criterion can improve the reliability of the automatic AIF selection 
methods or aid manual AIF selection. the proposed criterion is based on tracer kinetic theory 
and tests whether the AIF measurement has an erroneous shape of the concentration-time 
curve (see Chapter 5). More specifically, specific shape errors that are normally not detected 
by the current automatic selection criteria. Most automatic AIF selection procedures focus on 
selecting local AIF measurements (region specific AIF measurements in small brain-feeding 
arteries). However, do the local AIF measurements reflect the true concentration-time curve of 
small arteries? Chapter 6 investigates the question whether automatic local AIF measurement 
can in theory select the correct AIFs of small brain-feeding arteries.
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Finally, we performed and analyzed a DSC-MrI study in patients with migraine to investigate 
whether interictal perfusion changes occur in the migraine patients, since this has not been 
convincingly demonstrated yet (see Chapter 7). this thesis concludes with a general discussion 




Chapter 2: Measurement of cerebral perfusion 
using MrI
Egbert JW bleeker and Matthias JP van Osch
ABstrACt
Cerebral Perfusion MrI is becoming an increasingly important method for diagnosing and stag-
ing brain diseases. Magnetic resonance imaging (MrI) provides the opportunity of combining 
perfusion imaging with high quality anatomical imaging and is therefore for most brain diseases 
the modality of choice. Perfusion MrI techniques can be categorized in two different groups 
based on tracer type. First, Dynamic Susceptibility Contrast (DSC-) MrI is a method based on 
the injection of an exogenous tracer, a gadolinium-based contrast agent, in the arm vein. by 
means of fast t2 or t2
*-weighted imaging the first passage of the contrast agent through the 
brain tissue is monitored. the second technique, arterial spin labeling (ASl), is a completely 
non-invasive technique that employs water protons as an endogenous tracer. In this review, 
the crucial elements for correct perfusion measurements by DSC-MrI and ASl are discussed. 
In DSC-MrI, the conversion from signal changes to concentration contrast agent, the arterial 
input function measurement and the deconvolution method are the most important elements. 
Whereas in ASl, the efficiency of the labeling method, correction for relaxation processes, 
and M0-calibration methods can be considered the most essential components of blood flow 
quantification. 







brain perfusion MrI characterizes the microvascular blood supply of brain tissue. blood sup-
plies the tissue with oxygen and nutrients and removes waste products. In many brain diseases 
and pathologies blood supply is altered and therefore perfusion MrI can aid in the diagnosis 
and staging of different brain diseases and pathologies (1-7). For example, in brain tumors the 
cerebral blood volume can be used to identify angiogenesis, the formation of new vascula-
ture that enables brain tumors to grow larger than 1-2 mm (8). Perfusion imaging can also 
be helpful in characterizing the autoregulation of cerebral blood flow. reduction in perfusion 
pressure, for example caused by stenosed or occluded brain feeding arteries, is counteracted 
by vasodilatation of especially the arterioles that reduce the resistance of the microvascular 
bed, thereby stabilizing blood flow (9, 10). this process of vasodilatation can be monitored by 
measuring the blood volume. Subsequent lowering of perfusion pressure will result in a reduc-
tion of cerebral blood flow (CbF), but by increasing the oxygen extraction, aerobic metabolism 
can be sustained. Parallel to this microvascular blood flow regulation, collateral blood flow, for 
example via the Circle of Willis or the leptomeningeal arteries, assists in continuing cerebral 
blood flow (11-13). transport times of the blood to the brain tissue provides some insight in the 
quality of collateral blood flow (14, 15). In acute stroke it is hypothesized that perfusion deficits 
enable differentiation between penumbra and core of the infarct (16-18). Finally, it is known 
that in patients with Alzheimer’s Disease reduction in cerebral perfusion precedes anatomical 
changes (19, 20), although the interplay between blood flow, amyloid-b deposition and tangle 
formation is not completely understood at the moment. 
Characterizing cerebral perfusion with MrI requires differentiating static brain tissue from 
moving blood. this can be performed by introducing a tracer in the blood stream, as first 
applied in humans by S.S. kety in the first half of the 20th century (21). the first group of Mr 
perfusion techniques, named Dynamic Susceptibility Contrast (DSC) MrI or first-passage 
bolus-tracking perfusion MrI, relies also on the injection of an exogenous tracer that for MrI is 
based on the lanthanum ion gadolinium (22). However, MrI is the only imaging modality that 
also allows the use of an endogenous tracer for perfusion imaging. this other Mr perfusion 
technique, called arterial spin labeling (ASl), employs rF-pulses to magnetically label proton 
spins in blood thereby creating an endogenous tracer (23). 
hemodynamic parameters
brain perfusion can be characterized using several hemodynamic parameters, each reflecting a 
different physiological element of the blood supply to tissue. the CbF describes the amount of 
blood supplied to the capillaries in a volume of tissue per minute that is [ml/100 ml of tissue/
min] or [ml/100 g of tissue/min]. Measuring CbF can for example be used to grade tumors (24-
26) or assess the hemodynamic effect of large vessel occlusions (27-29). the term perfusion is 
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often solely used for CbF, there are however more metrics characterizing microvascular blood 
supply.
Cerebral blood volume (CbV) is defined as the amount of blood in a given volume of tissue 
and is expressed in [ml/ 100 ml of tissue] or [ml / 100 g of tissue]. the CbV is a good marker for 
vasodilatation and angiogenesis (7, 30) and aids in the differentiation of the penumbra from 
the core of the infarct in acute stroke (31-33). 
the mean transit time (Mtt) is the averaged time the blood resides in the capillary bed. the 
Mtt can be used for delineating the penumbra and core of the infarct in stroke patients (6, 
33). Furthermore, 1/Mtt is an index of local cerebral perfusion pressure (34, 35) and provides 
therefore essential information on the cerebral autoregulation, for example in carotid occlusive 
disease.
the bolus arrival time (bAt), the time of arrival (tA) and the time to peak (ttP) are tim-
ing parameters related to the large vessel blood transport towards the capillaries and can for 
instance be used to assess occlusions in brain feeding arteries or collateral flow through the 
Circle of Willis (15). 
dynAmiC susCeptiBility ContrAst mri (dsC-mri)
DSC-MrI measures perfusion using the passage of an exogenous contrast agent through the 
brain vasculature. the contrast agent is injected in the arm vein and after passing the heart 
and lungs it passes through the brain (micro-)vasculature, which is dynamically monitored by 
fast Mr imaging. the presence of contrast agent decreases the longitudinal relaxation (t1) and 
transverse relaxation (t 2) and disturbs the local magnetic field in and around the vessels. Detec-
tion of contrast agent can therefore be based on t1, t2, or t2
*-weighted imaging. t1 weighted 
imaging will result in signal enhancement and is frequently used to obtain information about 
the permeability of the capillaries. this method is known under the name of Dynamic Contrast 
Enhanced MrI (DCE-MrI), but is beyond the scope of this review and we refer to other articles 
for more information (36-39). the name Dynamic Susceptibility Contrast MrI is reserved for 
perfusion measurements based on monitoring the first passage of contrast agent by t2 or t2
* 
weighted imaging. based on simulations of knutsson et al., the dynamic scan time should be 
chosen faster than 1.5 sec/image (40) to enable accurate perfusion quantification. to obtain 
such a high temporal resolution and still have whole brain coverage at a high resolution, acqui-
sition is performed with fast imaging techniques such as EPI most often in combination with 
parallel imaging (41, 42). guidelines for imaging settings used in acute stroke are described by 
Wintermark (43).
the actual signal drop observed in t2 and t2
* weighted magnitude images (see figure 1) is a 
combination of relaxation effects, diffusion of water protons over the local field changes and, 
for t2






the transformation from signal decrease to concentration contrast agent is important for 
accurate hemodynamic measurements.
Having a correct concentration-time curve of the first passage of contrast agent through 
brain tissue is, however, not sufficient to calculate the hemodynamic parameters. three of the 
hemodynamic parameters (CbF, CbV and Mtt see figure 2) can be obtained from the so-called 
impulse response function, which is mandatory for CbF and Mtt estimations. the impulse 
response is the outcome of the hypothetical experiment of a delta-injection of contrast agent 
in the brain-feeding artery. It describes the delay and broadening (dispersion) of this delta-
injection due to the transport through the vascular network. From tracer kinetic theory, it can 
be shown that the maximum value of the impulse response function equals the CbF and the 
area-under-the-curve equals the CbV. However, in clinical practice, the bolus is injected in the 
arm vein and the shape of the arterial input function (AIF), the concentration profile of a brain-
feeding artery, is therefore much broader and is dependent on the subject specific transport 
properties between the injection site and the AIF measurement location and on the cardiac 
ejection fraction. the impulse response function can be obtained by deconvolving the tissue 
response with the AIF. 
Figure 1: t2
* weighted PrEStO magnitude images before the contrast agent arrival (top left image) and at 
several time points during the contrast passage through the brain vasculature. the whole brain average is 
plotted in the top left corner of every magnitude image with a circle depicting the specific time point for 
the magnitude image. the signal decrease is especially observed in the gray matter and not so much in the 
white matter.
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In summary, DSC-MrI is based on the fast injection of contrast agent in arm vein, whose 
passage through a brain-feeding artery (AIF) and brain tissue is monitored by fast dynamic Mr 
imaging. Subsequently the Mr signal changes are converted to concentration-time curves and 
a deconvolution is performed; finally, the perfusion parameters are calculated from the impulse 
response function as based on tracer kinetics.
Contrast agent
Most clinically approved contrast agents consist out of a gadolinium ion (gd3+) and a chelate 
to prevent toxic reactions in vivo. the first clinically approved contrast agent was gadolinium-
diethylene triamine pentaacetic acid or gadopentetate dimeglumine (gd-DtPA, Magnevist, 
bayer Schering, berlin, germany). Since the approval of gd-DtPA for commercial use in 1988 
many new chelates have been developed. DtPA has a linear chemical structure and is ionic (see 
figure 3). Until recently gd-DtPA was used most often but recent studies showed that chelates 
with linear chemical structures have a chance of transmetallation, the uncoupling of the gd3+ 
with the chelate, which can lead to nephrogenic systemic fibrosis (NSF) in patients with reduced 
renal function (44, 45). New chelates with a cyclic structure such as gadoteridol (Prohance), 
gadobutrol (gadovist) and gadoterate meglumine (Dotarem), (see figure 3) reduce the chance 
of transmetallation. Furthermore, non-neutral chelates such as gadoterate meglumine bind the 
Figure 2: the resulting CbF, CbV and Mtt maps after post processing of the data presented in figure 1. 
the AIF was selected manually and a block circulant SVD was used for the deconvolution. the figure show 
that the gray matter has a higher CbF and CbV and the Mtt is almost the same for gray and white matter.
Figure 3: the chemical structure of the chelates gadoteridol, gadoterate meglumine and gadopentetate 
dimeglumine. the first two chelates have a cyclic structure the third chelate has a linear structure. the first 
chelate is neutral and the second and third are non-neutral chelates. the second chelates binds gadolinium 






gd3+ stronger than neutral chelates such as gadoteridol, hereby further reducing the chance 
of transmetallation. 
the concentration gadolinium can be 0.5 mol/l and 1.0 mol/l depending on the product. the 
increased concentration results in a lower volume to inject in the arm vein and this could lead 
to a shorter and sharper bolus with a higher peak concentration (46). However, a later study 
showed no significant difference in peak width when comparing equal doses with different 
molarities (47).
the effects of the contrast agent on the Mr signal are threefold: first, the susceptibility differ-
ence of the gadolinium-based contrast agent with blood results in local magnetic field changes 
in and around vessels. Second, the contrast agent decreases the transverse relaxation time of 
nearby water protons. third, the contrast agent decreases the longitudinal relaxation time of 
nearby water protons. 
the intravascular susceptibility is linearly related to the concentration of contrast agent and 
changes the local magnetic field (48, 49) in and around a vessel. For an infinite cylinder the local 
magnetic field changes due to the susceptibility difference can be obtained from the Maxwell 
equations (see also figure 4): 
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where ΔBint is the magnetic field change inside the cylinder, ΔBext is the magnetic field 
change outside the cylinder, δχ is the susceptibility difference per mol/l of gadolinium 
between the interior and exterior compartments, [Gd] is the concentration of gadolinium, 
a is the radius of the cylinder, ρ is the distance from any given point (p) to the cylinder 
center, θ is the angle between the cylinder axis and B0, and φ is the angle of p in the plane 
perpendicular to the cylinder axis. The interior magnetic field change for a parallel 
oriented cylinder is twice as strong and opposite of sign of the interior magnetic field 
change for a perpendicular oriented cylinder. Whereas a parallel cylinder does not change 
the magnetic field outside the cylinder, magnetic field changes outside the cylinder do 
occur for other orientations, where a pattern with positive and negative lobes can be 
observed. 
For a voxel in tissue filled with randomly oriented capillaries the signal decrease as 
observed in T2* weighted images is a result of susceptibility effects in and around the 
capillary network, diffusion through these magnetic field inhomogeneities and relaxation 
changes inside the vasculature (50). A numerical study by Kjølby et al. showed that the 
susceptibility effects in the surrounding of the capillaries are the main cause of the signal 
decrease in the magnitude images (51).  
The concentration contrast agent in tissue can be determined by relating the signal 
intensity of the dynamic T2(*)-weighted images to the signal intensity prior to the arrival 
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changes inside the vasculature (50). A numerical study by Kjølby et al. showed that the 
susceptibility effects in the surrounding of the capillaries are the main cause of the signal 
decrease in the magnitude images (51).  
The concentration contrast agent in tissue can be determined by relating the signal 
intensity of the dynamic T2(*)-weighted images to the signal intensity prior to the arrival 
of contrast agent. The equilibrium signal relation of gradient echo sequences is as 
follows: 
 [2]
Figure 4: Magnetic field change due to a susceptibility difference in and around an infinite cylinder 
oriented perpendicular to the main magnetic field (t p) and parall l to the main magnetic field (bottom). 
For the perpen icular orient d cylinder, there is a lobular pattern around the cylinder and a homogenous 
magnetic field inside the cylinder. For a parallel oriented cylinder, there is only a homogenous magnetic 
field ch nge insid  the cylinder. the subfigures 1 to 4 correspond with the lines 1 to 4 in each of the 
magnetic field graphs.
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where Δbint is the magnetic field change inside the cylinder, Δbext is the magnetic field change 
outside the cylinder, δχ is the susceptibility difference per mol/l of gadolinium between the 
interior and exterior compartments, [gd] is the concentration of gadolinium, a is the radius 
of the cylinder, ρ is the distance from any given point (p) to the cylinder center, θ is the angle 
between the cylinder axis and b0, and φ is the angle of p in the plane perpendicular to the cyl-
inder axis. the interior magnetic field change for a parallel oriented cylinder is twice as strong 
and opposite of sign of the interior magnetic field change for a perpendicular oriented cylinder. 
Whereas a parallel cylinder does not change the magnetic field outside the cylinder, magnetic 
field changes outside the cylinder do occur for other orientations, where a pattern with positive 
and negative lobes can be observed.
For a voxel in tissue filled with randomly oriented capillaries the signal decrease as observed 
in t2
* weighted images is a result of susceptibility effects in and around the capillary network, 
diffusion through these magnetic field inhomogeneities and relaxation changes inside the 
vasculature (50). A numerical study by kjølby et al. showed that the susceptibility effects in 
the surrounding of the capillaries are the main cause of the signal decrease in the magnitude 
images (51). 
the concentration contrast agent in tissue can be determined by relating the signal inten-
sity of the dynamic t2
(*)-weighted images to the signal intensity prior to the arrival of contrast 
agent. the equilibrium signal relation of gradient echo sequences is as follows:
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Where S(t) is the evolution of the magnitude of the MR signal, α is the flip angle, TR is 
the repetition time, T1(t) is the longitudinal relaxation time which will decrease during the 
contrast agent passage, TE is the echo time and T2*(t) the transverse relaxation time, 
which is also dependent on the contrast agent concentration. For sequences insensitive to 
longitudinal relaxation time changes, this relation simplifies to: 







When using short TR sequences, like in PRESTO (Principles of echo-shifting with a train 
of observations) or segmented EPI, T1-effects of the contrast agent can no longer be 
neglected when the flip angle is chosen close to the Ernst angle. Such effects do not only 
lead to erroneous quantitative CBF-values, but also affect relative CBF measurements 
(52). From theoretical and simulation studies it has been shown that the relation between 
the concentration contrast agent in brain tissue and ΔR2* is linear with relaxivity r2*, 
whereas the ΔR2 has a slightly non-linear relation with the concentration contrast agent 
(50, 51, 53, 54). The ΔR2(*) is defined as: 



















With S(0) the magnitude signal before contrast agent arrival and T2(*)(0) the T2(*) without 
the presence of contrast agent. When acquiring more echoes, ΔR2*-measurements can be 
obtained that are insensitive to T1-effects of the contrast agent (55-58). Whereas spin 
echo sequence are slower, show less signal changes for a certain concentration contrast 
agent and have a non-linear relationship with the concentration contrast agent, it shows 
specific sensitivity towards the microvascular bed yielding perfusion maps less affected 
by large vessel artifacts (53).  
Inside brain feeding arteries the relation between the ΔR2* and the concentration contrast 
agent is more complex. In vitro experiments showed that the relation between the ΔR2* 
and the concentration contrast agent in human blood is quadratic and dependent on the 
hematocrit level (49, 59). This quadratic relation can be explained by the 
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obtained that are insensitive to T1-effects of the contrast agent (55-58). Whereas spin 
echo sequence are slower, show less signal changes for a certain concentration contrast 
agent and have a non-linear relationship with the concentration contrast agent, it shows 
specific sensitivity towards the microvascular bed yielding perfusion maps less affected 
by large vessel artifacts (53).  
Inside brain feeding arteries the relation between the ΔR2* and the concentration contrast 
agent is more complex. In vitro experiments showed that the relation between the ΔR2* 
and the concentration contrast agent in human blood is quadratic and dependent on the 
hematocrit level (49, 59). This quadratic relation can be explained by the 
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the method for determining the hemodynamic parameters CbF, CbV and Mtt as measured with 
DSC-MrI is based on classic tracer kinetic theory as develop by Zierler and excellent reviewed 
by lassen (62, 63). the concentration contrast agent in the capillaries c(t) is dependent on the 
concentration contrast agent in the artery cAIF(t) supplying the blood to the tissue microvascu-
lature (arterial input function (AIF)) and the transport properties of the microvasculature itself. 
the output of the microvasculature, cout(t), can be expressed as a convolution of the AIF with a 
blood transport function h(t):
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the blood transport function h(t) represents th  distribu ion of transit times through the 
microvasculature. Under the assumption of an intact blood-brain barrier, all contrast agent 
will leave the microvasculature at some moment and therefore h(t) possesses the following 
property:
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the AIF to have the same the area-under-the-curve as the venous output function (64-66). It 
should however be noted t at p rtial volume effects can also lead to shape changes, which 
are not corrected for in this approach (see section AIF measurements). DSC-MrI does, however, 
not measure the output of the microvascular system, but the amount of contrast agent still 
present in tissue. therefore, it is easier to describe the tracer kinetics in terms of the residue 
function ℜ(t), which describes the fraction of the concentration contrast agent that remains in 
the microvasculature after a delta injection contrast agent at the input of the microvasculature. 
the tissue residue function is equal to the impulse response normalized to unity. ℜ(t) can be 
deduced from h(t):
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Where voxelVf  equals the CBF except for some conversion factors.  
The CBF can therefore be obtained by means of a deconvolution from the tissue passage 
curves and the AIF, when keeping in mind that  (0)=1: 
     tctctCBF AIFt 1
When the AIF was actually delayed by TA (time-of-arrival) seconds, then  (t) will be 
zero for t<TA and will reach the value of one at TA sec. Therefore, CBF is in practice not 
calculated from  (0), but as the maximum value of  (t):  
    tctcCBF AIFt 1max 
 [9]
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where as the timepoint of the maximum value of ℜ(t) is taken as tA. this method assumes 
that the applied deconvolution method handles delays correctly. this was not the case for the 
original SVD method, but recent methods provide delay-insensitive results (67-70).
the CbV can be calculated from the product of the blood flow and the transport time func-
tion, comparable to the calculation of distance traveled from the product of velocity and time:
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The CBV can also be calculated from the ratio of the areas-under-the-curve of the tissue 
passage curve and the AIF, although this results in slightly worse quantification due to 
difficulties in differentiating between the first passage and the recirculation (71). It 
should be noted that an additional correction for CBF and CBV is used to account for the 
difference in hematocrit in large (artery) and small (capillary) vessels. 
Finally, the MTT of the blood through the capillary network can be calculated by using 
the central volume theorem, which describes the relation between CBF, CBV and the 
mean transit time (72, 73): 
CBF
CBVMTT 
As can be seen from 14, the MTT can also be calculated by taking the area-under-the-
curve of the residue function. 
Arterial input function measurements 
The AIF measurement is a crucial element for obtaining the hemodynamic parameters 
CBF, CBV and MTT with DSC-MRI. The AIF represents the concentration in time of the 
contrast agent through a brain-feeding artery (referred to as concentration-time curve). 
The concentration-time curve needs a correct shape and the right peak height to provide 
quantitative values for CBV, CBF and MTT. If the shape of the AIF is correctly 
measured, but the height is incorrect, then CBV and CBF will only show correct relative 
values, but MTT will still be quantitatively correct, since CBV and CBF will scale by the 
same factor. If the shape of the AIF is incorrect, all perfusion parameters calculated  from 
the impulse response function will be incorrect, although relative CBV values can be 
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As can be se n from equation 14, the Mtt can also be calculated by taking t  r - r-
the-curve of the residue function.
Arterial input function measurements
the AIF measurement is a crucial element for obtaining the hemodyna ic para eters CbF, 
CbV and Mtt with DSC-MrI. the AIF represents the conc ntration in time of the contras  ag nt 
through a brain-feeding artery (referred to as concentration-time curve). the concentration-
time curve needs a correct shape and the right peak height to provide quantitative values for 
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CbV, CbF and Mtt. If the shape of the AIF is correctly measured, but the height is incorrect, then 
CbV and CbF will only show correct relative values, but Mtt will still be quantitatively correct, 
since CbV and CbF will scale by the same factor. If the shape of the AIF is incorrect, all perfusion 
parameters calculated from the impulse response function will be incorrect, although relative 
CbV values can be obtained from the area-under-the-curve of the tissue response. AIF selec-
tion is often performed manually but a number of automatic selection procedures have been 
proposed based on shape characteristics of a correct AIF, like high peak height, small full-width-
half-maximum, low first moment and steep rise (74-76). 
Initial approaches to measure the AIF measurement with both correct height and correct 
shape concentrated on finding voxels located completely inside a brain-feeding artery. In this 
case a quadratic relaxation rate for magnitude-based AIF measurements should be used and 
a linear relation for phase-based AIF measurements (49, 59, 77). At an optimal dose and echo 
time phase-based AIF measurements have increased signal-to-noise ratio (SNr) compared to 
magnitude-based AIF measurements (78, 79). However, phase-based AIF measurements still 
require a magnitude-based estimation of the brain tissue response, because the contrast agent 
induces almost no phase changes in a voxel filled with randomly oriented capillaries (80). Due 
to the high maximum concentration of the AIF (approximately 15 mM at 1.5 t), the Mr signal 
can drop into noise level, which would corrupt the shape of the concentration-time curve inde-
pendent of whether the amplitude or the phase of the Mr signal is used for the measurement. 
reducing the echo time or lowering the contrast agent dose could prevent signal depletion, 
but both methods would result in a lower SNr of the tissue response measurement. therefore, 
dual echo approaches have been proposed with a short echo time for the AIF measurement 
and a longer echo time for the tissue response (55). An additional advantage of dual echo 
sequences is that longitudinal relaxation effect can be compensated for (58, 81). 
the AIF can theoretically be measured correctly in a voxel located completely within an 
artery, but due to the limited spatial resolution of DSC-MrI such voxels cannot be found in 
actual experiments and partial volume effects can therefore not be avoided. Due to mixing 
of arterial signal with signal from the surrounding tissue, non-linear distortions of the AIF can 
occur when gradient echo imaging is employed. these distortions occur because the phase 
evolution of the arterial compartment will differ from the phase evolution in the surroundings, 
leading to in- and out-of-phase effects depending on the concentration contrast agent. Partial 
volume effects affect both the magnitude-based and phase-based AIF measurements and can 
attain different manifestations as shown in figure 5. AIF shape distortions due to partial volume 
effects can only be corrected for arteries parallel to the main magnetic field, because only in 
this orientation magnetic field changes are not present in the surrounding tissue when the 
contrast agent passes through the artery (82) (see figure 4). 
Since AIF measurements in voxels located in or near the artery are hampered by these par-
tial volume effects, the AIF is often selected in tissue surrounding the artery. When the artery 






also change due to the passage of the contrast agent within the vessel. these magnetic field 
changes lead to changes in the phase and amplitude of the Mr-signal of tissue surrounding 
the vessel, which can therefore be used to estimate the AIF. Voxels located close to the vessel 
wall but completely outside the artery are unaffected by partial voluming with arterial signal, 
but show still reasonable large signal changes during the arterial bolus passage. by numerical 
modeling it has been shown that at specific locations outside an artery a correct measurement 
of the shape of the AIF can be obtained using either the magnitude or the phase of the Mr 
signal (83-85). A disadvantage of measuring the AIF in tissue surrounding an artery is that such 
measurements will be affected by the tissue response of the same voxel. thornton et al. pro-
posed subtraction of the tissue response to improve the magnitude-based AIF measurements 
(86). Phase-based AIF measurements have almost no tissue response and are therefore very 
little affected by the tissue passage.
traditionally, a single (global) AIF is used for all voxels in the brain tissue and such a global 
AIF is frequently measured in the internal or middle cerebral artery. However, these arteries are 
located at a relatively large distance from the microvasculature. All dispersion between these 
arteries, where the AIF is measured and the actual input of the microvasculature, would be 
incorrectly interpreted as microvascular dispersion and thus lead to quantification errors in 
the CbF (68). thijs et al. showed for example that for stroke patients the AIF is best selected 
on the contralateral side of the infarct (87). based on the original ideas of Alsop et al., several 
investigators have looked into the possibility of estimating an individual AIF for every tissue 
voxel (88). Such ‘local’ AIFs would much less be affected by dispersion effects. Independent 
component analysis, factor analysis, and feature extraction have been proposed for obtaining 
local AIF measurements (88-91). the benefit of reduced dispersion effects for local AIFs comes 
Figure 5: Simulated partial volume effects on AIF measurements for the magnitude-based approach (A) 
and the phase-based approach (b). these partial volume effects lead to errors in the shape of the AIF 
measurement. the gray line represents the ground truth scaled to have an equal CbV obtained from the 
first passage. All profiles are created in noise free simulations. 
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with potential disadvantages, such as increased risk of partial volume effects (92) and reduced 
signal-to-noise.
deconvolution
A correct AIF and tissue response still require a deconvolution approach to produce the impulse 
response from which the CbF, CbV and Mtt are derived. there are two general approaches 
for deconvolution: (i) model dependent approaches (93-96) and (ii) model independent 
approaches (69, 97, 98). the model independent approaches are little dependent to the under-
lying vasculature but can be sensitive to noise and dispersion of the bolus. Dispersion effects 
lead in general to an underestimation of CbF and hence an overestimation of Mtt (68) the 
effect of dispersion is excellently reviewed by Calamante (99). 
the simplest model employed for model dependent approaches is an exponential decay; 
this model describes the microvasculature as a single well-mixed compartment. Models that 
are more complex can describe in some extent delay and dispersion, but with additional 
parameters fitting the residue function becomes more difficult. Moreover, if the model is dif-
ferent from the true vascular response the obtained hemodynamic parameters have erroneous 
values. 
Currently most post-processing methods of DSC-MrI rely on model independent deconvo-
lution techniques that do not pose restrictions on the shape of the impulse response. A number 
of different model independent deconvolution approaches have been reported. For example, 
the SVD and block-circulant SVD (which is a modified version of the SVD in order to make the 
deconvolution delay insensitive) (67, 69, 70) or the tikhonov regularization (100). A different 
approach is the Fourier based deconvolution, where deconvolution is a mere division (97, 101). 
Deconvolution can also be performed using a statistical approach such as the maximum likeli-
hood estimation maximization (MlEM) and its modified version mMlEM (in order to make the 
deconvolution less sensitive to delay and dispersion) (98, 102, 103).
All deconvolution methods are susceptible to noise on the tissue response and the AIF. Noise 
on the concentration profiles can corrupt the outcome of the deconvolution and therefore 
each deconvolution method employs some kind of filtering, either by spectral filtering (96, 97), 
cutoff value on the eigenvalues of the matrix inversion (69, 104), or by limiting the number of 
iterations in iterative methods (98, 102). 
ArteriAl spin lABeling (Asl)
Arterial spin labeling is a completely non-invasive perfusion imaging technique that employs 
water protons as an endogenous tracer to probe the blood supply to tissue (23, 105). Since 
water transport across the blood brain barrier is relatively unrestricted, water protons are 






is performed at the location of the larger brain-feeding arteries such as the internal carotid 
artery or the basilar artery and after labeling a delay is inserted in the sequence to allow the 
labeled spins to travel towards the microvasculature. the spin of water protons located in the 
brain-feeding arteries are either inverted (23) or saturated (110, 111) by a radiofrequency pulse. 
the imaging performed after the labeling is proton density weighted, having a short echo time, 
to limit the influence of transverse relaxation. Since such images are not only sensitive to the 
inflow of labeled spins, but also to signal from static tissue, a second image is acquired without 
labeling arterial blood. A subtraction of the label from the control image provides an image that 
is only sensitive to the presence of labeled spins. Such a single subtraction image is, however, 
of limited quality and therefore 30-60 averages are usually obtained to increase SNr (see figure 
6). In the following sections the labeling part, the imaging part, and quantification of the CbF 
are discussed. Furthermore, ASl provides the possibility to label only a single artery, enabling 
the possibility to image the flow territory of a single vessel. this has importance in pinpointing 
the origin of emboli in acute stroke (112), differentiating en passage feeders from direct feeders 
in arterio-venous malformation, and to understand collateral blood flow in large vessel disease 
(28, 29, 113, 114). the different approaches of flow territory mapping will also be discussed.
labeling of arterial blood
labeling approaches for ASl can be subdivided into three categories: continuous ASl (CASl), 
pulsed ASl (PASl), and velocity selective ASl (VSASl). these three categories differ based on 
the temporal layout of the sequence and the spatial extent of the labeling sequence. ASl is a 
Figure 6: ASl based cerebral blood flow images for different numbers of signal averages. Note that for a 
single average the gray-white matter contrast already is already evident, whereas 75 averages are necessary 
for an adequate depiction of the white matter. Acquisition employs pseudo-continuous labeling with a 
label duration of 1650 msec, a delay of 1515 msec and background suppression.
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subtraction technique based on the assumption that the only difference between the label and 
control image originates from the inflow of labeled spins. When designing a labeling approach 
it is therefore essential that the influence on the spins in the imaging slices is equal for the label 
and control module. In this respect, it is essential to avoid magnetization transfer (Mt) effects 
(see next section). 
Magnetization transfer effects
All labeling approaches employ slice selective rF pulses to invert or saturate water spins at 
the labeling location. Whereas water protons in blood have a narrow frequency spectrum, the 
frequency spectrum of macromolecules in brain tissue is much broader. therefore, slice selec-
tive rF pulses of the labeling module do still affect macromolecular spins even when they are 
located at a different location along the slice selection gradient and this magnetization can be 
transferred to the free water signal. When the total power of rF pulses in the labeling part of 
the sequence differs from the control part, a net difference in magnetization will be created 
that will show as subtraction errors in the ASl CbF images. For some ASl implementation the 
Figure 7: Schematic pulse diagrams for different continuous ASl sequences with schematic images for 
the labeling slab (yellow) and read-out slices (white). read-out modules are indicated by gray boxes. 
Figure a shows the diagram for continuous ASl, figure b shows the pulse diagram for CASl with amplitude 






occurrence of this type of error is easily tested by labeling superior from the imaging slices 
instead of the neck region (e.g. in (115)).
Continuous ASL 
In continuous ASl labeling is performed using a small labeling plane through the brain-feeding 
arteries (see figure 7). the water protons that flow through that labeling plane are inverted 
using a flow driven adiabatic inversion rF pulse in combination with a small gradient in the flow 
direction (23, 116, 117). the labeling is switched on for a relatively long period of 1.5-2.5 seconds 
to create sufficient label resulting in a long bolus of labeled blood. because of the continuous 
rF pulse, the total rF power is high, thereby potentially leading to severe magnetization trans-
fer effects. to avoid such Mt-effects, the control image needs to have the same rF power with 
minimal effect on the magnetization of arterial blood. two different approaches have been 
proposed: the first approach limits the coverage to a single plane, by changing the position 
of the labeling plane to the other side of the imaging plane. When extending the coverage 
to more than a single plane, this approach would result in slightly asymmetrical excitation of 
the macromolecules for the control and the label part, which will lead to subtraction errors. 
therefore, a second approach has been proposed that employs amplitude modulation of the 
rF pulse for the control images to create two inversion planes close to each other, thereby 
resulting in a double inversion of the blood flowing through these planes. the last approach 
is at the moment the most common implementation of CASl, although the double inversion 
plane approach results in a slightly lower labeling efficiency of approximately 80%. 
Advantages of CASl are that all spins are labeled at the same level of the arterial tree and 
that the temporal width of the bolus is determined by the labeling duration. both charac-
teristics result in a straightforward quantification of the CbF as long as all labeled spin have 
reached the microvasculature in the imaging volume before the start of the readout (118, 119). 
Disadvantages of CASl are the difficult implementation of the continuous rF pulse on modern 
rF amplifiers and the relatively high specific absorption rate (SAr) of the sequence. 
Pseudo or pulsed CASl (PCASl) was recently proposed to reduce the demands on the rF 
amplifier and to lower the SAr while keeping the advantages of CASl (120-122). PCASl splits the 
continuous rF pulse of CASl into a train of short, slice selective rF pulses that gradually invert 
the spins of the water protons when combined with a small net gradient along the artery. As 
control scan, the amplitude of the odd pulses can be inverted or the net gradient can be nulled. 
It has been shown that the labeling efficiency of PCASl can be higher than the amplitude-
modulated CASl implementation, although the sequence is sensitive to off-resonance effects 
and the efficiency depends on the arterial velocity (120, 122).
Pulsed ASL
the labeling approach in pulsed ASl is fundamentally different from the CASl approach: 
instead of a temporal long but spatially confined labeling pulse, a short labeling pulse is 
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employed over a large region. Although the labeling period is short, in the order of 10-15 msec, 
still a large amount of spins can be labeled, since a much larger part of the brain-feeding vas-
culature is labeled. Many different approaches have been proposed for PASl, although in the 
end all implementations create a situation in which spins proximal to brain vasculature have an 
opposite magnetization during labeling compared to the control situation (123-133), see also 
the overview in (134). three of the best-known PASl sequences are flow-sensitive alternating 
inversion recovery (FAIr), signal targeting with alternating radiofrequency (StAr) and transfer 
insensitive labeling technique (tIlt) (see figure 8). FAIr employs a slice-selective inversion of 
the imaging slices as label condition and a non-selective inversion pulse in the control situa-
tion. StAr and tIlt are both based on a slice selective inversion below the imaging slices, where 
StAr employs no rF-pulses for the control image and tIlt uses a +90 and -90 pulse as control. 
Figure 8: Schematic pulse diagrams for different pulsed ASl sequences indicating the labeling slab in 
yellow, saturation slab in red and read-out slices in white. Figure a shows the diagram for the FAIr sequence, 
figure b shows the pulse diagram for the StAr sequence and figure c shows the pulse diagram for the tIlt 






Figure 9: Whole brain perfusion imaging at a resolution of 3x3 mm2 acquired in a total scan time of 4m10s. 
Acquisition is based on pseudo-continuous ASl at 3 tesla with 1650 msec label duration, 1525 msec delay, 
background suppression and a multi-slice single-shot EPI readout module. 
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Advantages of PASl are the high labeling efficiency and the lower SAr due to the short 
rF-pulses. Disadvantages are the potentially lower SNr of the CbF-images and difficulties in 
quantification, because labeling is performed spatially, thereby incorporating a dependency 
on the layout of the arterial tree. 
Velocity selective ASL
Whereas both CASl and PASl differentiate flowing arterial blood from static tissue signal by 
spatially limiting the labeling to the region below the imaging slice, velocity selective ASl dif-
ferentiates flowing from stationary spins by employing flow encoding gradients. In the label 
condition spins that flow faster than approximately 2 cm/sec are saturated, whereas only mini-
mal flow sensitive components are used in the control condition (111). Since arterial blood flow 
is gradually slowing when flowing from the brain-feeding arteries into the microvasculature 
and venous blood is accelerating when leaving the microvasculature, this approach enables 
discrimination of arterial and venous signal. Flow encoding can be performed in the imaging 
slab thereby labeling the arterial blood much closer to the microvasculature and thus mini-
mizing transport times of the labeled spins. However, comparable to PASl it is ill-defined how 
much spins are exactly labeled, thereby making accurate quantification difficult. 
read-out approaches for Asl
In principle, any readout sequence can be used for ASl as long as the sequence is predomi-
nantly proton density weighted. However, since the combination of labeling and delay-times 
are time-consuming (at least 1.5 sec), the imaging sequence should enable to acquire all image 
data after a single (or a few) labeling periods. Single-shot EPI or fast low-angle shot (FlASH) 
readout sequences are therefore the most commonly used readout protocols (134-136). With 
the recent advances in gradients performance and the introduction of parallel imaging, it has 
become feasible to acquire whole brain perfusion images at a resolution of 3x3 mm2 within a 
total readout time of 900 msec, thereby resulting in high quality perfusion images in 4 minutes 
(see figure 9). More recently, the application of true-fast imaging with steady state precession 
(FISP) as readout module for ASl has been investigated (137-139).
traditionally, CASl has been frequently combined with spin echo EPI and PASl with gradient 
echo EPI. However, the choice of readout sequence is not depending on the kind of labeling 
module, but only on the clinical research question, e.g. lower in the brain spin echo sequences 
provide better image quality than gradient echo at the expense of slower imaging. Since 
recently, 3D single (or multishot) acquisition methods (gradient and spin echo, grASE), have 
gained much attention, for two reasons: first, 3D sequence have an inherently higher SNr 
than multi slice sequences and second, all blood flow information is acquired at exactly the 
same moment (140). this last issue avoids modulation of the blood flow information by dif-
ferent transport times for different slices and enables perfect background suppression for the 







All implementations of ASl use a subtraction to separate the signal from static tissue from 
the perfusion signal. Since cerebral blood volume is less than 5%, the perfusion signal is more 
than a factor of 20 smaller than the signal from static tissue. this implies that a few percent 
signal fluctuations of the static tissue signal are of same order of magnitude as the perfusion 
signal. Physiological noise caused by for example the respiratory cycle, can result in such signal 
fluctuations, thereby degrading the SNr of the ASl. When the relative signal contribution of 
static tissue and perfusion signal would be more comparable, the influence on the SNr of ASl 
images of such signal fluctuations would decrease considerably. this is the basis of the so-called 
background suppression: by including additional non-selective inversion pulses prior to the 
read-out module, background signal of static tissue can be nulled during acquisition (see figure 
10) (141). Although nulling of the background signal would in principle leave exclusively the 
signal of the labeled spins, nulling of all tissue components cannot be achieved and to avoid 
uncertainties in the sign of the magnetization of these residual components, a small positive 
residual signal of approximately 5-10% is aimed for. For multi-slice sequences, background sup-
pression will be optimal for the first slice, but gradual regrow of the static tissue magnetization 
will result in sub-optimal background signal for subsequent slices.
Quantification of cerebral blood flow by Asl
After subtraction of the label from the control image, an image is obtained that reflects the 
amount of labeled spins present in the tissue at the moment of imaging. Since MrI provides 
only arbitrary numbers, the values from the subtraction image should be normalized. this is 
Figure 10: background suppression using two inversion pulses. White matter (WM), gray matter (gM) and 
CSF have different longitudinal relaxation values; therefore, the gM relaxes back much faster than CSF. the 
two inversion pulses are set to specific inversion times to create low signal for both brain tissue and brain 
fluids during readout of the ASl images. the images below show the effect of the inversion pulses on a 
single slice. 
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often referred to as the M0-measurement and the different approaches to obtain this calibra-
tion factor are discussed below. Although information on the cerebral perfusion is included in 
the calibrated subtraction image, other factors affect the amount of detected labeled spins, 
like the input function (that is the amount of labeled spins), loss of label due to longitudinal 
relaxation while the spins reside in the blood and tissue compartment, loss of signal due to 
transversal relaxation, imperfect excitation pulses, etc. these different factors will be discussed 
in the following sections.
M0 measurement
Quantification of cerebral blood flow by ASl is based upon the idea to create label in brain-
feeding arteries and to monitor what brain tissue is fed by this label. therefore, the signal 
intensities in the subtraction image should be compared to the signal intensity of pure blood, 
which is the maximal signal that could be obtained if perfectly created label would fill a com-
plete voxel. the first step in quantification of ASl images is therefore to normalize the signal 
intensities of the subtraction image by M0, the signal intensity of pure blood in a proton density 
sequence. to measure M0, several approaches have been proposed, all based on measurement 
of the Mr signal intensity in reference areas, like the ventricles, the sagittal sinus, or by employ-
ing the signal intensity of the control images as a reference. Except for the sagittal sinus, all 
other approaches need correction factors to compensate for differences in proton density, 
for example between cerebral spinal fluid (CSF) and blood (142). When measuring the M0 of 
brain tissue in the control images, division by the brain-blood partition coefficient (frequently 
represented by l = M0
brain tissue/M0
blood ≈ 0.9 (143)) needs to be performed to obtain M0
blood. 
When using M0
brain tissue differences in proton density in e.g. gray and white matter or pathology 
will bias the CbF values, although on the other hand differences in coil sensitivity profiles are 
automatically compensated for. Measurements in smaller regions-of-interest like the sagittal 
sinus or the ventricles are known to introduce a considerable amount of noise in the quantifica-
tion, thereby limiting the usefulness of these calibration methods. Sub-optimal measurement 
of M0 is probably still one of the main sources of quantification errors in ASl (144).
Input function of labeled spins
As a second step in the quantification process, the temporal profile of the bolus of labeled spins 
that leave the labeling area has to be known, which is determined by the labeling efficiency and 
the temporal-spatial layout of the labeling pulses. Since almost all ASl-methods (except VSASl) 
create an inversion difference between label and control, the maximum difference between 
label and control equals two times M0 (e.g. +M 0 versus –M0). For PASl an almost perfect labeling 
efficiency can be obtained by using adiabatic inversion pulses that provide a proper inversion 
over a large area, independent of local b0 and b1 inhomogeneities (145). However, also such 
adiabatic inversion pulses do lead to some efficiency losses due to transverse relaxation. For 






dependency on the arterial flow velocity. Estimates of the labeling efficiency, frequently repre-
sented by a, have been obtained by using the single slice CASl as reference or by simulations of 
the bloch equations (116, 117, 119, 122). Finally, it has recently been proposed to use a separate 
phase contrast quantitative flow sequence in combination with an estimation of the total brain 
volume, to estimate the labeling efficiency and thereby normalizing the CbF maps (146). When 
an estimate of the labeling efficiency is obtained, the difference image is be divided by this 
factor to correct for the imperfect labeling efficiency. 
CASl and PCASl perform the labeling at a single position in the brain feeding arteries for a 
period of 1-2 sec. this implies that the input function can be considered to be a block-function 
with an amplitude of a and a temporal width equal to the labeling duration. this width will 
be equal for all labeled vessels, although a might be variable for different arteries. For PASl 
the input function is more complicated, since labeling is performed over a much larger region 
of the arterial tree (see figure 8). the temporal width of the input function when it leaves the 
upper part of the labeling slab will be determined by the length of the vessels within the label-
ing slab and the blood velocity therein. the input function will be different for different vessels 
due to these dependencies. Furthermore, spins that are labeled more proximal in the arterial 
tree will leave the labeling later and during this transport delay, some label will be lost due 
to longitudinal relaxation. the input function will therefore have an exponential decreasing 
shape. Finally, the slice profile of the inversion pulses will modulate the shape of the input 
function. this can be especially important for the most proximally labeled spins, where the slice 
profile can be affected by the coil transmit profile (147, 148). Especially due to the uncertainties 
in the temporal width of the input function in PASl, quantification becomes challenging. to 
circumvent this issue, three different solutions have been proposed:
1. Wong and co-workers have proposed to cut off the input function by means of a saturation 
pulse at the labeling location shortly (approximately 800 msec) after the inversion pulse 
(125). When not all inverted spins have left the labeling slab, this implies that the width of 
the input function has been fixed to the same duration (e.g. 800 msec). However, the width 
of the input function would still be undetermined when the saturation pulse is played out 
too late, e.g. all labeled spins of a certain artery have already left the labeling slab. A correct 
choice of the timing of the saturation pulse is therefore essential: when chosen too short, 
only very little spins have been labeled, whereas a too late applied saturation pulse will 
no longer fix the width of the label bolus. this approach is named QUIPSS-II (quantitative 
imaging of perfusion using a single subtraction) and can be combined with most PASl 
approaches. When the saturation pulse is replaced by a train of saturation pulses with a 
smaller slice thickness, the approach is dubbed Q2tIPS (149).
2. Instead of influencing the shape of the input function, the width can also be estimated 
by monitoring the signal evolution over time in the brain tissue. In this approach, images 
are not acquired at a single delay time as is usually performed with ASl, but a series of 
images with different delay are acquired (118, 131, 150). In such an approach images will 
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be acquired directly (100 msec) after labeling until most signal is lost (approximately 3000 
msec after labeling) at a 150-300 msec interval. Modeling of the signal-time curves results 
indirectly in an estimate of the width of the input function.
3. Finally, it is possible to incorporate the measurement of the shape of the input function 
into the ASl sequence (151, 152). this shape can be obtained by subtracting an ASl image 
with vascular crushing (tissue signal) from an ASl image without crushing of fast flowing 
spins (tissue plus arterial signal). Since this approach needs to acquire images with and 
without vascular crushing, the sequence will last longer than conventional approaches. 
After obtaining the correct shape of the input function, this knowledge is incorporated into 
the analysis, thereby enabling an improved quantification of the cerebral blood flow.
Transport of the label towards the brain tissue
After leaving the labeling slab, the labeled spins will be transported to the microvasculature. 
these transport times can be different for different brain regions and may especially vary in 
patients with vascular occlusive disease. While residing in blood, the label as encoded in the 
longitudinal magnetization will decay due to longitudinal relaxation. When the transport time 
is longer than the delay in the sequence not all labeled spins will have arrived in the brain tissue 
when imaging, leading to an underestimation of the perfusion. Errors due to prolonged transit 
times are especially prominent in patients with large vessel disease and multi inversion time (tI) 
approaches have been used to correct for this.
When the capillaries are reached, the label will start to cross the blood-brain barrier and 
exchange with the brain tissue (109). Finally, label will also leave the tissue into the venous 
compartment (see figure 11). While the label resides in the brain tissue, it will no longer decay 
with the t1 of blood, but with the t1 of tissue. the fact that decay of label differs in which 
Figure 11: Schematic overview of labeled water protons that will leave the microvasculature and will return 






compartment the label resides complicates quantification, but fortunately the longitudinal 
relaxation times of blood and tissue are comparable and most commonly a single t1 is assumed. 
However, several researchers have investigated how this assumption affects quantification 
(106, 107, 109). From these studies, it can be concluded that the error made by this so-called 
single compartment assumption are smaller for PASl than for CASl and more prominent for 
white than gray matter for low perfusion values. 
Transverse decay of signal
Except for spiral readout approaches, all imaging modules employed in ASl result in t2 or t2
* 
decay of the signal after the excitation pulse (153). Whereas most researchers will assume a 
single reference value for t2
* and employ a correction factor when converting the signal 
intensities to CbF-values, this assumption might breakdown regionally, in pathology, or when 
monitoring CbF changes upon brain activation. Especially, in the frontal areas and above the 
petrous bones, magnetic field inhomogeneities result in a much shorter t2
* than in more 
homogenous brain tissue (154). this can result in an underestimation of the regional CbF by 
30%. In a preliminary study employing a dual echo readout module, we have further shown 
that t2
* changes upon activation have only marginal effects in ASl (154). this implies that the 
ASl-signal originates predominantly from the arterial side of the microvasculature, whereas 
blood oxygen level dependent (bOlD) effects are on the venous side. Dual echo ASl sequences 
can therefore be used to monitor simultaneously cerebral blood flow changes (first, short tE) 
and bOlD (second, long tE) (155, 156).
Taking it all together: the Buxton model
buxton and co-workers were among the first to describe a model of ASl that includes most 
terms affecting ASl perfusion quantification. this model was dubbed the general kinetic 
model, but is recently better known under the name “buxton-model”. the simplest version of 
the general kinetic model consists of three functions: the input function of labeled spins at the 
tissue level (cinput), the residue function describing how long labeled water molecules will stay 
in the tissue voxel (r(t)=exp(-f·t/l)), and the magnetization relaxation function (m(t)=exp(-t/
t1)) that describes the loss of label due to longitudinal relaxation. the only difference between 
PASl and CASl is in the shape of the input function at the entrance of the tissue, reflecting the 
difference in travel times of labeled water molecules in PASl depending on the localization 
within the label slab:
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the input function at the entrance of the tissue, reflecting the difference in travel times of 
labeled water molecules in PASL depending on the localization within the label slab: 
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with t equaling the transit delay and  the fresh inflow time (PASL) or labeling duration 
(CASL or QUIPSS). This model is the basis for multi TI ASL measurements, which is 
based on fitting Eq. 16 to measured ASL difference signal at multiple delay times. 
Imaging artifacts 
B1 variations are especially eminent at medium (3 Tesla) and higher magnetic field 
strengths (7 Tesla). Any variation in B1 deposition will result in deviations from the 
perfect 90º excitation pulse and will result in a modulation of the CBF map. By acquiring 
images at multiple flip angles, this effect can be corrected for, although at the expense of 
a time penalty (152). Also, variations in receive profile of the reception coil can result in 
erroneous CBF-maps, although coil sensitivity profiles are now frequently measured and 
corrected for as part of the implementation of parallel imaging. Finally, it should be noted 
that the urge of using fast sequences can result in distortions or blurring of the CBF-
maps. By limiting the readout-time of the sequence, for example by parallel imaging, 
such distortions and blurring can be minimized. Single shot 3D sequences bare the risk of 
significant blurring in the z-direction due to T2-decay of the signal during the long 
readout.  
Flow territory imaging 
In the last decade, flow territory mapping based on ASL methods have gained much 
attention, especially since the only alternative for flow territory mapping by ASL is the 
invasive method of conventional catheter angiography with the associated mortality and 
morbidity. The principal idea of flow territory mapping, is to restrict the labeling pulses 
  [16]
with Dt equaling the transit delay and t the fresh inflow time (PASl) or labeling duration (CASl 
or QUIPSS). this model is the basis for multi tI ASl measurements, which is based on fitting Eq. 
16 to measured ASl difference sign l at multiple delay times.
Imaging artifacts
b1 variations are especially eminent at medium (3 tesla) and higher magnetic field strengths 
(7 tesla). Any variation in b1 deposition will result in deviations from the perfect 90º excitation 
pulse and will result in a modulation of the CbF map. by acquiring images at multiple flip angles, 
this effect can be corrected for, although at the expense of a time penalty (152). Also, variations 
in receive profile of the reception coil can result in erroneous CbF-maps, although coil sensitiv-
ity profiles are ow frequently measured and corr ct d f r as part of th  implement tion of 
parallel imaging. Finally, it should be noted that the urge of using fast sequences can result 
in distortions or blurring of the CbF-maps. by limiting the readout-time of the sequence, for 
example by parallel imaging, such distortions and blurring can be minimized. Single shot 3D 
sequences bare the risk of significant blurring in the z-direction due to t2-decay of the signal 
during the long readout. 
Flow territory imagi g
In the last decade, flow territory mapping based on ASl methods have gained much attention, 
especially since the only alternative for flow territory mapping by ASl is the invasive method 
of conventional catheter angiography with the associated mortality and morbidity. the princi-
pal idea of flow territory mapping, is to restrict the labeling pulses to a single artery, thereby 
exclusively imaging the tissue supplied by this artery. Several different approaches have been 
proposed to limit the labeling to a single artery, like:
1. Separate labeling coil
 by positioning a small labeling coil on top of a vessel, the rF is limited to this vessel and 
the labeling will therefore also be restricted to this artery (157-159). this method is easily 
implemented, although it relies on separate hardware and yield only limited flexibility in 
which arteries can be labeled during a single session.






 Whereas traditionally ASl labeling planes are always in the transverse orientation, this 
labeling plane can also be tilted and positioned in such a way that only a single vessel 
is labeled (129, 160) . After tilting the labeling plane, the plane could intersect with the 
imaging slices and therefore it is essential that saturation pulses before and after labeling 
are included in the sequence to circumvent artifacts in the subtraction images. Secondly, it 
can be challenging to plan this tilted plane in such a way that only a single vessel is labeled. 
this method is therefore mainly used to differentiate between left and right internal carotid 
artery flow territories and posterior circulation.
3. For CASl and PCASl the gradient in the flow direction of vessel can be rotated during 
labeling to limit labeling to a single spot in the labeling plane (161). this approach enables 
superselective labeling of the smallest vessels. For CASl this method can result in artifacts 
in the imaging slices, but for PCASl this issue does not occur, since the rotating gradients 
are played in between the rF-pulses (162).
4. Wong and co-workers have developed a plannings-free method for flow territory mapping, 
that is based on the acquisition of four or more images with different labeling distribution 
over the different brain feeding arteries (see figure 12) (163-166). the first two images are 
the control and label images of a normal ASl experiments and a subtraction of these two 
images results in a normal non-selective perfusion map. In the following images the label-
ing efficiency is varied in the right-left or anterior-posterior (or any other) direction (see 
figure 12b and c). Subtraction of these images from the control image and normalizing 
with respect to non-selective perfusion map, results in a relative labeling efficiency map. 
based on clustering methods regions are identified that have comparable relative labeling 
efficiency independent of how the labeling efficiency of the arteries is changed. 
ConCluding remArks And Future perspeCtive 
both DSC-MrI and ASl are becoming important tools in the radiological clinic and both 
perfusion methods are considered essential for many different clinical indications, like brain 
tumors and acute stroke. Furthermore, ASl is starting to play an important role in psychological 
research since it enables positron emission tomography (PEt)-like studies of the cognitive state 
of subjects. both methods will continue to benefit from hardware improvements, like tech-
niques for parallel transmission and reception, improved coil design and higher magnetic field 
strengths. these developments will continue to provide improved new insights in the cerebral 
hemodynamics. In the coming years quantification of cerebral perfusion will remain the most 
challenging part of both MrI techniques and more research is definitely needed to obtain 
absolute quantification of CbF and CbV. Finally, it is anticipated that reactivity measurements, 
that is relative blood flow changes upon a vasodilatory challenge such as acetazolamide or 
breath-holding will improve the hemodynamic characterization of neurodegenerative disease.
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Figure 12: Overview of plannings-free flow territory mapping. A normal ASl experiment (see a) consisting 
of a non-selective label (red) and a control (white) image, results in a global perfusion image (right pane 
of a). Subtraction of an image in which the labeling was modulated in the right-left direction (figure b) or 
anterior-posterior direction (figure c) from the control image results in vessel specific perfusion images. 
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Chapter 3: Optimal location for arterial input 
function measurements near the middle 
cerebral artery in first pass perfusion MrI
Egbert JW bleeker, Mark A van buchem, Matthias JP van Osch
ABstrACt
One of the main difficulties in obtaining quantitative perfusion values from dynamic susceptibil-
ity contrast-magnetic resonance imaging is a correct arterial input function (AIF) measurement, 
as partial volume effects can lead to an erroneous shape and amplitude of the AIF. Cerebral 
blood flow and volume scale linearly with the area under the AIF, but shape changes of the AIF 
can lead to large nonlinear errors. Current manual and automated AIF selection procedures 
do not guarantee the exclusion of partial volume effects from AIF measurements. this study 
uses a numerical model, validated by phantom experiments, for predicting the optimal loca-
tion for AIF measurements in the vicinity of the middle cerebral artery (MCA). three different 
sequences were investigated and evaluated on a voxel-by-voxel basis by comparison with the 
ground truth. Subsequently, the predictions were evaluated in an in vivo example. the findings 
are fourfold: AIF measurements should be performed in voxels completely outside the artery, 
here a linear relation should be assumed between Dr2
* and the concentration contrast agent, 
the exact optimal location differs per acquisition type, and voxels including a small MCA yield 
also correct AIF measurements for segmented EPI when a short echo time was used.







Perfusion-weighted imaging can provide important physiological parameters related to the 
cerebral microvasculature, parameters such as cerebral blood flow (CbF), cerebral blood vol-
ume (CbV), mean transit time (Mtt), and time of arrival (tA) (1, 2). these parameters enable 
the identification and characterization of pathological areas in brain tissue. Perfusion-weighted 
imaging can identify tissue at risk of infarction in stroke patients, facilitate grading and delinea-
tion of brain tumors, and can provide important hemodynamic information in, for example, 
Alzheimer’s disease, obstructive cerebrovascular disease and migraine (3-6).
Dynamic susceptibility contrast-magnetic resonance imaging (DSC-MrI) measures brain 
perfusion by monitoring dynamically the first passage of a bolus of contrast agent through 
the microvasculature of the brain tissue. because the concentration of the contrast agent pass-
ing through the tissue microvasculature increases, the transverse relaxation time decreases 
leading to decreased signal magnitude. An arterial input function (AIF), which describes the 
concentration of the contrast agent passing through an artery feeding the brain, is required for 
deconvolution to calculate the perfusion parameters CbV (area-under-the-curve of the impulse 
response) and CbF (the peak-height of the impulse response). the Mtt is the ratio of CbV over 
CbF. An erroneous measurement of the area under the AIF, would not affect the quantitative 
value of the Mtt, because both CbV and CbF scale equally with the area under the AIF. there-
fore, it is sufficient to measure the correct shape of the AIF for Mtt quantification. However, 
for correct quantification of CbF and CbV it is necessary to measure the AIF with both a correct 
shape and a correct peak-height (1, 7).
Although both the magnitude and phase of the DSC-MrI signal can be used for AIF measure-
ments (8, 9), the magnitude of the Mr signal is used most often. Voxels for the AIF are normally 
selected either manually (6) or automatically (10, 11). Most automatic and manual AIF selection 
methods are based on criteria, such as an early rise, small width, high peak-height and large 
area-under-the-curve. It is known that partial volume effects can affect both the shape and 
peak-height of the measured AIF, thereby leading to large quantification errors of CbF and CbV 
(12). because these effects can also lead to more narrow curves or a higher maximum value, 
most selection procedures do not prohibit the inclusion of voxels that exhibit partial volume 
effects. For parallel-orientated arteries, such as the internal carotid artery, partial volume errors 
(PVEs) can be corrected (13), but in normal clinical practice the AIF is measured in the vicinity of 
the middle cerebral artery (MCA) because of its size and location close to brain tissue. because 
the MCA is oriented approximately perpendicular to the main magnetic field, correction for 
PVEs is not possible, and distortions of the AIF can occur. A good theoretical basis for the proper 
criteria to select the optimum location to measure the AIF (e.g. exhibiting the correct shape and 
height) in the vicinity of the MCA is currently lacking.
the goal of this study is to provide a theoretical basis for AIF selection close to the MCA, 
using a numerical model validated using phantom experiments. the optimal location for 
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selecting the AIF in the vicinity of the MCA was identified for several different types of gradient 
echo sequences that are commonly used in DSC-MrI. Furthermore, the findings were tested in 
a clinical example of a patient who was scanned twice with different DSC-MrI sequences.
mAteriAls And methods
the aim of this study is to find the optimal location for AIF selection in the vicinity of the MCA. 
For this purpose, a numerical model was developed that included both image formation and 
the dependence of the relaxation time and magnetic field distribution on the presence of con-
trast agent. three commonly used DSC-MrI sequences, single shot echo planar imaging (EPI), 
dual echo-segmented EPI and PrEStO (Principles of echo-shifting with a train of observations) 
(14), were implemented in the numerical model and the model was validated by phantom 
experiments. 
After validation using parameters representative for the experimental setup, the model was 
adjusted to resemble in vivo AIF measurements more closely: the passage of contrast agent 
through brain tissue surrounding the artery was included and relaxation rates and values were 
changed to in vivo values. this extended model will be referred to as the advanced model. the 
diameter of the vessel was varied in the advanced model to study the influence of the size of 
the MCA on the AIF measurements.
numerical model
the MCA in the numerical model was modeled as an infinite cylinder perpendicular to the main 
magnetic field and parallel to the left and right axis. the reported diameter of the MCA varies 
from 2 to 4 mm (15, 16) and the average flow in the MCA is 2.6 ml/sec (17). For reasons of 
symmetry, only the plane whose normal is parallel to the vessel axis needs to be considered 
in the simulations. All results are therefore presented in a sagittal view, although the model 
represents acquisition of transverse slices.
Contrast agent properties
gadolinium-based contrast agents (e.g. gd-DtPA) affect magnetic susceptibility (χ=dχ [Gd],, 
with dχ = 0.3209∙10-3 [l mol-1] (13)), as well as longitudinal and transverse relaxation times. the 
dependence of the transverse relaxation rate on the concentration of gd-DtPA is different 
for aqueous solutions, as used in the phantom experiments; and for whole blood, where the 
presence of red blood cells causes a quadratic relation between transverse relaxation rate and 
contrast agent concentration (18). therefore, a linear relation between the transverse relaxation 
rate and concentration gd-DtPA was used for comparisons with phantom experiments (5.3 and 
5.2 l/mmol/sec at 1.5 t and 3 t respectively (19)). For the advanced model a quadratic relation 






gd-DtPA was used (linear term 7.62 l/mmol/sec quadratic term 0.57 l2/mmol2/sec at 1.5 t (13)). 
When modeling the passage of contrast agent through the microvasculature of tissue a linear 
relation was used (44 and 87 l/mmol/sec at 1.5 t and 3 t (20)). the effect of the contrast agent 
on the longitudinal relaxation was only taken into account for the tissue passage assuming 
a single longitudinal relaxation rate for the tissue and microvascular components combined 
and assuming an intact blood-brain barrier (4.3 and 3.3 l/mmol/sec at 1.5 t and 3 t (19, 21)). t1 
effects inside the MCA were assumed negligible, because these will be minimal for relatively 
long repetition times because of inflow of fresh spins (22).
Magnetic field changes
An intravascular susceptibility change in a vessel perpendicular to the main magnetic field 
results in local field changes in and around the vessel. these local field changes were calculated 
using Maxwell equations taking into account the sphere of lorenz (23):
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with Bint the magnetic field change inside the vessel, Bext the magnetic field change 
outside the vessel, B0 the main magnetic field strength, Δχ the susceptibility difference 
between the intra- and extravascular compartment, a the radius of the vessel, ρ, θ, and φ 
spherical coordinates where ρ equals the distance from the grid point to the vessel center 
and θ the angle between the vessel and the main magnetic field B0 (assumed to be 90º for 
the MCA). In the absence of contrast agent, it was assumed that there is no susceptibility 
difference between the interior and exterior of the MCA. 
Image formation 
Local magnetic field changes lead to distortions in MR images, especially when using 
fast imaging techniques such as EPI. Such image distortions were included in the model 
by simulating the image formation process. Frequency encoding was assumed parallel to 
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with bint the magnetic field change inside the vessel, bext the magnetic field change outside the 
vessel, b0 th main magnetic field strength, Δχ the susceptibility difference between he intra- 
and extravascular compartment,  the radius of the v ssel, ρ, θ, nd φ spherical coordinates 
where ρ equals the distance from the grid point to the vessel center and θ the angle between 
the vessel and the main magnetic field b0 (assumed to be 90º for the MCA). In the absence of 
contrast agent, it was assumed that there is no susceptibility difference between the interior 
and exterior of the MCA.
Image formation
local magnetic field changes lead to distortions in Mr images, especially when using fast imag-
ing techniques such as EPI. Such imag  ist rtions were included in the mod l by simulating 
the image formation process. Frequency encoding was assumed parallel to the MCA. Imaging 
for EPI and segmented EPI was modeled using the expression:
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the longitudinal relaxation (1.5 T: 0.95, 1.2 sec and 1.4 sec for tissue, MnCl2 doped water 
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with M0 the initial longitudinal magnetization, α the flip angle, tr the repetition time, t1 the 
longitudinal relaxation (1.5 t: 0.95, 1.2 sec and 1.4 sec for tissue, MnCl2 doped water and blood 
respectively (24)) and 3.0 t: 1.1 sec and 1.7 sec for tissue and blood (25, 26), tm the time from 
excitation to read-out of each k-line (the time between each k-line (Δtm) is 0.74 and 0.97 msec, 
for EPI and segmented EPI, respectively), t2
* is 0.1 sec at 1.5 t for tissue (24), MnCl2 doped 
water and blood and approximately 0.07 sec at 3 t for tissue, km the m
th k-line, x the position 
within the slice and γ the gyromagnetic ratio. Equation 3 is similar to that of Duhamel et al. (27). 
Imaging parameters were taken from local perfusion protocols and were equal to the imaging 
parameters of the phantom experiments. because PrEStO is commonly used as 3D sequence, 
Equation 3 is extended to two-phase encoding directions,
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Tm the time from excitation to read-out of each k-line (the time between each k-line 
(ΔTm) is 0.74 and 0.97 msec, for EPI and segm nted EPI, resp ctively), T2* is 0.1 sec at 
1.5 T for tissue (24), MnCl2 doped water and blood and approximately 0.07 sec at 3 T for 
tissue, km the mth k-line, x the position within the slice and γ the gyromagnetic ratio. 
Equation (3) is similar to that of Duhamel et al. (27). Imaging parameters were taken 
from local perfusion protocols and were equal to the imaging parameters of the phantom 
experiments. Because PRESTO is commonly used as 3D sequence, Equation 3 is 
extended to two-phase encoding directions, 
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with ΔTm 0.73 msec. PRESTO uses large gradients for echo-shifting that crush the 
intravascular signal, and therefore the intravascular signal was set to zero.  
The images from EPI and segmented EPI were reconstructed using 1D inverse discrete 
Fourier transformation; and those from PRESTO using 2D inverse discrete Fourier 
transformation. Before inverse Fourier transformation, windowing, using a Tukey 
window, and zerofilling was performed.  
Implementation
The model was implemented in MATLAB (R2006b, Natick, MA, USA) and evaluated on 
a spatial grid of 250 μm except for PRESTO for which a grid of 500 μm was used 
because of computational limitations. To study the influence of the location of the vessel 
with respect to the simulated voxels, the positions of the voxels was shifted in steps of 
500 μm with respect to the vessel center in both directions perpendicular to the vessel. 
The simulated voxels have the same dimensions as the voxels of commonly used MR 
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voxels, the positions of the voxels was shifted in steps of 500 μm with respect to the vessel 
center in both directions perpendicular to the vessel. the simulated voxels have the same 
dimensions as the voxels of commonly used Mr sequences, but the results of these simulations 
are depicted for each shift (e.g. at a 500 μm resolution). the shifts in the slice direction for EPI 
and segmented EPI were performed before calculating the local field changes. the shifts in 
the phase encoding direction were performed by adding a small phase to the signal before 
the inverse discrete Fourier transformation. For comparison with the phantom experiments, a 
linearly increasing concentration of gd-DtPA, in steps of 0.9 mmol/l, was simulated. 
the advanced model included not only an AIF-shaped passage of contrast agent through 
the MCA (28), but also the passage of contrast agent through the microvasculature of tissue 
surrounding the vessel. the tissue passage curve was created after convolving the concentra-
tion contrast agent profile of the AIF with an exponential residue function (CbF = 60 ml/100g/
min, Mtt = 4 sec, CbV = 4 ml/100g).
magnetic resonance imaging experiments
Phantom experiments
the flow-phantom consisted of a tube (4 mm internal diameter and 0.25 mm thickness) ori-
ented perpendicular to the main magnetic field. MnCl2-doped water was circulated through 
the tube at a constant velocity of 2.8 ml/sec. the tube was surrounded by the same MnCl2 
solution to create a background signal representing the tissue signal. the concentration of gd-
DtPA (Magnevist, Schering, germany) within the tube was increased in seventeen successive 
steps of 0.9 mmol/l.
All phantom experiments were performed at 1.5 t (Philips Achieva, best, the Netherlands) 
using a standard quadrature head coil. the imaging sequences had the following settings: 
single shot EPI, data matrix (MA) 96x95 zerofilled to 128x128, tE/tr 41/1500 msec, FA = 80º, 
field of view (FOV) = 230x230 mm2, 15 slices of thickness 6 mm with no interslice gap: dual 
echo-segmented EPI, MA 128x75 zerofilled to 128x128, tE1/tE2/tr 11/30/400 msec, FA = 53º, 
FOV 220x220 mm2, 8 slices of 6 mm thickness with 1 mm gap, 5 segments: PrEStO, MA 64x63 
zerofilled to 128x128, tE/tr 25/17 msec, FA = 7º, FOV 220x220 mm2, 30 slices of thickness 3.5 
mm, 90 segments.
the stack of slices was shifted in steps of 1 mm for the EPI and segmented EPI experiments 
and 0.5 mm for the PrEStO experiment in the slice direction in order to measure various loca-
tions of the vessel center inside an imaging slice.
In vivo example
two DSC-MrI scans were performed in a patient (woman, 32 years) diagnosed with Systemic 
lupus Erythematosus (13 months between the 2 Mr examinations). In vivo experiments were 
performed at 3 t (Philips Achieva, best, the Netherlands) using an 8-channel sense head coil, 
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0.1 mmol/kg-bodyweight gd-DtPA was injected at 5 ml/sec followed by a saline chaser of 25 
ml injected at the same speed. Perfusion scans were made as part of another research study. 
the imaging sequences had the following settings: first DSC-MrI scan, dual echo-segmented 
EPI: MA 96x94 zerofilled to 96x96, tE1/tE2/tr 11/31/600 msec, FA = 40º, FOV 220x220 mm
2, 
SENSE factor of 2.2, 10 slices of 6 mm thickness with 1 mm gap, EPI factor 21, 2 segments; 
second DSC-MrI scan, PrEStO: MA 64x53 zerofilled to 128x108, tE/tr 26/17 msec, FA = 5º, FOV 
224x168 mm2, SENSE factor of 2.4, 48 slices of 3.0 mm, EPI factor 21, 60 segments. the patient 
has given informed consent prior to the MrI examinations.
image analysis
Numerical model validation
For each concentration of gd-DtPA the set of transverse images that were shifted with respect 
to the vessel center were merged into a single image viewed in a sagittal orientation. Each 
pixel in this higher resolution image therefore represents a voxel with a larger volume (e.g. a 




The stack of slices was shifted in steps of 1 mm for the EPI and segmented EPI 
experiments and 0.5 mm for the PRESTO experiment in the slice direction in order to 
measure various locations of the vessel center inside an imaging slice. 
In vivo example 
Two DSC-MRI scans were performed in a patient (woman, 32 years) diagnosed with 
Systemic Lupus Erythematosus (13 months between the 2 MR examinations). In vivo 
experiments were performed at 3 T (Philips Achieva, Best, the Netherlands) using an 8-
channel sense head coil, 0.1 mmol/kg-bodyweight Gd-DTPA was injected at 5 ml/sec 
followed by a saline chaser of 25 ml injected at the same speed. Perfusion scans were 
ade as part of another research s u y. The imaging sequences had the f llowing 
settings: first DSC-MRI scan, dual echo-segmented EPI: MA 96x94 zerofilled to 96x96, 
TE1/TE2/TR 11/31/600 msec, FA = 40º, FOV 220x220 mm2, SENSE factor of 2.2, 10 
slices of 6 mm thickness with 1 mm gap, EPI factor 21, 2 segments; second DSC-MRI 
scan, PRESTO: MA 64x53 zerofilled to 128x108, TE/TR 26/17 msec, FA = 5º, FOV 
224x168 mm2, SENSE factor of 2.4, 48 slices of 3.0 mm, EPI factor 21, 60 segments. 
The patient has given inf med consent prior to the MRI examinations. 
Image analysis 
Numerical model validation 
For ea h conce tration of Gd-DTPA the set of transverse imag s that were shifted with 
respect to the vessel center were merged into a single image viewed in a sagittal 
orientation. Each pixel in this higher resolution image therefore represents a voxel with a 
larger volume (e.g. a typical volume encountered in clinical DSC-MRI scans) than 
depicted in the image. The ΔR2* was calculated using: 
   0*2 ln1 SSTER 
with S the signal magnitude, S0 the signal magnitude without contrast agent and TE the 
echo time. 
The model was validated using the phantom measurements by visually comparing the 
distorted pattern of signal decrease in the magnitude images for all concentrations; and 
using the Pearson’s correlation coefficient, a measure of correct shape, and relative signal 
 [5]
with S the signal magnitude, S0 the signal magnitude without contrast agent and tE the echo 
time.
the model was validated using the phantom measurements by visually comparing the dis-
torted pattern of signal decrease in the magnitude i ages for all concentrations; and using the 
Pearson’s corr lation coeffi ient,  measure of correct shape, and relative signal strength (rSS), 
a measure of amplitude, for quantitative comparison. the rSS was defined as the regressing 
coefficient (in percent) between the measured Δr2
* and the expected Δr2
* (the concentration 
of the contrast agent multiplied by the relaxivity (5.3 l/mmol/sec)). the correlation was calcu-
lated using a Pearson’s correlation method between the measured Δr2
* and the expected Δr2
*.
Advanced model
the advanced numerical model is used for predicting the optimal location for AIF selection 
near the MCA and is adjusted to closely resemble in vivo AIF measurements. the advanced 
model included the quadratic relation for relaxivity in the vessel and the contrast agent passage 
through tissue surrounding the MCA. the model was evaluated by the Pearson’s correlation 
and the rSS; both quality measures were calculated from the beginning of the first pass of the 
AIF to the end of the recirculation. 
because the final outcome of AIF measurements will also depend on the applied postpro-






uses a previously published calibration curve of contrast agent in whole human blood that 
shows a quadratic relation of Δr2
* as a function of the concentration contrast agent (13). this 
approach should therefore be valid for measurements inside the vessel. the second approach 
employs a linear relation between Δr2
* and concentration contrast agent, which is assumed to 
be valid for measurements outside the vessel. the final approach employs also a linear assump-
tion, combined with subtraction of the tissue curve from the measured AIF (29). this method 
should correct the input function measurement for contamination with the passage of contrast 
agent through tissue surrounding the artery. the model was analyzed both in the absence of 
noise as well as by including noise (SNr of 25 defined in terms of gaussian noise on real and 
imaginary part of the precontrast signal intensity). A single simulation (PrEStO, Ø 4 mm) was 
performed using 3.0 t literature values and analyzed for both out-vessel both with and without 
tissue curve subtraction. to visualize the optimal locations for AIF measurements near the MCA, 
the correlation was depicted for all voxels with a rSS larger than 25% and a correlation value 
higher than 0.97. 
In vivo evaluation
the location of the M1 segment of MCA in the patient was determined in the t1-weighted image. 
the coordinates were transformed to the PrEStO and dual echo-segmented EPI coordinates. 
the normalized Δr2
* profiles of the voxels in and around the MCA are presented without further 
postprocessing. based on the findings of the simulation study, the most optimal locations were 
highlighted.
results
numerical model validation by phantom experiments
the numerical model was validated using phantom experiments by comparing a sagittal view 
of the transverse acquired magnitude images at different concentrations of contrast agent (0 
to 15 mmol/l gd-DtPA) and using the Pearson’s correlation and rSS for quantitative validation 
(Figures 1 and 2). the images of the model show good agreement with the images from the 
phantom experiments. 
the acquisition voxel sizes of the simulation and phantom experiments are the same and 
similar to the voxel size of normal in vivo DSC-MrI protocol, although the pixel sizes in the 
images are different due to different shifting steps (0.5 mm in both directions in the simula-
tions, and 1.0 mm (0.5 mm for PrEStO) in the slice direction in the phantom experiments). It 
was concluded that the simulations provide a correct representation of the Mr signal processes 
around a vessel during the passage of contrast agent.
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Figure 2: the relative signal strength (rSS in percent, first and third column) and correlation (second and 
fourth column) for the phantom experiments (first two columns) and the simulations (last two columns), 
with the vessel depicted as a white circle. From top to bottom: single shot EPI, segmented EPI (tE2) and 
PrEStO.
Figure 1: Merged magnitude images (sagittal-view) of the phantom experiments and the simulations for 
single shot EPI (left), segmented EPI (tE2; middle) and PrEStO (right) at three concentrations of gd-DtPA 
(4.4 mM, 8.8 mM and 13.2 mM). the phantom images are formed by merging several multi-slice acquisitions 
(acquired in a transverse plane) that are shifted in the slice selection direction. therefore, each pixel in this 
image represents a larger acquisition voxel. the phase encoding is oriented anterior to posterior. In the 
phantom, the stack of slices was shifted in steps of 1 mm for both EPI acquisitions and in steps of 0.5 mm 
for the PrEStO experiment. In the simulation, the stack of slices was shifted for all three acquisitions in steps 







Figure 3 shows the normalized Δr2
* profiles of voxels acquired using segmented EPI (tE2) in and 
around the MCA grouped according to the correlation with respect to the ground truth. In the 
group with a correlation value between 0.7 and 0.8, peaks are observed on top of the passage 
curve that can be attributed to PVE. In this study we define a correct measurement of the shape 
of the AIF as a correlation between the measured AIF and the ground truth that is higher than 
0.99 (correlation values based on noise free simulations).
Figure 4 shows the results for PrEStO using in-vessel strategy and both out-vessel strategies. 
Independent of the used postprocessing strategy, the most optimal locations for AIF measure-
ments were always observed outside the MCA. Optimal locations were found diagonally from 
the vessel center at a distance of approximately 4 mm. Simulations were repeated, now with 
addition of gaussian noise on top of the complex signals. this resulted in a lower correlation 
with the ground truth, whereas the signal strength remained unchanged.
three diameters of the MCA were investigated with the out-vessel strategy and tissue curve 
subtraction employed for postprocessing (see figure 5). this resulted for single-shot EPI some 
feasible locations for AIF determination, but not every position of the MCA within the imaging 
slice provided voxels that passed our criterion for correct shape measurement (correlation higher 
than 0.99 with the ground truth). For large and medium-sized vessels, the optimal location is 
found in an area 3.5 to 6 mm posterior to the vessel center. Segmented EPI yields larger regions 
suitable for AIF selection. AIF selection using segmented EPI is less sensitive to the exact location 
of the vessel center within the imaging slice (see figure 5, 2nd and 3rd columns). Optimal locations 
are found all around the vessel (note that voxels located above the vessel are actually located in a 
slice superior to the slice through which the MCA runs). For the first echo time optimal locations 
are located relatively close to the vessel, but still outside the vessel, except for a small-sized MCA 
(Ø 2 mm), in this special case optimal locations are within a circle approximately 4 mm from the 
Figure 3: the measured AIF profiles of all simulated voxels for segmented EPI (tE2) were normalized 
and grouped according to the correlation value with respect to the ground truth (between 0.7 and 0.8 
(1st graph), between 0.8 and 0.9 (2nd graph), between 0.9 and 0.95 (3rd graph), between 0.95 and 0.99 (4th 
graph) and between 0.99 and 1 (5th graph)). Upper row shows curves without tissue subtraction; lower row 
shows curves with tissue subtraction.
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vessel center including voxels that are primarily sensitive to the intravascular signal. 
For the longer echo time, optimal locations are found at a larger distance from the vessel 
center. Also for PrEStO, the optimal locations for AIF selection are found outside the vessel in 
the surrounding tissue, but here the optimal locations are found on the diagonal axis from the 
vessel center (see figure 5, 4th column). Figure 6 shows the results of the simulations performed 
using 3.0 t literature values for PrEStO image formation. the results are comparable to the 
findings of the 1.5 t simulations (compare to Figure 4).
Figure 4: the relative signal strength (rSS in percent; left column), the correlation (middle column) and the 
rSS-thresholded correlation image (correlation coefficient larger than 0.97 and rSS larger than 25%; right 
column) for PrEStO at 1.5 tesla using the in-vessel strategy (first row), out-vessel strategy (second row), 
out-vessel strategy with tissue subtraction (third row) and with noise included in the simulations (SNr=25 







Figure 7 shows the Δr2
* bolus-passage measured in the voxels close to the MCA (middle profile 
is encompassing the vessel). the thicker lines are the predicted optimal locations from the 
simulations for AIF selection. Notice, that signs of PVEs, like peaks on the Δr2
*-curves are almost 
absent in the selected curves. For the PrEStO sequence it is obvious that voxels closest to the 
vessel, show most artifacts. Voxels located superior or inferior from the MCA show still reason-
able signal strength without erroneous peaks, although the SNr is lower than for voxels in and 
next to the MCA. the AIF measurements obtained from segmented EPI tE1 (middle panel) show 
for a large region in and around the MCA curves with little to no shape errors. this is in good 
agreement with the simulations. However, the signal strength of the curves is higher outside 
the MCA than predicted from the simulations. For segmented EPI tE2 (lower panel) the signal 
strength in the voxel encompassing the MCA is lower than the signal strength in the voxels 
located anterior or posterior from the MCA as expected from the simulations. the shape in the 
voxels directly anterior or posterior from the MCA is also free of peaks or signs of PVEs. this is 
also in agreement with the simulations.
Figure 5: the rSS-thresholded correlation image (correlation coefficient larger than 0.97 and a voxel with 
greater than 25% rSS) for single shot EPI (1st column), segmented EPI (tE1 and tE2, 2
nd and 3rd column 
respectively) and PrEStO (4th column) using the optimal strategy for measurements outside the vessel. 
Different rows represent different vessel sizes, diameters (respectively 4 mm, 3 mm and 2 mm).
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disCussion And ConClusions
the main findings of this study are fourfold. First, AIF measurements near the MCA are best 
performed in voxels located completely outside the artery, within tissue surrounding the MCA. 
Second, a linear relation between Δr2
* and the concentration of gd-DtPA is the best assump-
tion when measuring the AIF in voxels that are not completely located inside the MCA. third, 
the position with respect to the MCA that yields a correct AIF measurement depends on the 
particular imaging sequence, echo time and diameter of the MCA. Finally, AIF measurements 
can also be performed in voxels that encompass the MCA for a specific combination of small 
MCA and short echo time (tE1) when using a segmented EPI readout. 
In this study, we focused on finding the optimal location for AIF selection near the MCA 
based on theoretical modeling and evaluated this finding in an in vivo example. Using the MCA 
for AIF selection has several advantages; the MCA is almost always located inside the imaging 
Figure 6: the relative signal strength (rSS in percent; left column), the correlation (middle column) and 
the rSS-thresholded correlation image (correlation coefficient larger than 0.97 and rSS larger than 25%; 
right column) for PrEStO at 3.0 tesla using out-vessel strategy (first row), out-vessel strategy with tissue 
subtraction (second row) and with noise included in the simulations (SNr=25 using out-vessel strategy 
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volume, whereas AIF measurements in the ICA require the acquisition of an additional slice; 
second, the angle between the vessel axis and the main magnetic field is approximately 90º, 
resulting in maximal signal change in the surrounding tissue. 
this study shows that AIF measurements are best performed in tissue near the MCA rather 
than in voxels that partly encompass the artery. this finding can be counterintuitive because 
in the brain, the contrast agent resides intravascular and therefore one may be tempted to 
assume that voxels within an artery provide the best opportunity for measuring the AIF. How-
ever, the presence of contrast agent within the MCA causes local magnetic field changes inside 
and outside the vessel and thus also affects the gradient echo Mr-signal outside the vessel. 
Furthermore, AIF measurements encompassing or partly in the MCA are hampered by PVEs. 
When the bolus contrast agent passes through the artery and alters the relaxivity, this leads 
to a smaller transverse relaxation rate for the intravascular compartment and the phase of this 
compartment will change because of altered susceptibility. the presence of contrast agent 
within the MCA will also lead to magnetic field changes in the surrounding tissue. Averaging 
over the extravascular compartment will therefore lead to dephasing and a general shift in 
phase of the signal will occur. 
When the total signal of partial volume voxels is formed, the contributions of the two 
compartments can add either constructively or destructively, depending on the relative phase 
difference between the two compartments. Destructive addition of the intra- and extravascular 
signal can lead to almost zero total signal, resulting in a high value of Δr2
*, showing as a sharp 
peak in the Δr2
* curves. Such peaks in the Δr2
* profiles can be observed in the simulation as 
well as in the in vivo AIF measurements (Figures 3 and 7). Figure 3 also shows that PVEs can 
lead to smaller widths or higher peaks in the Δr2
* profile, illustrating that AIF selection rules 
based on a small width or maximum height of the Δr2
* profile do not always exclude voxels that 
exhibit partial volume effects. 
the effect of errors in shape of the measured AIF on CbF and the influence of the deconvolu-
tion technique has been studied by Calamante et al. (30). It was concluded that the influence of 
erroneous AIF measurement on the CbF was highly dependent on the type of shape changes 
of the AIF, e.g. a too steep rise of the AIF resulted in the highest errors in CbF (30). the advanced 
model simulations show correct measurements of shape of the AIF near the MCA as evidenced 
by high correlation values with the ground truth. It is difficult to relate the correlation with the 
expected errors in CbF measurements, since these will depend strongly on the used deconvo-
lution technique (1, 2, 31), especially as each deconvolution techniques employs a different 
approach to suppress noise. to avoid the influence of a particular deconvolution technique on 
our results, it was chosen to use a quality parameter of the shape of the AIF instead. A correct 
shape of the AIF will yield correct relative CbF and CbV values, and correct absolute Mtt values, 
because CbV and CbF scale equally with the amplitude of the AIF. When using an additional 
method for quantitative CbV measurements (e.g. bookend-Method (32)) or quantitative CbF 






We used three different strategies for the conversion of Mr-signal changes to the concentra-
tion of gd-DtPA. In the first strategy a quadratic relation between Δr2
* and the concentration 
of contrast agent was used, which is in correspondence with the relation as measured in whole 
blood (13) (a strategy optimized for intravascular AIF measurements). the second strategy is 
optimized for AIF measurements in tissue in the direct vicinity of the artery. traditionally, a lin-
ear relaxivity constant is used for AIF measurements outside the artery and this approach was 
therefore adopted for the second strategy. However, voxels located outside the MCA are not 
only subjected to signal changes caused by the presence of contrast agent within the MCA, but 
experience also signal changes due to the passage of contrast agent through the microvascula-
ture of the tissue. therefore a third strategy was employed using a previously proposed method 
to reduce the effect of the tissue passage (29). this approach is based on the subtraction of the 
Δr2
* curve of pure gray matter from the measured AIF. When our simulations were performed 
without noise, tissue subtraction resulted in almost complete elimination of the tissue passage 
curve from the measured AIF (Figure 3). However, for the simulation that included noise, tissue 
subtraction did not improve the shape and induce sometimes even undesired errors in shape. 
It can therefore be concluded that the out-vessel strategy without tissue curve subtraction 
provided the best opportunities for a correct AIF measurement, but improved tissue subtrac-
tion approach does certainly provide opportunities for even better AIF measurements. the 
simulations also show that a linear relation between Dr2
* and the concentration contrast agent 
is indeed the best assumption when converting Mr signal changes into concentration-time 
curves for AIF measurements outside the MCA. 
the exact location for optimal AIF measurement in the tissue surrounding the MCA differs 
for the various sequences that were studied. Voxels for AIF measurements using PrEStO should 
be selected above or beneath the vessel and posterior or anterior to the vessel. For single-
shot EPI, the optimal location is found in tissue posterior to the vessel. For certain positions of 
the vessel center within the imaging slices none of the voxels fulfilled our criteria when using 
single-shot EPI. Segmented EPI showed more feasible locations for AIF measurements. For the 
second echo time, correct locations are found both anterior and posterior to the vessel, and are 
in some cases found in the slice superior or inferior to the MCA. When using the first echo time 
the best locations are found closer to the vessel. For a relatively small MCA (Ø 2 mm), short-echo 
segmented EPI also gives correct AIF measurements for voxels partly in the MCA. 
Imaging using longer echo times causes larger signal drops both inside and outside the ves-
sel. For these longer echo times, the intravascular signal drops into the noise level for relatively 
small concentrations of contrast agent. the relative contribution of the intra- versus extra-
vascular compartments will therefore change significantly when measuring the AIF in voxels 
encompassing the MCA, leading to an erroneous shape. However, also the extravascular signal 
will at some point drop into the noise-level, at which point noise will dominate the Dr2
* mea-
surement, thereby affecting the shape of the curve, especially the peak, dramatically. therefore 
not only PVEs but also signal saturation and noise can lead to errors in the measured shape of 
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the AIF. the influence of the echo time on the occurrence of signal saturation can be observed 
in the results of the dual echo segmented EPI (Figure 5), which show optimal locations for AIF 
measurement much closer or even on top of the MCA for the small echo time compared to the 
longer echo time. this can be explained by the fact that the extent of the field inhomogeneities 
increase with longer echo times, leading to signal saturation at larger distances from the vessel 
center. the finding of correct AIF measurements, using segmented EPI with a short echo time, 
on top of the MCA could be useful for local AIF selection-methods, where AIF measurements 
are performed at the level of small arteries that supply the adjacent tissue with blood. However, 
further research is required to determine the effect of the orientation and the exact size of the 
small artery on the shape of the AIF measurements.
the findings from the simulations were subsequently applied to an in vivo example (Figure 
7). Although in general the findings of the simulations were reproduced in this in vivo example, 
some discrepancies were observed. In our opinion, these differences can be explained by 
uncertainties in the exact location of the MCA in the DSC images, as movement of the patient 
and distortions of the Mr images can lead to misidentification of the location of the MCA. 
However, several important observations can be made from this example. First, the short echo 
time of the segmented EPI sequence, did indeed lead to a large region around the MCA where 
the AIF can be measured without suffering from PVEs, like erroneous peaks on the AIF. When 
comparing the short echo time data with the second echo time, it is clear that the number of 
voxels showing correct AIF shape is much lower when using the longer echo time. Second, the 
PrEStO data (upper panel) show that AIF measurements can indeed better be performed in 
the slice above or below the MCA, as voxels in these curves show less erroneous deformations 
than the voxels located in the same slice as the MCA. Furthermore, it is clear that the SNr of a 
single voxel is too low when using it as input for the deconvolution analysis. In general, the SNr 
of the AIF can be improved by averaging a number of AIF measurements with correct shape, 
e.g. along the MCA or in voxels around the MCA (when using segmented EPI with a short echo 
time). However, care should be taken to avoid voxels where smaller arteries branch off the MCA.
All phantom experiments performed on 1.5 t resemble a concentration dose of 0.2 mmol/
kg-bodyweight gd-DtPA. the in vivo experiments performed at 3.0 t used 0.1 mmol/kg-
bodyweight gd-DtPA. the susceptibility changes, field strength and echo train length have 
the largest contribution to the pattern of signal decreases observed in and outside the vessel 
for gradient echo images. With double the field strength and half the concentration gd-DtPA 
the signal decrease patterns will remain comparable, as both effects cancel out, although 
other differences (e.g. resulting from differences in relaxation rates and values) might lead to 
discrepancies. Nonetheless, when repeating the simulations for 3.0 tesla with half the dose of 
contrast agent, the same optimal locations were found as observed in the simulations of 1.5 t 
(compare Figures 4 and 6).
the advanced numerical model was designed to closely resemble in vivo AIF selection in 






infinite cylinder oriented perpendicular to the main magnetic field; therefore the conclusions 
only holds for a straight part of the MCA at least 4 times the diameter (34). the cardiac effects 
on the MCA were not taken into account. Imaging with single-shot EPI takes on the order of 0.1 
seconds and can be considered as a snapshot compared to the cardiac cycle (approximately 
0.8 sec). PrEStO was used as a 3D sequence and takes about 2 cardiac cycles (1.5 or 2 seconds), 
however the large gradients used for echo shifting crush the intravascular signal.
In summary, AIF measurements are best performed using the short echo time in combina-
tion with segmented EPI. For this setup a large area around the MCA provide AIF curves with 
little errors because of PVEs and signal depletion, leading to the best measurement of the shape 
of the AIF. In most situations, the AIF measurement is best performed in voxels located com-
pletely in tissue surrounding the MCA. Segmented readout sequences such as segmented EPI 
or PrEStO result in more possible locations for AIF selection and are less sensitive to the exact 
position of the vessel in the through-plane direction than single-shot EPI. For most sequences, 
the best location for AIF measurements is posterior to the vessel and is for some cases found in 
the slice superior to the MCA. Converting the profile to concentration is best performed using 
a linear relation when measuring outside the artery.
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Chapter 4: Phase-based arterial input function 
measurements for dynamic 
susceptibility contrast MrI 
Egbert JW bleeker, Mark A van buchem, Andrew g Webb, and 
Matthias JP van Osch
ABstrACt
In dynamic susceptibility contrast (DSC-) MrI arterial input function (AIF) measurements using 
the phase of the Mr signal are traditionally performed inside an artery. However, phase-based 
AIF selection is also feasible in tissue surrounding an artery such as the middle cerebral artery 
(MCA), which runs approximately perpendicular to b0, since contrast agents also induce local 
field changes in tissue surrounding the artery. the aim of this study was to investigate whether 
phase-based AIF selection is better performed in tissue just outside the MCA than inside 
the artery. Additionally, phase-based AIF selection was compared to magnitude-based AIF 
selection. both issues were studied theoretically and using numerical simulations, producing 
results which were validated using phantom experiments. Finally, an in vivo experiment was 
performed to illustrate the feasibility of phase-based AIF selection. three main findings are 
presented: first, phase-based AIF selections are better made in tissue outside the MCA rather 
than within the MCA, since in the latter approach partial volume effects affect the shape of the 
estimated AIF. Second, optimal locations for phase-based AIF selection are similar for different 
clinical DSC-MrI sequences. third, phase-based AIF selection allows more locations in tissue to 
be chosen which show the correct AIF than does magnitude-based AIF selection.







First-pass perfusion MrI, also termed dynamic susceptibility contrast MrI (DSC-MrI), is used in 
clinical practice to diagnose brain disease and to stage its severity (1, 2). DSC-MrI provides a set of 
hemodynamical parameters such as cerebral blood flow (CbF), cerebral blood volume (CbV), mean 
transit time (Mtt), time of arrival (tA) and time to peak (ttP), (3, 4). However, the values of CbF, CbV 
and Mtt obtained with DSC-MrI are qualitative rather than quantitative. One of the key elements 
currently missing is an accurate measurement of the arterial input function (AIF), an estimate of the 
concentration of contrast agent as it passes through an artery close to the brain tissue. 
the AIF can be measured using the change in magnitude or the phase (Δφ) of the Mr-signal. 
Signal processing involves the magnitude of this signal change being transformed to Δr2
*. 
Phase-based AIF selection within a brain-feeding artery was first proposed more than a decade 
ago (5), but up to now clinical applications have been limited. Phase-based AIF measurements 
have several potential advantages over magnitude-based AIF measurements. First, the phase 
is linearly related to the concentration of contrast agent in blood, and the linearity is indepen-
dent of the hematocrit level (6, 7), whereas for magnitude-based AIF measurements there is a 
quadratic relation between Δr2
* of whole blood and the concentration of contrast agent with 
the quadratic component dependent on the hematocrit level (8, 9). Second, the phase-based 
AIF measurement is expected to be more precise with a ten-fold signal-to-noise (SNr) increase 
compared to magnitude-based AIF selection averaged over the entire curve (10). 
the original studies of Akbudak and Conturo were limited to phase-based AIF measure-
ments within the artery (5), although phase-based AIF measurements can also be performed in 
surrounding tissue, since magnetic field changes are also induced outside arteries that are not 
oriented parallel to b0 by the presence of contrast agent within the vessel (11). Furthermore, 
several potential advantages can be anticipated for phase-based AIF measurements outside 
the artery. First, voxels located completely in tissue are not affected by partial volume effects 
with the arterial signal, whereas partial volume effects between artery and tissue often lead to 
errors in the shape of the AIF profile (12, 13). Second, outside the artery signal dephasing is less 
severe, resulting in an increased precision of the phase-determination since the noise in the 
phase of the Mr-signal depends inversely on the magnitude of the signal. A potential drawback 
for phase-based AIF measurements in tissue could be the contamination of the AIF with the 
passage of the contrast agent through the capillaries (also referred to as the tissue response) 
as has been observed in magnitude-based AIF measurements in tissue (14). However, it is 
expected that for phase-based AIF measurements this effect will be minimal, since capillaries in 
a given voxel are likely to be oriented randomly and phase effects therefore cancel. 
the aim of this study is to determine whether phased-based AIF measurements in tissue are 
advantageous compared to phase-based AIF measurements in an artery. Additionally, extra-
vascular phase-based AIF measurements are compared to extravascular magnitude-based AIF 
measurements. this study focuses on AIF measurements in the vicinity of the middle cerebral 
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artery (MCA), which is ideally suited for AIF determination due to its size, location in the brain 
and the orientation perpendicular to the main magnetic field. Equations for susceptibility 
effects in and around straight vessels were used to create a numerical model. Different effects 
that can lead to errors in the shape of the AIF such as partial volume, signal cancellation, image 
distortions (including the apparent vessel shift), and the point spread function of the particular 
imaging sequence were investigated using this numerical model. the numerical model has pre-
viously been validated for magnitude-based AIF measurements (15) and in the current study 
the numerical model is evaluated for phase-based AIF measurements. the findings obtained 
from the simulations are confirmed using an in vivo DSC-MrI exam.
theory
Contrast agents employed in DSC-MrI have a higher susceptibility than blood and change both 
the longitudinal and transverse relaxation times of nearby water. the intravascular susceptibil-
ity is linearly related to the concentration of contrast agent and changes the local magnetic 
field (9, 16). For an infinite cylinder, 
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precision of the phase-determination since the noise in the phase of the MR-signal 
depends inversely on the magnitude of the signal. A potential drawback for phase-based 
AIF measurements in tissue could be the contamination of the AIF with the passage of 
the contrast agent through the capillaries (also referred to as the tissue response) as has 
been observed in magnitude-based AIF measurements in tissue (14). However, it is 
expected that for phase-based AIF measurements this effect will be minimal, since 
capillaries in a given voxel are likely to be oriented randomly and phase effects therefore 
cancel.  
The aim of this study is to determine whether phased-based AIF measurements in tissue 
are advantageous compared to phase-based AIF measurements in an artery. Additionally, 
extravascular phase-based AIF measurements are compared to extravascular magnitude-
based AIF measurements. This study focuses on AIF measurements in the vicinity of the 
middle cerebral artery (MCA), which is ideally suited for AIF determination due to its 
size, location in the brain and the orientation perpendicular to the main magnetic field. 
Equations for susceptibility effects in and around straight vessels were used to create a 
numerical model. Different effects that can lead to errors in the shape of the AIF such as 
partial volume, signal cancellation, im ge distortions (incl ding the ap rent vessel 
shift), and the point spread function of the particular imaging sequence were investigated 
using this numerical model. The numerical model has previously been validated for 
magnitude-based AIF measurements (15) and in the current study the numerical model is 
evaluated for phase-based AIF measurements. The findings obtained from the 
simulations are confirmed using an in vivo DSC-MRI exam. 
Theory 
Contras  agents mployed in DSC-MRI have a higher susceptibility t  blo d and 
change both the longitudinal and transverse relaxation times of nearby water. The 
intravascular susceptibility is linearly related to the concentration of contrast agent and 
changes the local magnetic field (9, 16). For an infinite cylinder,  
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where ΔBint is the magnetic field change inside the vessel, ΔBext is the magnetic field 
change outside the vessel, δχ is the susceptibility difference per mole per liter of 
gadolinium between the intra- and extravascular compartments, [Gd] is the concentration 
of gadolinium, a is the radius of the vessel, ρ is the distance from any given point (p) to 
the vessel center, θ is the angle between the vessel axis and B0, and φ is the angle of p in 
the plane perpendicular to the vessel axis.  
From these formulae, it can be seen that intravascular phase-based AIF measurements of 
arteries such as the internal carotid artery, which are oriented parallel to the main 
magnetic field, have twice the induced contrast compared to intravascular phase-based 
AIF measurements inside arteries, such as the MCA, which are oriented perpendicularly. 
However, the magnetic field in the tissue surrounding the perpendicular-oriented artery is 
also affected and at some locations these magnetic field changes are even larger than the 
intravascular field changes for a parallel oriented artery. Larger magnetic field changes 
lead to larger phase changes and therefore to higher SNR in the phase difference images, 
assuming that the temporal phase changes can still be accurately unwrapped. The phase 
signal change between two time points is dependent on three factors: the echo time, 
change in contrast agent concentration, and the distance from the vessel center (see 
equation 2). Due to the dependence on the change in concentration, the phase signal 
change is also dependent on the dynamic scan time.  
Acquisition of DSC-MRI is characterized by a relatively coarse spatial resolution due to 
the necessity of a high temporal resolution. Therefore, partial volume effects will occur in 
the neighborhood of the MCA and a set of numerical simulations using the theory for an 
infinite cylinder oriented perpendicular to the main magnetic field (see equations 1 and 2) 
was used to gain insight into how partial volume effects affect phase-based AIF 
measurements. Gaussian noise was added to the real and imaginary part of the complex 
signal with an SNR of 50:1 and an ideal point spread function was assumed. In figure 1 
the absolute correlation with the “ground truth” of the concentration profile derived from 
a modeled AIF (17) is presented for different voxel sizes, and for different echo times 
(10, 20, 30, 40 msec). Longer echo times allow measurements of the AIF more distant 
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where Δbint is the magnetic field change inside the vessel, Δbext is the magne ic field change 
outside the vessel, δχ is the susceptibility difference per mole per liter of gadolinium between 
the intra- and extravascular compartments, [gd] is the concentration of gadolinium, a is the 
radius of the vessel, ρ is the distance from any given point (p) to the vessel center, θ is the angle 
between the vessel axis and b0, and φ is the angle of p in the plane perpendicular to the vessel 
axis. 
From these formulae, it can be seen that intravascular phase-based AIF measurements of 
arteries such as the intern l carotid artery, which are oriented parallel to th  main magnetic field, 
have twice the induced contrast compared to intravascular phase-based AIF measurements 
inside arteries, such as the MCA, which are oriented perpendicularly. However, the magnetic 
field in the tissue surrounding the perpendicular-oriented artery is also affected and at some 
locations these magnetic field changes are even larger than the intravascular field changes 
for a parallel oriented artery. larger magnetic field changes lead to larger phase changes and 
therefore to higher SNr in the phase difference images, assuming that the temporal phase 
changes can stil  be accurately unwrapped. th  phase sign l change between two tim  points 






distance from the vessel center (see equation 2). Due to the dependence on the change in 
concentration, the phase signal change is also dependent on the dynamic scan time. 
Acquisition of DSC-MrI is characterized by a relatively coarse spatial resolution due to the 
necessity of a high temporal resolution. therefore, partial volume effects will occur in the neigh-
borhood of the MCA and a set of numerical simulations using the theory for an infinite cylinder 
oriented perpendicular to the main magnetic field (see equations 1 and 2) was used to gain 
insight into how partial volume effects affect phase-based AIF measurements. gaussian noise 
was added to the real and imaginary part of the complex signal with an SNr of 50:1 and an ideal 
point spread function was assumed. In figure 1 the absolute correlation with the “ground truth” 
of the concentration profile derived from a modeled AIF (17) is presented for different voxel 
sizes, and for different echo times (10, 20, 30, 40 msec). longer echo times allow measurements 
of the AIF more distant from the cylinder, up to 6 times the radius for an echo time of 40 msec, in 
comparison to 4 times the radius for an echo time of 10 msec. Voxels partly encompassing the 
cylinder have partial volume effects, which corrupt the shape of the estimated AIF. For smaller 
voxel sizes, the AIF measurements with the correct shape can be found closer to the arterial 
wall. In general, the locations for correct AIF measurements are superior, posterior, inferior and 
anterior to the cylinder. 
Figure 1: Assessment of the shape errors in the phase-based AIF measurements based on the theoretical 
equations of magnetic field changes around an infinite cylinder (Eq 1, 2). Shown are the optimal locations 
for phase-based AIF measurements for several echo times based on the correlation with the ground truth 
(the absolute value of the correlation greater than 0.97). the columns correspond to different relative voxel 
sizes with respect to the radius of the vessel while assuming an ideal point spread function. the gray circles 
show the distance from the vessel center in steps of the radius. the white rectangles depict the voxel size.
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A series of phase-based and magnitude-based AIF shapes are presented in figure 2. the 
voxels close to the center of the cylinder have large shape errors. the voxels more distant from 
the center have reduced scaling.
methods
In a previous report a numerical model described magnitude-based AIF selection in and near 
the MCA (15). the numerical model has been validated for magnitude-based AIF selection, and 
in the current study, the numerical model was evaluated for phase-based AIF selection.
An extended numerical model was used for in vivo prediction using numerical values more 
appropriate to the in vivo case. this “in vivo” model was employed to study magnitude-based 
and phase-based AIF selection in and near the MCA. Finally, an example of an in vivo experi-
ment was used to confirm the results from the simulations. 
numerical models including imaging effects
the M1 segment of the MCA was modeled as an infinite cylinder perpendicular to the main mag-
netic field and parallel to the left/right axis. Partial volume effects and dephasing were modeled 
using a 250 μm high resolution 2D grid for 2D acquisition and a 500 μm 2D grid for 3D acquisi-
tion. Phase encoding was modeled explicitly to include image distortions, whereas frequency 
encoding was assumed to be instantaneous and ignored in the numerical model. Single shot EPI 
(voxel size 2.4x2.4x6 mm3 zerofilled to 1.8x1.8x6 mm3, tE 41 msec) and segmented double-echo 
EPI (voxel size 1.7x2.9x6 mm3 zerofilled to 1.7x1.7x6 mm3, tE1/tE2 11/30 msec) were modeled 
as 2D sequences, whereas PrEStO (Principles of echo-shifting with a train of observations (18)) 
Figure 2: Simulated AIF measurements for phase-based (Δφ) AIF measurements (a) and magnitude-based 
(Δr2
*) AIF measurements (b); the left panel shows the phase and magnitude image at the peak contrast 
agent concentration. the sign of the phase-based profiles is reversed so that the phase change is positive. 
the first two profiles of the phase-based and magnitude-based AIF measurement show partial volume 
effects because these are partly encompassing the MCA. the third profile is suffering from signal saturation, 
which corrupts the peak concentrations. the fourth and fifth profiles of the phase-based AIF measurement 
have the correct shape of the concentration profile but the SNr is reduced. In all graphs, the ground truth 






was modeled as a 3D sequence (voxel size 3.4x3.5x3.5 mm3 zerofilled to 1.7x1.7x3.5 mm3, tE 25 
msec). the numerical model was implemented in MAtlAb (r2007b, Natick, MA, USA). 
the basic model is based on bolus passage properties encountered in phantom experiments, 
whereas the “in vivo” model resembles in vivo AIF selection by including the passage of contrast 
agent through surrounding tissue and using relevant tissue parameters (whole blood trans-
verse relaxivity r2
*
,blood with a linear term 7.62 l/mmol/sec and a quadratic term 0.57 l
2/mmol2/
sec (9); the longitudinal relaxivity in tissue r1,tissue 4.3 l/mmol/sec (19); the transverse relaxivity 
in tissue r2
*
,tissue 44 l/mmol/sec (20)). gaussian noise was added to the real and imaginary part 
of the Mr-signal to study the influence of noise on the shape of the AIF measurements. the 
baseline signal-to-noise (SNrbaseline) was set to 50:1, which is typical for clinical experiments. 
Since the results do not depend on the position along the vessel, all results are presented in 
a sagittal view (although the model “acquires” transverse slices). In the model, the vessel center 
was shifted in small steps (500 μm) in both phase-encoding and slice direction. this shifting was 
performed to study the effect of the exact location of the vessel inside a voxel; the vessel center 
is shifted in smaller steps that the voxel size (see figure 3). these stacks with different locations 
of the vessel center were merged into a single image. therefore, the resolution of this image 
appears to be higher but the pixels in the image actually represent normal clinical voxel sizes. 
Figure 3: A schematic representation (a) is shown of shifting and merging in the slice direction; the different 
shifts are depicted in grayscales and slices are indicated by a symbol. In this example, the stacks of slices are 
shifted with a step size a quarter of the slice thickness. the merged image shows how the image is built up 
from the different shifts. the resolution appears to be higher for the merged image but each pixel reflects a 
voxel with original slice thickness. the image representation (b) of the shifting shows that the shifting leads 
to blurring of the underlying magnetization.
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post processing
the phase difference was calculated with respect to φ0, the initial phase without contrast agent. 
For evaluation of the model three metrics were computed for each voxel and a fourth was 
constructed from the combination of two of these values. these metrics were:
1) the Pearson correlation coefficient (ρ), a measure for shape/accuracy with respect to the 
ground truth, defined as the expected intravascular phase change obtained from the 
analytical expression:
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TE 25 msec). The numerical model was implemented in MATLAB (R2007b, Natick, 
MA, USA).  
The basic model is based on bolus passage properties encountered in phantom 
experiments, whereas the “in vivo” model resembles in vivo AIF selection by including 
the passage of contrast agent through surrounding tissue and using relevant tissue 
parameters (whole blood transverse relaxivity r2*,blood with a linear term 7.62 l/mmol/sec 
and a quadratic term 0.57 l2/mmol2/sec (9); the longitudinal relaxivity in tissue r1,tissue 4.3 
l/mmol/sec (19); the transverse relaxivity in tissue r2*,tissue 44 l/mmol/sec (20)). Gaussian 
noise was added to the real and imaginary part of the MR-signal to study the influence of 
noise on the shape of the AIF measurements. The baseline signal-to-noise (SNRbaseline) 
was set to 50:1, which is typical for clinical experiments.  
Since the results do not depend on the position along the vessel, all results are presented 
in a sagittal view (although the model “acquires” transverse slices). In the model, the 
vessel center was shifted in small steps (500 μm) in both phase-encoding and slice 
direction. This shifting was performed to study the effect of the exact location of the 
vessel inside a voxel; the vessel center is shifted in smaller steps that the voxel size (see 
figure 3). These stacks with different locations of the vessel center were merged into a 
single image. Therefore, the resolution of this image appears to be higher but the pixels in 
the image actually represent normal clinical voxel sizes.  
P st processing 
The phase difference was calculated with respect to φ0, the initial phase without contrast 
agen . For evaluation of the model thre  metrics were computed for e ch voxel and a 
fourth was constructed from the combination of two of these values. These metrics were: 
1) The Pearson correlation coefficient (ρ), a measure for shape/accuracy with respect to 
the ground truth, defined as the expected intravascular phase change obtained from the 
analytical expression: 
 GdTEFB e   02 ,       
with γ = 42.58 MHz T-1 and δχ = 0.3209 10-3 l mol-1 (9), Fe = -1/6 for vessels 
perpendicular to the main magnetic field and TE the echo time.  
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 with γ = 42.58 MHz t-1 and δχ = 0.3209 10-3 l mol-1 (9), Fe = -1/6 for vessels perpendicular to 
the main magnetic field and tE the echo time. 
2) the regression with the ground truth intravascular signal in percent, a measure for the rela-
tive scaling of Δr2
*(t) or Δφ(t) with respect to the ground truth. 
3) the SNrs of the contrast agent passage curve (SNrcurve) calculated as the ratio of the maxi-
mum of Δr2
*(t) or Δφ(t) divided by the standard deviation of the pre-contrast agent images. 
4) the values of the correlation and the SNrcurve were used to form a single image that 
shows locations in which a correct AIF measurement, that is with the correct shape and 
high SNr, could be obtained. based on previous results, the cutoff value for the correlation 
to represent a correct shape was set to 0.97 (15). the SNrcurve was used to determine the 
locations with high precision; the threshold was set at 25 for both magnitude-based and 
phase-based AIF measurements. 
phantom experiments
the flow-phantom consisted of a tube (inner diameter 4 mm, wall thickness 0.25 mm) oriented 
perpendicular to the main magnetic field. MnCl2-doped water was circulated through the tube 
at a constant volume flow rate of 2.8 ml/sec, which is close to the blood volume flow through 
the MCA (21). the t1 value of the solution was close to the t1 value of blood at 1.5 t. the tube 
was surrounded by the same MnCl2 solution to create a background signal representing the 
tissue. In the solution within the tube, the concentration of gd-DtPA (Magnevist, Schering, 
germany) was increased in seventeen successive steps of 0.9 mM.
All phantom experiments were performed at 1.5 t (Philips Achieva, best, the Netherlands) 
using a standard quadrature head coil. the imaging sequences had the following settings: 
single shot EPI, data matrix 96x95 zerofilled to 128x128, tE/tr 41/1500 msec, flip angle (FA) 80º, 
field of view (FOV) 230x230 mm2, 15 slices of 6 mm thickness without interslice gap; dual echo 
segmented EPI, matrix 128x75 zerofilled to 128x128, tE1/tE2/tr 11/30/400 msec, FA 53º, FOV 
220x220 mm2, 8 slices of 6 mm thickness with 1 mm gap, 5 segments; PrEStO, matrix 64x63 







the stack of slices was shifted in steps of 1 mm (double the step size of the simulations) for 
the EPI and segmented EPI experiments and 0.5 mm for the PrEStO experiment in the slice 
direction in order to measure various locations of the vessel center within the imaging slice.
the phantom experiments were evaluated by the same procedure as the numerical models, 
although limited to the first two evaluation measures (Pearson correlation and regression with 
the ground truth).
in vivo experiment
As an in vivo example, a DSC-MrI experiment of a patient diagnosed with arteriovenous mal-
formation (AVM) was used. the protocol was approved by the local ethics committee. Imaging 
was performed at 3 t (Philips Achieva, best, the Netherlands) using a PrEStO sequence, matrix 
96 x 87, zerofilled to 128 x 128, 30 slices 3.5 mm thick with no interslice gap, FOV 240 x 190 mm2, 
75 dynamic scans, scan duration 118 sec, tE/tr 30/20 msec, FA 8º, EPI factor 15, SENSE factor 2, 
phase encoding was set from right to left. 
the locations of both left and right MCAs were determined (and found to be distant from 
the malformation) using the DSC-MrI data. the unwrapped phase AIF measurements and the 
magnitude-based AIF measurements in and around the arteries are presented, together with 
the results of the simulations. because the exact concentration profile of the contrast agent is 
unknown, only qualitative evaluation can be performed.
results
First, the numerical model for phase-based AIF measurements was evaluated by means of 
phantom experiments (see figure 4). the sagittal images displayed are formed from several 
sets of transverse slices, which are shifted in the slice direction to study the influence of the 
location of the vessel inside the imaging volume. Figure 4a compares the Δφ images of both 
model and phantom experiments at three different concentrations of contrast agent for the 
three sequences investigated. A visual comparison between the phantom results and simula-
tions for single shot EPI (left two columns) and segmented EPI (middle two columns) show 
good agreement. When comparing the phantom measurements and simulations for PrEStO 
imaging a small discrepancy can be observed for voxels encompassing the vessel. this can 
probably be attributed to incomplete crushing of the intravascular signal by the gradients used 
for echo-shifting, whereas the model assumed complete crushing. Additionally, a quantitative 
evaluation was performed using the correlation and regression with the ground truth of the 
intravascular signal in percent, which is presented in figure 4b. these both show good agree-
ment between model and phantom experiments although at large distance from the vessel 
differences can be observed, which can be explained by a small global phase drift. For single 
shot EPI, this global drift is more pronounced and results in a clear offset in the regression. 
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the “in vivo” model was used for determining the optimal locations for AIF selection, as 
defined by a correct shape and high SNrcurve. Figure 5 shows a series of simulation data from 
a single shot EPI readout that describe the AIF measurement for both magnitude-based and 
phase-based AIF selection. the SNrcurve for phase-based AIF measurement is higher, which is 
in agreement with the results of kotys et al. (10). For the magnitude-based AIF selection very 
few locations provide a correct AIF measurement, and all of these locations are outside the 
vessel. For phase-based AIF measurements, voxels with a correct shape and high SNrcurve are 
also located in tissue. In voxels more distant from the vessel, noise corrupts the shape of the 
Figure 4:  a) Merged Δφ images (sagittal view; FOV 30 x 30 mm) of the phantom experiments and the 
simulations for single shot EPI (left), segmented EPI (middle) and PrEStO (right) at three concentrations of 
gd-DtPA (4.4 mM, 8.8 mM and 13.2 mM). b) Correlation (first row) and regression in percent with the ground 
truth, the expected intravascular signal, (second row) of phantom and simulations with the tube depicted 
as a white circle. the phantom images are formed by merging several stacks of transverse images into a 
single image and therefore each pixel represents a larger voxel. the phase encoding is oriented anterior to 
posterior. In the phantom experiments, the stack of slices was shifted in steps of 1 mm (single shot EPI and 
segmented EPI) and 0.5 mm (PrEStO). For the simulation, the stack of slices is shifted in all cases in steps 
of 0.5 mm and, in addition, the stack was also shifted in steps of 0.5 mm in the phase encoding direction. 
Although the resolution for the phantom and simulations appear different, the simulated and acquired 







AIF measurement, and when located more than 1.5 cm from the vessel center the SNrcurve 
becomes very low.
Different fast imaging sequences were investigated, each with different voxel sizes and 
exhibiting different distortion patterns (see figures 4 and 6). For both phase-based AIF selection 
as well as magnitude-based AIF selection, the locations with correct shape and high SNrcurve 
are in the tissue surrounding the MCA for all sequences studied. Furthermore, phase-based 
AIF selection results in a greater number of locations than magnitude-based AIF selection. the 
optimal locations for phase-based AIF selection are approximately the same for each of the 
different fast imaging sequences investigated. Shorter echo times induce less phase difference 
and therefore the area of bordering voxels is reduced (see figure 6) and the AIF measurement is 
thus more sensitive to the exact location of the vessel center inside the slice. For single shot and 
segmented EPI the optimal locations for AIF measurements are approximately three voxels (7.5-
10 mm) posterior or anterior to the voxel encompassing the center of a 4 mm diameter MCA, 
and for the superior and inferior location the optimal locations are in the slice directly above 
or beneath the MCA. For a 2 mm diameter MCA the optimal location is approximately two 
voxels (5 mm) from the center of the MCA. For PrEStO with 3.5 mm isotropic voxels the optimal 
locations are closer to the MCA. For a 4 mm MCA the optimal locations are approximately two 
voxels (5-10 mm) posterior, anterior, inferior or superior to the center of the MCA and for a 2 mm 
MCA one voxel (2.5-5 mm) from the center of the MCA. 
A PrEStO exam of a patient suffering from AVM was used for in vivo evaluation (see figure 
7 and 8). In figure 7 negative phase changes are observed posterior and anterior to the MCA 
and positive phase changes are observed superior and inferior; this is in agreement with both 
theory and simulations. Diagonally to the vessel, there are no phase changes; this is also in 
agreement with theory and this shows that the tissue response of the signal phase is indeed 
close to zero. For both the left and right MCA there are partial volume effects, which hinder AIF 
measurements close to the artery (see figure 7). the AIF measurements near the right MCA also 
Figure 5: the regression with the ground truth in percent, correlation with the ground truth, absolute value 
of the correlation, SNrcurve (averaged over ten simulation runs) and combined image of correlation and 
SNrcurve (shown is a correlation larger than 0.97 in combination with an SNr larger than 25) for the phase-
based AIF selection (a) and magnitude-based AIF selection (b). 
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Figure 6: the optimal locations for a) phase-based AIF selection and b) magnitude-based AIF selection 
based on numerical modeling. the optimal locations were determined with SNrcurve thresholded 
correlation images (the absolute value of the correlation greater than 0.97 and a voxel with SNrcurve larger 
than 25). respectively are shown single shot EPI (1st column), segmented EPI tE1 (2
nd column), segmented 
EPI tE2 (3
rd column) and PrEStO (4th column), for different diameters from top row to bottom row 4 mm, 
3 mm and 2 mm. the white circle represents the location of the MCA. the white rectangle shows the true 





















































































































































































































































































































































































































































































































































































show that accurate AIF measurement can be made more difficult by the presence of anatomical 
structures; in this case by a small artery branching from the main MCA segment, which affects 
the anterior AIF measurement. Figure 8 shows the magnitude-based AIF measurements for the 
same voxels as in figure 7. the voxels in the center (within the MCA) clearly show partial volume 
effects corrupting the shape of the AIF profile.
disCussion And ConClusions
there are three main findings from this study. the first is that phase-based AIF measurements in 
tissue near the MCA are superior to those made inside the MCA. Second, the optimal locations 
for phase-based AIF selection are approximately the same for different fast-imaging sequences. 
third, phase-based AIF selection results in more voxels having the correct shape of the AIF 
compared to magnitude-based AIF selection.
the first aim of this study was to investigate whether phase-based AIF selection in tissue 
surrounding the MCA is advantageous compared to inside the MCA. AIF selection based on 
the phase of the Mr-signal was proposed more than a decade ago, although it was limited to 
intravascular AIF measurements (5). In that study, AIF selection was performed in the largest 
arteries, combined with a high spatial resolution to avoid partial-volume effects. However, in 
DSC-MrI, voxel sizes are normally larger than the arteries and therefore partial-volume effects 
will always be present. Since the phase of the tissue and arterial compartment of a partial-
volume voxel depends differently on the concentration of contrast agent, the sum of the 
complex signals may be greater or less than the individual components, thereby leading to 
changes in the shape of both magnitude-based and phase-based AIF measurements (12, 13). 
However, for parallel oriented vessels there are no local field changes in tissue and therefore 
partial volume effects can be corrected (12). Correction for such shape errors is not feasible for 
arteries, which are not oriented parallel to b0. the theory and the results from the numerical 
model in this present study show that no voxel encompassing the MCA passed our shape cri-
teria based on correlation and SNrcurve (see figures 1 and 6a). this is in contrast to extravascular 
phase-based AIF measurements, where several voxels located completely in tissue did pass our 
shape criteria. Insensitivity to the exact vessel location is observed in figures 1 and 6a, where 
four large clusters of voxels pass the shape criteria. 
the optimal locations for AIF selection are superior, inferior, anterior and posterior from 
the MCA in voxels located completely outside the MCA. the inferior and anterior locations will 
sometimes be hindered by the lack of homogeneous tissue. the in vivo example also showed 
that small branches of the MCA can hinder the AIF measurements (see figures 7 and 8). Figures 
1 and 6a show that in voxels located more distant from the vessel center the observed phase 
changes are very small and noise hinders the accuracy of the AIF measurement. Close to the 
vessel wall, signal depletion and image distortion can corrupt the AIF measurement. the theory 
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shows that voxels approximately two vessel diameters from the vessel center have the correct 
shape. the simulations show that for the specific imaging sequences considered here the AIF 
measurements should be 2-3 voxels from the vessel center depending on the vessel size. the 
noise in the phase of the Mr-signal depends inversely on the magnitude of the Mr-signal, lead-
ing to poor SNr in the phase measurements when severe dephasing of the Mr-signal occurs. 
Since the strongest dephasing occurs close to the vessel wall, phase-based AIF measurements 
should not be performed in this region (see figure 6a). the phase of the Mr-signal is also 
dependent on the echo time. the echo time affects the SNr of the phase-based AIF measure-
ment in two ways. First, longer echo times reduce the magnitude of the baseline Mr-signal and 
therefore reduce the SNrcurve of the phase of the Mr-signal. Second, longer echo times result 
in stronger phase effects, thereby increasing the SNrcurve. the simulations clearly showed the 
beneficial effect of stronger induced phase changes, as can be seen in figures 1 and 6a (how-
ever, the effect of decreased baseline magnitude on the SNrcurve was not taken into account). 
the effect of echo time on the SNrcurve has been studied extensively in a previous study (10).
the most important findings of the numerical model for phase-based AIF selection are also 
observed in the in vivo example. Intravascular AIF measurements in both the left and right 
MCAs show very large shape errors (see figures 7 and 8). At the optimal location predicted 
by the simulation the AIF profiles do indeed have the shapes that most closely represent the 
“correct” AIF profiles. Unfortunately, the ground truth is unknown and therefore the shape of 
the AIF measurements could only be assessed qualitatively. the in vivo experiment shows that 
the best locations for AIF measurements are outside the artery and that the phase changes 
behave in a similar pattern compared to the simulations: anterior and posterior negative phase 
changes occur, whereas superior and inferior positive phase changes are found; in between 
very small phase changes occur (see figure 7). 
the second aim of the study was to compare phase-based AIF measurements with magni-
tude-based AIF selection in tissue surrounding the MCA, and determine whether phase-based 
AIF selection is advantageous. In the current study, the simulations show that the SNrcurve 
of magnitude-based AIF measurements is lower than the SNrcurve of the phase-based AIF 
measurements (see figure 5). A more extensive study has been performed by kotys et al., and 
they found that the SNr per time point can be 4 to 80 times higher depending on contrast 
agent dose and the time at which data are acquired. Over the entire curve a tenfold increase in 
SNrcurve has been observed at the optimal contrast dose (10). 
the second advantage is that more voxels with correct AIF measurement (according to our 
shape criteria) were found for phase-based compared to magnitude-based AIF measurements. 
this leads also to less dependence on the exact location of the vessel center within the imaging 
slice. this can be observed in figures 1 and 6 where the large clusters of voxels with correctly 
shaped AIF measurements imply that one or two good voxels in these areas can always be 
found independent of the exact location of the vessel center inside the imaging volume. Since 






performed to boost the SNr. For both types of EPI scans, this averaging will be best performed 
in-plane and for PrEStO with its thinner voxels averaging in the slice-select direction should 
also be possible. Note that averaging phase-based AIF profiles requires changing the sign of 
the anterior and posterior selected AIF profiles. Voxels selected at a location more distant from 
the artery are hindered by low SNrcurve: however, the simulation showed that the underlying 
profile remains correct. the more distant locations for magnitude-based AIF measurement 
are also affected by low SNrcurve, but the major cause of the incorrect shape of the AIF is the 
contamination from the tissue response. 
the insensitivity to the tissue response is the third advantage of phase-based AIF measure-
ments over magnitude-based AIF measurements. For magnitude-based AIF measurements 
contamination with the tissue response can in theory be compensated for using tissue curve 
subtraction (14), but due to noise in the tissue response the benefit can be limited. In phase-
based AIF selection, the tissue response is close to zero because the overall phase effect of 
randomly oriented vessels is very small and therefore, under the assumption of random ves-
sel orientation, there is almost no contamination of the AIF measurement. the lack of tissue 
response was also observed in the in vivo example diagonally above the MCA (see figure 7) 
where voxels show almost no phase changes over time. 
Somewhat surprisingly, our results show that the optimal locations for magnitude-based 
AIF selection and phase-based AIF selection are different. this can be explained by the fact 
that the large signal drops lead to less precise estimations of the phase. Nonetheless, both 
phase-based AIF selection and magnitude-based AIF selection are best performed in tissue 
completely outside the vessel where partial volume effects do not hinder the measurement. 
A disadvantage for phase-based AIF measurements is that scanner drift can affect the phase 
images as also observed in the phantom experiments (see figure 4). 
One of the reasons why an accurate AIF is important is that deconvolution techniques, 
such as singular value decomposition (SVD) (3), Fourier deconvolution (4) and maximum likeli-
hood estimation (MlEM) (22), are used to calculate CbV and CbF values from the AIF and the 
tissue passage curves. Noise in the AIF curves and the fact that deconvolution is an ill-posed 
problem means that regularization of the deconvolution process is necessary. Partial volume 
effects lead to non-linear errors in the shape of the AIF measurement, which can result in for 
example sharp spikes on top of the profile as observed in our previous study (15). Since each 
deconvolution technique handles noise differently, incorrect AIF profiles will produce different 
perfusion values depending on the choice of the deconvolution and regularization method. 
For correct relative values, the deconvolution requires an AIF with the correct shape, which is 
why we chose to use the shape of the AIF measurement as an important evaluation parameter 
and did not include deconvolution techniques, which would be too dependent on the exact 
implementation. the influence of deviations in the shape of the AIF on CbF has been studied 
previously, and showed that the upslope of the bolus passage curve, in particular, influences 
the CbF measurement (23). 
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In conclusion, phase-based AIF selection near the MCA is best performed in tissue supe-
rior, inferior, posterior and anterior to the middle cerebral artery. the optimal locations are 
approximately the same for different fast imaging sequences. Finally, phase-based AIF selection 
provide more opportunities for AIF selection and has higher SNrcurve compared to magnitude-
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ABstrACt
Dynamic susceptibility contrast MrI requires an arterial input function (AIF) to obtain cerebral 
blood flow, cerebral blood volume (CbV) and mean transit time. the current AIF selection criteria 
discriminate venous, capillary and arterial profiles based on shape- and timing-characteristics 
of the first passage. Unfortunately, partial volume effects (PVEs) can lead to shape errors in the 
bolus passage, including a narrower and higher peak, which might be selected as a “correct” 
AIF. In this study, a new criterion is proposed that detects shape errors based on tracer kinetic 
principles for computing CbV. this criterion employs the ratio of the steady-state value to the 
area-under-the-curve of the first passage, which should result in an equal value for tissue and 
arterial responses. by employing a reference value from tissue, PVEs-induced shape errors of 
the AIF measurement can be detected. Different factors affecting the ratio were investigated 
using simulations. these showed that the new criterion should only be used in studies with 
t1-insensitive acquisition. In vivo data were used to evaluate the proposed approach. the data 
showed that the new criterion enables detection of shape errors, although false positives do 
occur, which could be easily avoided when combined with current AIF selection criteria. 







Dynamic susceptibility contrast (DSC)-MrI is a valuable clinical tool to aid in the diagnosis and 
staging of many brain diseases (1). DSC-MrI provides a set of hemodynamic parameters such 
as cerebral blood flow (CbF), cerebral blood volume (CbV) and mean transit time (Mtt) (2, 3). 
these three parameters can be obtained after deconvolution of the tissue response (the pas-
sage of contrast agent through the capillaries in tissue) with the arterial input function (AIF, the 
passage of contrast agent through a brain-feeding artery). 
the AIF is often selected manually by a trained expert, but a number of automatic AIF selec-
tion procedures have been proposed (4-9). the major advantages of automatic selection are 
operator independence and speeding up of the analysis resulting in fast, standardized and 
reproducible results. Fast analysis is especially important for clinical decision-making in acute 
stroke as evidenced by the frequently used slogan “time is brain” (10). Automatic selection is 
often performed using criteria such as early time-to-peak, steep rise, low first moment, high 
peak-height and small full-width-half-maximum (FWHM) (4-7, 9) or a metric using a set of these 
criteria combined with a gamma-variate fit through the first passage (8). With these criteria, 
venous, capillary and arterial profiles can be discriminated.
Unfortunately, AIF measurements are susceptible to partial volume effects (PVEs) due to 
the relatively low spatial resolution of the acquisitions, and these PVEs alter the shape of the 
AIF measurement (11-13). Ideally, automatic procedures would only select AIF profiles unaf-
fected by PVEs. However, some specific shape errors, such as a narrower peak with a higher 
peak-height than the true shape (13), fulfill the currently used AIF selection criteria and could 
therefore easily be selected as a “correct” AIF measurement. therefore, we propose an addi-
tional criterion for automatic AIF selection, which could also be useful for guiding manual AIF 
selection. this criterion relies on the fact that, theoretically, perfusion parameters cannot only 
be measured from the first passage but also from the second passage. this would however, 
require that the signal-versus-concentration relation is linear and this condition fails for AIFs 
that exhibit shape changes due to PVEs (12, 13). Shape errors could therefore be detected 
by comparing perfusion parameters obtained from the first and second passage. the second 
passage is, however, difficult to determine due to the overlap with the first and subsequent 
passage. the theory, described in this manuscript, shows that the first passage in combination 
with the steady-state (or post-bolus equilibrium) can be used in a similar manner to detect 
shape errors in the AIF. therefore, we propose to use the ratio of the mean steady-state value to 
the area-under-the-curve (AUC) of the first passage of contrast agent as a metric to detect PVEs 
in AIF measurements. this metric is compared to a reference value obtained from tissue in the 
same DSC-MrI data, since linearity of the signal versus concentration contrast agent has been 
proven for brain tissue (14). 
the purpose of this study is to describe a new AIF selection criterion based on tracer kinetic 
theory that can detect AIF measurements corrupted by PVEs. AIF selection guided by the new 
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proposed criterion was studied by means of numerical simulations and evaluated using six in 
vivo exams. both the reference ratio value of tissue and the ratio value of AIF measurements 
(with and without PVEs) were investigated. 
methods
partial volume effects
the presence of contrast agent in an artery will lead, except for arteries at the magic angle 
(54.7º) or parallel to the main magnetic field b0, to a homogenous magnetic field change inside 
the artery and a lobular shaped pattern of magnetic field changes outside the artery (15). For 
a partial volume voxel, this implies that the total complex MrI signal from that voxel is made 
up of several components that show different phase changes for a particular contrast agent 
concentration. the amplitude of the total signal will therefore depend on how much the differ-
ent components are in-phase or out-of-phase. For different concentrations of contrast agent, 
the same voxel may show different gradations of in- or out-of-phase contributions, thereby 
leading to non-linear shape changes of the estimated contrast concentration profile. Different 
manifestations of PVEs were simulated using the Maxwell equations corrected for the sphere of 
lorenz by shifting of a voxel partly encompassing a cylinder oriented perpendicular to the main 
magnetic field (described in more detail in the Methods section Simulations). Subsequently, 
Figure 1: Different manifestations of partial volume effects manually grouped into three groups. A group 
with narrower and higher peaks in the first passage than the true shape (a), a group with two peaks in the 
first passage in close succession (b) and a third group with almost no first passage peak (c). the black line 
is the ground truth and all profiles are rescaled to have equal area-under-the-curve. the corresponding 
complex trajectory of the Δr2






the curves were manually grouped according to common shape features as presented in figure 
1. Figure 1a, 1b and 1c show the Δr2
* profiles together with the ground truth, these profiles 
were scaled according to their area-under-the-curve. Figure 1d, 1e and 1f show the corre-
sponding complex trajectories of the Δr2
* profiles in 1a, 1b and 1c respectively. the first group 
(Figure 1a), consists of curves showing a narrower and higher peak than the true shape. the 
high and narrow peak in Δr2
* is formed when, at the maximum concentration, all components 
add destructively (see Figure 1d). this leads to an underestimation of the amplitude of the Mr 
signal, resulting in a severe overestimation of Δr2
* (12, 13). the second group of curves (Figure 
1b) show, instead of a single peak in the first passage, two peaks in close succession. this occurs 
when the complex signal passes close to the zero for a concentration lower than the maximum 
concentration (see Figure 1e). the third group (Figure 1c) shows curves with almost no peak in 
the first passage and a high post-bolus equilibrium. Automatic AIF selection criteria are likely to 
exclude AIF measurements suffering from partial volume errors of the second and third group, 
but AIF measurements with PVEs such as those in the first group are not excluded, because 
these curves have a small width, early time-to-peak and high peak-height. 
the proposed criterion
the aim of the proposed criterion is to identifying voxels with minimal shape distortions due 
to PVEs. the proposed metric is the ratio of the mean steady-state value to the area-under-the-
curve (AUC) of the first passage of contrast agent, further referred to as “SS:AUC1st ratio”. this 
metric follows from tracer kinetic principles to calculate CbV. the CbV can be calculated, using 
the area-under-the-curve of the different passages or the steady-state concentration (16), by 
taking the ratio of the tissue response to the AIF:
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where C(t) is the concentration contrast agent in tissue, CAIF(t) is the concentration 
contrast agent in the brain-feeding artery, tss is the time at which the concentration of 
contrast agent is in steady-state (17, 18). Rewriting equation [1] results in three ratios that 
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where C(t) is the concentration contrast agent in tissue, CAIF(t) is the concentration contrast 
agent in the brain-feeding artery, tss is the time at which the concentration of contrast agent is 
in steady-st te (17, 18). rewriting equation  results in hree ratios that ar  con tan  for a terial 
and tissue concentration-versus-time profiles of a single experiment:
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These relations are only valid when C(t) reflects the true concentration-time curve, 
although a general scaling factor would not affect the validity of these relations. In DSC-
MRI the MR-signal changes are converted to ΔR2*. The ΔR2* profiles of the AIF 
measurements in or close to a brain-feeding artery are often hampered by PVEs. These 
PVEs lead to scaling errors and more importantly to shape errors with respect to the true 
concentration-versus-time profile. When such shape errors are present the SS:AUC1st 
ratio of the AIF measurement deviates from the ground truth SS:AUC1st ratio. The 
reference value reflecting the ground truth SS:AUC1st ratio can be determined in tissue, 
because the ΔR2* profile in tissue is linear with respect to the concentration of contrast 
agent under the assumption that the arterioles and capillaries are randomly oriented (14).  
Two of the three metrics were not investigated because of practical considerations: (i) the 
second passage has lower signal-to-noise than the first passage (where SNR is defined as 
the signal difference between pre-bolus and peak concentration over the noise at 
baseline), and (ii) the gamma-variate fit through the second passage is more difficult to 
determine than the steady-state due to its overlap with the first and subsequent bolus 
passages (see Figure 2).  
In this study, the mean steady-state level was determined by averaging the last ten 
dynamics of the perfusion scan. The AUC of the first passage was determined using a 
gamma-variate fit through the first passage (see Figure 2). Good starting values are 
important for preventing the fit to end up in a local minimum. The starting values for the 
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These relations are only valid when C(t) reflects the true concentration-time curve, 
although a general scaling factor would not affect the validity of these relations. In DSC-
MRI the MR-signal changes are converted to ΔR2*. The ΔR2* profiles of the AIF 
measurements in or close to a brain-feeding artery are often hampered by PVEs. These 
PVEs lead to scaling errors and more importantly to shape errors with respect to the true 
concentration-versus-time profile. When such shape errors are present the SS:AUC1st 
ratio of the AIF measurement deviates from the ground truth SS:AUC1st ratio. The 
reference value reflecting the ground truth SS:AUC1st ratio can be determined in tissue, 
because the ΔR2* profile in tissue is linear with respect to the concentration of contrast 
agent under the assumption that the arterioles and capillaries are randomly oriented (14).  
Two of the three metrics were not investigated because of practical considerations: (i) the 
second passage has lower signal-to-noise than the first passage (where SNR is defined as 
the signal difference between pre-bolus and peak concentration over the noise at 
baseline), and (ii) the gamma-variate fit through the second passage is more difficult to 
determine than the steady-state due to its overlap with the first and subsequent bolus 
passages (see Figure 2).  
In this study, the mean steady-state level was determined by averaging the last ten 
dynamics of the perfusion scan. The AUC of the first passage was determined using a 
gamma-variate fit through the first passage (see Figure 2). Good starting values are 































































These relations are only valid when C(t) reflects the true concentration-time curve, 
although a general scaling factor would not affect the validity of these relations. In DSC-
MRI the MR-signal changes are converted to ΔR2*. The ΔR2* profiles of the AIF 
measurements in or close to a brain-feeding artery are often hampered by PVEs. These 
PVEs lead to scaling errors and more importantly to shape errors with respect to the true 
concentration-versus-time profile. When such shape errors are present the SS:AUC1st 
ratio of the AIF measurement deviates from the ground truth SS:AUC1st ratio. The 
reference value reflecting the ground truth SS:AUC1st ratio can be determined in tissue, 
because the ΔR2* profile in tissue is linear with respect to the concentration of contrast 
agent under the assumption that the arterioles and capillaries are randomly oriented (14).  
Two of the three metrics were not investigated because of practical considerations: (i) the 
second passage has lower signal-to-noise than the first passage (where SNR is defined as 
the signal difference between pre-bolus and peak concentration over the noise at 
baseline), and (ii) the gamma-variate fit through the second passage is more difficult to 
determine than the steady-state due to its overlap with the first and subsequent bolus 
passages (see Figure 2).  
In this study, the mean steady-state level was determined by averaging the last ten 
dynamics of the perfusion scan. The AUC of the first passage was determined using a 
gamma-variate fit through the first passage (see Figure 2). Good starting values are 
important for preventing the fit to end up in a local minimum. The starting values for the 
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these relations are only valid when C(t) reflects the true concentration-time curve, although 
a general scaling factor would ot affect the alidity f these relations. In DSC-MrI the Mr-
signal changes are converted to Δr2
*. the Δr2
* profiles of the AIF measurements in or close 
to a brain-fe ding artery are often hampered by PVEs. these PVEs lead to scaling errors and 
more importantly to shape errors with respect to the true concentration-versus-time profile. 
When such shape errors are present the SS:AUC1st ratio of the AIF measurement deviates from 
the ground truth SS:AUC1st ratio. the reference value reflecting the ground truth SS:AUC1st 
ratio can be determined in tissue, because the Δr2
* profile in tissue is linear with respect to the 
concentr tion of contrast agent under the assumption that the arterioles and capillaries are 
randomly oriented (14). 
two of he th ee metrics were not investigated because of practical considerations: (i) the 
second passage has lower signal-to-noise than the first passage (where SNr is defined as the 
signal difference between pre-bolus and peak concentration over the noise at baseline), and 
(ii) the gamma-variate fit through the second passage is more difficult to determine than the 
steady-state due to its overlap with the first and subsequent bolus passages (see Figure 2). 
In this study, the mean t -st t  level was determined by averaging the la t ten dynam-
ics of the perfusion scan. the AUC of the first passage was determined using a gamma-variate 
fit through the first passage (see Figure 2). good starting values are important for preventing 
the fit to end up in a local inimum. the starting values for the simulations were obtained from 
Figure 2: the gamma-variate estimation of the first (a) and second passage (b) and the steady-state 
estimation (c). the gamma-variate fit through the first passage is feasible but the gamma-variate fit through 
the second passage only contains a few data points due to the overlap with the first and subsequent tissue 
passage. two of these three measurements can be used to determine the ratio, which assesses the shape 






the gamma-variate fitting values through the simulated tissue curve (to reflect closer the in 
vivo situation, see below); the tissue curve was calculated from the first passage of the ground 
truth AIF convolved with an exponential residue function.
simulations
All simulations were implemented in MAtlAb (r2007b, Natick, MA, USA). In the simulations, 
a modeled AIF (19) and a modeled tissue response were used. the tissue contrast agent con-
centration was created after convolving the modeled AIF with an exponential residue function 
(CbF = 60 ml/100g/min, Mtt = 4 sec, CbV = 4 ml/100g). 
Partial volume effects simulations
the numerical model to study partial volume shape errors in the AIF measurements included 
local magnetic field changes and relaxation rate changes due to the passing contrast agent. For 
these simulations, only the contrast agent passage within the artery is modeled. the artery is 
assumed to be a cylinder (diameter = 4 mm) oriented perpendicular to b0 and the artery is sur-
rounded by tissue. the longitudinal, transverse relaxation times and the relaxivity values were 
set to in vivo values at 1.5 t (which are used for all other simulations): t1 is 0.95 sec and 1.4 sec 
for tissue and blood respectively (20), t2
* is 0.1 sec for tissue and blood (20), transverse relaxiv-
ity of the contrast agent in arterial blood with a linear term 7.62 l/mmol/sec and a quadratic 
term 0.57 l2/mmol2/sec (21). the local field changes, resulting from the susceptibility difference 
(molar susceptibility χm = 0.3209∙10
-3 l/mol (21)), were calculated using the Maxwell equations 
corrected for the sphere of lorenz on a spatial grid of 250 μm. the double-dose experiment at 
1.5 t is also representative for a single-dose experiment at 3 t (11). A rectangle voxel with a size 
of 1x3 times the radius of the cylinder was used (due to symmetry in the direction of the vessel, 
only two dimensions need to be included). this voxel was shifted over the local field map and 
the gradient-echo signal was calculated taking in account the relaxivity effects of the contrast 
agent within the artery. the shifting generates a large range of PVEs that can occur when there 
is a linear phase effect inside the artery and a blooming effect outside the artery. the simulated 
AIF profiles were studied and three groups were manually selected (see Figure 1). 
Factors affecting the SS:AUC1st ratio
the effects of t1 relaxation changes on SS:AUC
1st ratio of the tissue response for a gradient-echo 
Mr-signal were studied using the modeled tissue response. the effect of t1 relaxation changes 
on the arterial response is expected to be minimal due to fresh inflow of spins and were not 
further studied. the flip angle and repetition time were varied in the simulations, since these 
two parameters influence the t1-effect in tissue the most (22). gradient echo signals with tE/tr 
31/1500 msec and tE/tr 31/600 msec were simulated and the flip angle was varied from 5º to 
90º in steps of 5º using a longitudinal relaxivity (r1) of 4.3 l/mmol/sec (23). 
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the second factor that can affect the SS:AUC1st ratio is the SNr, since the ratio measured 
in the AIF and the reference ratio obtained from the tissue response are subject to noise. the 
effect of noise on the SS:AUC1st ratio was studied using the modeled tissue response. Four dif-
ferent SNr levels were simulated (20:1, 30:1, 40:1 and 50:1) with 10000 random noise repeats. 
From these simulations the mean value and the standard deviation of the SS:AUC1st ratio were 
calculated.
It has been shown that AIF measurements are best selected in locations where PVEs do not 
corrupt the measurements (11, 12). these locations are, for example, in homogenous tissue 
close to but completely outside the middle cerebral artery (MCA) (11). Unfortunately, AIF mea-
surements performed in tissue are hampered by the tissue response. therefore, the third factor 
studied is the contamination of the AIF measurement by the tissue response. the influence of 
the tissue response on the extravascular susceptibility induced contrast was studied using a 
previously published numerical model (11). this model, which was validated using phantom 
experiments, simulates AIF measurements in and near a cylinder that is oriented perpendicular 
to b0 (a model for arteries such as the MCA). the model is based on the numerical model used 
to study PVEs (see above), but is extended and includes also imaging effects such as the phase-
shifts and distortions from the EPI readout train as well as a tissue passage of the contrast agent 
in the surrounding. the imaging settings for the simulations were the following: segmented 
EPI, matrix size 96x96, tE/tr 31/600 msec, flip angle (FA) 40º, field of view (FOV) 220x220 mm2, 
10 slices of 6.2 mm thickness with 1 mm gap, number of echoes per echo-train 21. the SS:AUC1st 
ratios of the simulated AIF measurements were calculated, the difference with the ground truth 
in percent was determined and the AUC of the first passage was used as a measure for SNr.
in vivo
In vivo DSC-MrI exams of six patients (1 man, 5 women; mean age 36, range 16-46) suffering 
from Systemic lupus Erythematosus were used for evaluation of both the reference SS:AUC1st 
ratio obtained from the tissue response and measured AIF SS:AUC1st ratio in and around the 
MCA. In vivo experiments were performed at 3 t (Achieva, Philips, best, the Netherlands) using 
an 8-channel receive array head coil, 0.1 mmol/kg-bodyweight gd-DtPA was injected at 5 ml/
sec followed by a saline chaser of 25 ml injected at the same speed. the imaging sequence 
had the following settings: dual-echo segmented EPI: data matrix 96x96, tE1/tE2/tr 11/31/600 
msec, FA 40º, FOV 220x220 mm2, SENSE factor of 2.2, 10 slices of 6.2 mm thickness with 1 mm 
interslice gap with one additional slice through the carotid artery just above the bifurcation, 
number of echoes per echo-train 21. the study was approved by the local ethics committee.
in vivo post processing
the in vivo DSC-MrI exams were acquired with two echo times. by using a dual-echo sequence, 







calculated, the difference with the ground truth in percent was determined and the AUC 
of the first passage was used as a measure for SNR. 
In vivo 
In vivo DSC-MRI exams of six patients (1 man, 5 women; mean age 36, range 16-46) 
suffering from Systemic Lupus Erythematosus were used for evaluation of both the 
reference SS:AUC1st ratio obtained from the tissue response and measured AIF 
SS:AUC1st ratio in and around the MCA. In vivo experiments were performed at 3 T 
(Achieva, Philips, Best, The Netherlands) using an 8-channel receive array head coil, 0.1 
mmol/kg-bodyweight Gd-DTPA was injected at 5 ml/sec followed by a saline chaser of 
25 ml injected at the same speed. The imaging sequence had the following settings: dual-
echo segmented EPI: data matrix 96x96, TE1/TE2/TR 11/31/600 msec, FA 40º, FOV 
220x220 mm2, SENSE factor of 2.2, 10 slices of 6.2 mm thickness with 1 mm interslice 
gap with one additional slice through the carotid artery just above the bifurcation, number 
of echoes per echo-train 21. The study was approved by the local ethics committee. 
In vivo post processing 
The in vivo DSC-MRI exams were acquired with two echo times. By using a dual-echo 
sequence, correction for T1-relaxation effects (caused by the passage of contrast agent) is 
possible (24, 25): 
















































where TE is the echo time and S(t) is the magnitude of the MR-signal. 
To segment gray matter, white matter and vessels, a relative CBV was calculated using 
the AUC of the ΔR2*-curves. The CBV value intervals for the segmentation were 
empirically determined and the resulting gray and white matter segmentation was 
compared to the pre-bolus T2* image. Furthermore, a lobular mask was used to segment 
the tissue in the following lobes and areas: the frontal, parietal, occipital and temporal 
lobe, the cerebellum, the insula and a combined area of thalamus, caudate nucleus and 
putamen (26). Before segmentation, the dataset was normalized using an EPI template in 
SPM 5 (Wellcome Trust Centre for Neuroimaging, Institute of Neurology, UCL, London 
 [5]
where tE is the echo time and S(t) is the magnitude of the Mr-signal.
to segment gray matter, white matter and vessels, a relative CbV was calculated using the 
AUC of the Δr2
*-curves. the CbV value intervals for the segmentation were empirically deter-
mined and the resulting gray and whit  matter segmentation was comp red to the pre-b lus 
t2
* image. Furthermore, a lobular mask was used to segment the tissue in the following lobes 
and areas: the frontal, parietal, occipital and temporal lobe, the cerebellum, the insula and a 
combined area of thalamus, caudate nucleus and putamen (26). before segmentation, the data-
set was normalized using an EPI template in SPM 5 (Wellcome trust Centre for Neuroimaging, 
Institute of Neurology, UCl, london Uk – http://www.fil.ion.ucl.ac.uk/spm). the average tissue 
response was determined for the gray matter and white matter part of the different lobe-areas. 
the SS:AUC1st ratio was determined and a two-sided paired t-test was used to compare the 
SS:AUC1st ratio obtained from gray matter and white matter. the mean value and the standard 
deviation of the SS:AUC1st ratios for the different gray matter and white matter areas of the 
lobular mask were calculated. the acceptance range for the SS:AUC1st ratio was defined as the 
mean value plus or minus two times the standard deviation (referred to as “range of accep-
tance”). the in vivo DSC-MrI exams were also used to evaluate AIF measurements near the 
MCA, and to illustrate whether PVEs can be detected in vivo. 
results
simulations: the influence of t1-effects, noise and the tissue passage curve on 
the proposed criterion
Figure 3 shows the influence of t1-effects on the SS:AUC
1st ratio of the tissue response. the 
t1-effects for relatively short repetition times (as used in segmented EPI) are large for normal 
flip angles. Flip angles close to the Ernst angle result in a post-bolus equilibrium around zero 
and therefore the SS:AUC1st ratio is close to zero. For flip angles around 5º the t1-effect is 
reduced and the SS:AUC1st ratio is close to the ground truth, but with such small flip angles the 
SNr of the acquisition is reduced. Single shot EPI with its longer repetition time is less sensi-
tive to t1-effects, as shown in figure 3c and d. Nevertheless, flip angles around the Ernst angle 
reduce the SS:AUC1st to around 50% of the ground truth. these results show that the error in 
the SS:AUC1st ratio due to t1-effects is large for techniques that are t1-sensitive. the dual-echo 
approach can make the acquisition t1-insensitive and for this reason, t1-effects were ignored in 
further simulations. 
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the influence of noise on determining the SS:AUC1st ratio was studied using repeated 
simulations with random noise. the SNr was varied from 20:1 to 50:1 in steps of 10:1, and the 
results are presented in table 1 (the ground truth of the SS:AUC1st ratio for this simulated case 
was 0.0176). the standard deviation of the SS:AUC1st estimation reduces with increasing SNr. 
However, a single voxel AIF measurement with a typical SNr of 50:1 still has a 95% confidence 
interval of the mean value ± 7.6%. 
the third factor influencing the SS:AUC1st ratio is the contamination of the AIF with the tis-
sue response. Figure 4a shows the SS:AUC1st ratio for the simulated AIF measurements in and 
around the MCA (presented as a sagittal section); the ground truth is 0.0176. the % deviation 
from the ground truth better shows the accuracy of the SS:AUC1st ratio (see Figure 4b). Figure 
4b shows that the SS:AUC1st ratio is higher than the ground truth in voxels encompassing the 
MCA. Furthermore, it can be seen that the tissue remote from the vessel in the superior-inferior 
Figure 3: the influence of t1-effects. top: segmented EPI (tE/tr 31/600 msec), bottom: single shot EPI 
(tE/tr 31/1500 msec). the various curves in (a) and (c) correspond to the different flip angles simulated 
(bottom curve = 90o; upper curve = 5o); the gray dashed line corresponds to the curve in the absence of 
t1-effects. left: the profiles of Δr2
*, right: the SS:AUC1st ratio versus the flip angle (the ground truth for this 
case is 0.0176). the vertical gray line in (b) and (d) correspond to the Ernst angle.
table 1: the mean SS:AUC1st ratio, the standard deviation (SD) and the standard deviation as percent of 
the mean value for the modeled AIF with different SNr levels and 10000 random noise repeats. ground 
truth for this case: 0.0176
snr mean sd sd [%]
20:1 0.0175 0.0015 8.8
30:1 0.0176 0.0011 6.1
40:1 0.0176 0.0008 4.7






direction has a SS:AUC1st ratio close to the ground truth. However, in this region, the AUC of the 
first passage is low (see figure 4c). More importantly, Figure 4b shows that AIF measurements 
in the vicinity of the MCA also have a correct SS:AUC1st ratio, but only in a narrow rim because 
further anterior and posterior the SS:AUC1st ratio reduces to a value lower than the ground 
truth. the AUC of the first passage indicates regions with high SNr and low SNr; high SNr is 
found in voxels encompassing the MCA and low SNr is found in tissue.
in vivo: evaluation of the proposed criterion 
the reference SS:AUC1st ratio was determined for different lobes and areas in the segmented 
gray and white matter, since averaging over a large number of voxel increases the SNr substan-
tially and hence improves the accuracy. Unfortunately, for small regions (such as the insula) 
averaging over a number of voxels did not provide particularly high SNr, SNr values were as 
low as 26:1 for gray matter and 16:1 for white matter. However, the average SNr over all regions 
and patients is high with an average SNr value of 169:1 for gray matter and 126:1 for white 
matter. the average SS:AUC1st ratio and the standard deviation over the different lobes and 
areas are presented in table 2.
Figure 4: the three figures show a) the SS:AUC1st ratio (ground truth is 0.0176) for simulated AIF 
measurements in and near a perpendicular oriented cylinder (model for the middle cerebral artery), b) the 
percentage difference from the ground truth value for the simulated AIF measurements and c) the AUC of 
the first passage. Note that the superior and inferior tissue response has a ratio value close to the ground 
truth and that a rim (indicated with a white arrow) around the perpendicular cylinder (indicated with a 
white circle) provides the same SS:AUC1st ratio.
table 2: the mean SS:AUC1st ratio for gray matter (gM) and white matter (WM), the standard deviation (SD) 
and the standard deviation in percent of the mean value for 6 patients based on the gray matter and white 
matter segmentation and averaged over the different brain lobes.
  mean gm sd sd [%] mean Wm sd sd [%]
patient 1 0.0236 0.0022 9.3% 0.0211 0.0038 17.8%
patient 2 0.0208 0.0014 7.0% 0.0194 0.0019 9.8%
patient 3 0.0262 0.0025 9.6% 0.0234 0.0016 7.0%
patient 4 0.0363 0.0036 10.0% 0.0319 0.0018 5.5%
patient 5 0.0261 0.0023 8.9% 0.0240 0.0018 7.6%
patient 6 0.0349 0.0034 9.7% 0.0317 0.0023 7.4%

















































































































































































































the mean SS:AUC1st ratio of the tissue response varies over subjects; the SS:AUC1st ratio for 
patients 4 and 6, for example, are much higher for both gray matter and white matter than 
the other patients. this could be due to a different fraction of blood flowing to the brain 
vasculature. the mean SS:AUC1st ratio of the gray matter is significantly higher than the white 
matter SS:AUC1st ratio (p<0.005) for each patient. the standard deviation (in percent of the 
mean value) for gray matter as calculated from different lobes is not larger than 10%; using this 
value the range of acceptance is formed with an interval of the mean value ± 20%. this range 
of acceptance was used to evaluate the SS:AUC1st ratio of AIF measurements in and around 
the MCA. the profiles of one patient are presented in figure 5; the range of acceptance for 
this patient (patient 1) is [0.019 0.028]. the individual profiles of the AIF measurements partly 
encompassing the MCA have SS:AUC1st ratios that fall outside the range of acceptance (see red 
dots in Figure 5) except for one profile. that profile has a first passage that is distorted and the 
gamma-variate model is not the right model to fit this first passage. the first passage of the 
second plot on the bottom row in figure 5 also has a different shape than the gamma-variate 
function, but here the result is that the SS:AUC1st ratio falls outside the range of acceptance. It 
is therefore important to test whether the gamma-variate fit is the right model to fit the first 
passage. A profile with a very high peak and a small width is observed in the bottom row first 
plot; it should be noted that the sharp peak of this profile is similar to the first group of the 
simulated PVEs. therefore, this profile may not necessarily be recognized as distorted by previ-
ously proposed automatic AIF selection algorithms; however, the SS:AUC1st ratio falls outside 
the range of acceptance since the mean steady-state value is close to zero and the AUC of 
the first passage is high. A number of voxels with SS:AUC1st ratios that fall inside the range of 
acceptance (see green dots in Figure 5) are superior to the vessel and posterior to the vessel, 
which is in agreement with predictions from a previous study (11).
disCussion And ConClusions
the most important findings of this study are four-fold. First, a new criterion based on tracer 
kinetic theory can detect non-linear shape errors due to PVEs in the estimated evolution of the 
AIF (measured using the Δr2
*) using a reference value obtained from tissue. Second, for cor-
rect use of the ratio approach, t1-insensitive techniques should be employed for the DSC-MrI 
acquisition, because t1-effects predominantly affect the steady-state of the tissue response, 
leading to different SS:AUC1st ratios for AIF versus tissue. third, we suggest that the best refer-
ence SS:AUC1st ratio is obtained from the gray matter tissue. Finally, the proposed criterion 
should be used as an additional criterion in automatic AIF selection procedures and not as a 
stand-alone criterion. 
In this study, a new criterion is proposed to aid in the AIF selection to exclude shape errors 
arising from PVEs. the criterion uses a metric that is based on tracer kinetic principles. the 
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metric is the ratio of the mean steady-state (determined using a number of time-points of the 
post-bolus equilibrium) to the AUC of the first passage (determined using a gamma-variate 
fit through the time-points of the first passage). the SS:AUC1st ratio for the AIF measurement 
is guided by the reference SS:AUC1st ratio obtained from tissue. the gray matter voxels, which 
are used for the reference SS:AUC1st ratio, can for example be selected by a simple gray matter 
segmentation based on the relative CbV determined using the AUC of the tissue response. We 
determined a range of acceptance for the SS:AUC1st ratio based on in vivo data. the in vivo 
example in figure 5 confirms that AIF measurements with severe PVEs fall outside the range of 
acceptance (the mean value ± 20%). In particular, it was found that PVEs voxels with high and 
narrow peaks do occur in vivo (see figure 5, bottom row left; compare figure 1(a)); such peaks 
would be selected as good examples of AIF voxels using most automated approaches, but they 
can be identified and excluded using the proposed additional criterion.
there are, however, a number of factors that influence the SS:AUC1st ratio either of the AIF, 
the tissue reference value or both. t1 relaxation effects affect the shape of the tissue response 
and, especially, the steady-state signal, which in turn affect the SS:AUC1st ratio. In general, 
t1-effects lead to an underestimation of the reference SS:AUC
1st ratio. the simulations showed 
that for segmented EPI, with its relatively short repetition time, the t1-related error in SS:AUC
1st 
ratio is large. Using a very small flip angle can reduce t1-effects (22), but this also reduces the 
baseline SNr. Acquiring segmented EPI with two echo times makes correction for t1-effects 
possible, and is therefore advantageous over normal segmented EPI acquisition. Single shot EPI 
does also suffer from t1-effects although in a lesser extent. When there is fresh inflow of spins, 
such as in arteries, these t1-effects can be ignored. Finally, it could be studied whether the 
influence of t1-effects on the SS:AUC
1st ratio of tissue could be corrected for e.g. by assuming a 
certain average steady-state concentration.
We suggest that the reference SS:AUC1st ratio is best obtained from gray matter in areas 
distant from arteries and veins. In vivo, differences in reference SS:AUC1st ratio were observed 
between the gray and white matter, which is not in line with the findings of kjølby et al. (14), 
who predicted, based on simulations and analytical models, a linear relation between Dr2
* and 
concentration of contrast agent for both white and gray matter. Although the reason is not 
fully understood, this difference could be because the area of dephased signal from a particular 
vessel touches the dephasing area of other vessels for the higher concentrations of contrast 
agent in gray matter. the overlapping dephasing areas would induce a leveling off of the Dr2
* 
versus gadolinium concentration curve, thereby indeed leading to a higher SS:AUC1st ratio for 
gray matter than white matter as was observed. the theoretical model of kjølby et al. assumes 
that each vessel can be treated as a separate object, not influencing or influenced by other 
vessels and this leveling-off effect is therefore not included. An alternative reason could be that 
the static dephasing regime is not valid for low concentrations that occur in the steady-state of 
white matter (27, 28), or the fact that the mesoscopic structure of the gray matter is different 






Contamination of white matter voxels in the gray matter average would lower the reference 
ratio value. this effect is however expected to be small due to the small difference between the 
white and gray matter values. 
Since the SS:AUC1st is determined over a region of interest with many voxels, the SNr is 
increased compared to a single voxel. However, the SNr for a small rOIs (e.g. the insula) in the 
lobular mask had low SNr values resulting in reduced accuracy of that specific SS:AUC1st ratio. 
the simulations show that for these low SNr values (approximately 20:1) the 95% confidence 
interval is the true value ± 18%. However, the average SNr over all rOIs and all patients is high 
for gray and white matter. In addition, the frontal and temporal areas show for all patients a 
higher SS:AUC1st ratio than the occipital and parietal areas (data not shown). these regional 
differences together with the inaccuracy due to low SNr of a few regions lead to the approxi-
mately 10% standard deviation in the ratio estimation of gray matter. It can be expected that 
averaging the total gray matter would further reduce this source of error.
the new proposed selection criterion is not designed as a stand-alone criterion, but as an 
additional selection criterion for automatic AIF selection or for guiding manual AIF selection. 
Errors can occur when the gamma-variate fit no longer describes the first passage accurately. 
Estimation of the SS:AUC1st ratios for the AIF measurement shows false positives for some partial 
volume errors. However, these false positives could be easily avoided by including boundary 
constraints on the gamma-variate fit through the first passage, or by using an additional stan-
dard criterion, such as a small FWHM. Alternatively, more specialized methods for first passage 
extraction can also be used to improve the ratio estimation (27, 30, 31).
Errors in the SS:AUC1st ratio can also occur when there are motion artifacts. In the post-
bolus equilibrium, motion artifacts can lead to a sudden increase, sudden decrease or sharp 
transient peaks (data not shown). When incorporating the proposed criterion in an automatic 
AIF selection program, these motion artifacts should be detected. In addition, the post-bolus 
equilibrium should have a sufficient number of time-points, therefore the acquisition of the 
DSC-MrI exam should be long enough to properly characterize the tail of the bolus passage. 
Moreover, since the SS:AUC1st ratio is highly dependent on the AUC1st passage, having proper 
starting values for the gamma-variate fit is of high importance. We used as starting values for 
the simulation the fitting values of the fit through the ground truth, and as starting values 
for the in vivo ratio estimates the fitting values of the whole brain average, which is primarily 
weighted to the tissue response. both approaches led to appropriate fitting of the first passage.
Since the new criterion aims at detecting PVEs, AIF measurements that are only hampered 
by noise will not be excluded. Noise originating from physiological pulsations or instrumental 
noise can alter the AIF profile to produce a wider peak and a smaller peak-height. Including 
these AIF measurements is crucial for unbiased averaging. less stringent criteria concerning 
the first passage can aid in unbiased averaging of several “correct” AIF measurements. 
Although the simulations are only performed for an artery perpendicular to b0, the generic 
pattern of a linear phase effect inside and a blooming phase effect outside the artery is typical 
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for all angles except arteries at the magic angle or parallel to b0. the shifting of the voxel in 
steps smaller than the voxel size generated a large range of PVEs. We expect that the shape 
errors encountered in the simulations are representative for shape errors of arteries with other 
orientations.
In conclusion, we propose a metric that can aid in either manual or automatic AIF selection. 
the metric checks whether the AIF is corrupted by PVEs. Having an AIF that is not corrupted by 
PVEs greatly improves the quantification of the hemodynamic parameters. Since the proposed 
approach is a post-processing method, the ratio can also be used retrospectively in previously 
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Chapter 6: Evaluation of signal formation in local 
arterial input function measurements of 
dynamic susceptibility contrast MrI
Egbert JW bleeker, Andrew g Webb, Marianne AA van 
Walderveen, Mark A van buchem, and Matthias JP van Osch
ABstrACt
Correct arterial input function (AIF) measurements in dynamic susceptibility contrast-MrI are 
crucial for quantification of the hemodynamic parameters. Often a single global AIF is selected 
near a large brain-feeding artery. Alternatively, local AIF measurements aim for voxel-specific 
AIFs from smaller arteries. because local AIFs are measured higher in the arterial-tree, it is 
assumed that these will reflect the true input of the microvasculature much better. However, 
do the measured local AIFs reflect the true concentration-time curves (CtC) of small arteries? 
to answer this question, a 3D numerical model that simulated partial-volume effects (PVEs) 
in local AIF measurements was created and the simulated local AIFs were compared to the 
ground truth. In addition, in vivo data were used to evaluate local AIF candidates selected 
using two angiograms. the findings are two-fold. First, the simulations show that PVEs in the 
local AIF measurements lead to broader CtCs than the ground truth AIF due to extravascular 
susceptibility effects and the contrast agent passing through surrounding microvasculature. 
Second, the in vivo data showed that the shape-characteristics of local AIFs are similar to the 
shape-characteristics of gray matter CtCs. these findings suggest that local AIF measurements 








Dynamic susceptibility contrast (DSC-) MrI measures brain-perfusion by monitoring the pas-
sage of a bolus of contrast agent through the brain-vasculature. Voxel-based measurements 
of the bolus passage in tissue give information about local cerebral blood flow (CbF), cerebral 
blood volume (CbV) and subsequently the mean transit time (Mtt) (1, 2). these local perfu-
sion estimates are useful, for example, for staging tumors and assessing the tissue at risk of 
permanent damage after a stroke (3, 4). However, the tissue response needs to be calibrated via 
deconvolution with an arterial input function (AIF) i.e., the passage of contrast agent through 
a brain-feeding artery. Most DSC-MrI studies use a single (often manually selected) global AIF 
for all voxels. 
Alternatively, it has been suggested that local or regional AIF measurements can improve 
determination of the perfusion parameters (5-7). these local AIFs are measured closer to the 
capillaries of the brain tissue compared to global AIF measurements. Deconvolution with a local 
AIF produces residue functions that are less affected by delay and dispersion effects due to the 
transport of the contrast agent from the location of the AIF determination to the beginning 
of the capillary bed (8). the former can be corrected for by using delay-insensitive deconvolu-
tion techniques, but dispersion corrupts the perfusion estimates (2, 9, 10). In addition, local 
AIF measurements are flow territory specific, which can be especially beneficial when there 
is a stenosed or occluded large artery, since such large vessel pathologies lead to additional 
delay and dispersion in the corresponding flow territory (11). the use of a global AIF measured 
contralaterally from the stenosis or occlusion would create perfusion estimates for the flow 
territory of the stenosed artery that include the dispersive properties of the stenosis, leading to 
underestimation of CbF (12).
However, such local AIF measurements are performed with voxels larger than the small 
brain-feeding arteries from which the AIF is obtained. the Mr-signal from such a voxel will 
be influenced by the contrast agent within the artery, the magnetic field changes outside the 
artery induced by the intravascular contrast agent and by the contrast agent passing through 
the microvasculature of the tissue surrounding the artery (tissue response). the combination 
of the relaxation effects and local field changes can lead to shape changes in the AIF due to 
differences in phase evolution of the different compartments. For larger arteries, such non-
linear partial-volume effects (PVEs) have been shown to lead to erroneous perfusion estimates 
(13-15). 
Validation of local AIF measurements is ideally performed by comparing the measured local 
AIF with the true concentration-time curve (CtC) within the small brain-feeding artery. How-
ever, blood sampling cannot be performed at that point in the brain-vasculature. therefore, 
previous validations of local AIF measurements have been performed by comparing the perfu-
sion maps (and sometimes the CtCs) from local AIF measurements to those obtained from 
manually selected global AIF measurements (5-7, 16, 17). A single report showed additional 
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comparison to PEt perfusion maps (16). When validating local AIF methods one should keep in 
mind that all methods to automatically select (local) AIFs are based on features of a “proper” AIF, 
such as small width, early time-of-arrival (tA), high peak-height, etc, and the selected curves 
will therefore always exhibit exactly these properties (6, 7, 18-21). the important question in 
validation is: do the curves of the local AIF measurements really reflect the true CtC of small 
arteries? A previous simulation study by kjølby and coworkers reported that the contribution 
of the tissue response to an AIF measured in or near a large artery can lead to broadening 
of the measured bolus passage inside the artery, although the simulations only modeled two 
orientations (parallel and perpendicular to the main magnetic field) and in vivo verification was 
absent (14). 
In this study, the properties of the bolus passage curves in voxels located on top of small 
arteries are compared to curves obtained in the gray matter. the properties of these two collec-
tions of voxels should differ, with a much higher percentage of AIF-like curves in the first group 
required to justify a local AIF approach. In addition to the in vivo study, numerical simulations 
of partial-volume effects in local AIF measurement were used to investigate the influence of the 
tissue passage and extravascular magnetic field changes on the shape of local AIFs. 
methods
simulations
A small brain-feeding artery was modeled as a cylinder at different orientations to the main 
magnetic field and different locations within the voxel. Intra- and extravascular Mr-signal 
was modeled using Maxwell equations and normal gradient echo signal formation formulas, 
including relaxation changes and dephasing due to the local field changes. local AIF measure-
ments were modeled for single shot EPI and PrEStO (an ultra fast t2
*-weighted 3D acquisition 
with echo shifting (22)) sequences. Single shot EPI with voxels of 2x2x6 mm3 was simulated 
on a high-resolution 3D grid, with 250 μm interspacing, spanning 12x12 mm2 by 24 mm. the 
imaging settings, tE/tr 25/1500 msec and FA= 75º, were set to resemble typical in vivo settings. 
the PrEStO simulations consisted of voxels of 2.5x2.5x3.5 mm3 on a high-resolution 3D grid, 
with 250 μm interspacing, spanning 15x15 mm2 by 14 mm. the imaging settings, tE/tr 30/20 
msec and FA= 8º, were set the same as the in vivo settings employed in this study. Distortions 
due to the long echo train were ignored in the simulations due to computational limitations 
(13, 23). In order to generate a larger range of partial-volume effects in the simulations all voxels 
were shifted over the 3D grid in steps of 250 μm in all three directions. the numerical model 
was implemented in MAtlAb (r2007b, Natick, MA, USA).
the orientation of the cylinder with spherical angles θ (angle between the vessel axis and 






for φ from 0º to 45º in steps of 15º. the vessel size was set to have a radius of 0.5 mm, 1.0 mm 
and 1.5 mm.
Inside the cylinder the arterial CtC is simulated with a modeled AIF (24), outside the cylinder 
the tissue response is simulated by the same modeled AIF but convolved with an exponential 
residue function (CbF= 60 ml/100 g/min, Mtt= 4 sec, CbV= 4 ml/100 g).
the relaxation times were set to resemble blood and tissue at 3 tesla (t1 blood 1.7 sec (25), 
t2 blood 70 msec, t1 tissue 1.1 sec (26), t2 tissue 70 msec). A quadratic relation taken from 1.5 
tesla experiments and rescaled to 3 tesla was used for the relation between the intravascular 
Δr2
* and the concentration of gadolinium (linear term 15.24 l/mmol/sec, quadratic term 2.28 
l2/mmol2/sec (27)). the relaxivity in tissue was set to 87 l/mmol/sec (28), longitudinal relaxivity 
was ignored. the local field changes, resulting from the susceptibility difference (molar sus-
ceptibility of the contrast agent χm= 0.3209∙10
-3 l/mol (27)), were calculated using the Maxwell 
equations corrected for the sphere of lorenz.
to study the effect of the tissue response inside the voxel on local AIF measurements, simu-
lations were performed with and without the tissue response in the surroundings of the small 
artery. In addition, the effect of crushing the intravascular signal in PrEStO due to the large 
gradients employed for echo shifting was investigated by setting the intravascular signal to 
zero.
simulation post processing
the simulated signals were transformed to Δr2
*. Profiles were excluded from further analysis 
when a reference point on top of the axis of the simulated artery was not located within the 
simulated voxel, because otherwise the signal changes induced by the arterial passage are too 
minimal. the middle of the volume was chosen as the abovementioned reference point. the 
different orientations, radii and shifts for PVEs, all experienced some degree of partial-volume 
effects, and were treated as one group. Profiles with severe partial-volume shape errors were 
excluded using the steady state to the area-under-the-curve (AUC) of the first passage ratio 
(SS:AUC1st) criterion (29). this SS:AUC1st criterion used the modeled tissue response as a refer-
ence and a gamma variate fit was used to determine the AUC of the first passage. Additional 
exclusion of profiles was based on the time-to-peak (exclusion of too high ttPs, defined as 
ground truth AIF ttP value +2*standard deviation (SD) over all ttPs of the simulated profiles). 
the profiles were compared to the ground truth using the Pearson correlation coefficient. 
For evaluation of the shape-characteristics of the simulated local AIFs three metrics were 
used. two metrics (tA and relative ttP (rttP=ttP-tA)) were determined using the gamma vari-
ate fit and one metric (full-width-at-half-maximum (FWHM)) was determined using the Δr2
* 
profile. the histograms were evaluated and the mean values of the metrics were compared to 
the metrics of the ground truth. 
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in vivo experiments
In vivo DSC-MrI exams (five in total) of three patients suffering from arteriovenous malforma-
tion were employed in this study. One patient was scanned three times; the other two were 
scanned a single time. In vivo experiments were performed at 3 tesla (Achieva, Philips, best, 
the Netherlands) using an 8-channel receive array head coil, 0.1 mmol/kg-bodyweight gd-
DtPA was injected at 5 ml/sec followed by a saline chaser of 25 ml injected at the same speed. 
the imaging sequences had the following settings: PrEStO, data matrix 96x87, zerofilled to 
128x101, 30 slices 3.5 mm thick with no interslice gap, FOV 240x190 mm2, 75 dynamic scans, 
scan duration 120 sec, tE/tr 30/20 msec, FA 8º, EPI factor 15, SENSE factor 2.2, phase encoding 
was set from right to left; time-of-flight (tOF), data matrix 512x325, zerofilled to 512x488, 220 
slices 0.6 mm thick, FOV 180x172 mm2, tE/tr 3.5/23 msec, FA 15º; t1tFE, data matrix 192x192, 
zerofilled to 256x256, 130 slices 1.2 mm thick, FOV 220x175 mm2, tE/tr 4.6/10 msec, FA 8º. the 
study was approved by the local ethics committee.
in vivo post processing
In vivo data were all post processed using SPM5 (Wellcome trust Centre for Neuroimaging, 
Institute of Neurology, UCl, london Uk – http://www.fil.ion.ucl.ac.uk/spm) and MAtlAb. the 
entire hemisphere affected by the AVM was excluded. local AIF candidates were determined 
using two different angiograms: one based on the tOF angiogram and another based on the 
pre- and post-contrast t1-weighted images. A small artery tOF mask was created by threshold-
ing the tOF to such a level that the cortex and skull were excluded. In addition, a separate large 
artery tOF mask was created using an empirical threshold approximately twice the threshold 
for the small artery mask. both small artery mask and large artery mask were coregistered to 
the first t2
*-weighted DSC-MrI image and the large arteries were subsequently removed from 
the small artery mask. 
the small artery t1-based mask was constructed by subtracting the pre-contrast t1-weighted 
image from the coregistered post-contrast t1-weighted image. the t1-based mask was coregis-
tered to the first t2
*-weighted DSC-MrI image using the t1 pre-contrast image. 
In addition, a gray matter mask was created as a reference dataset to compare the CtCs of 
the small artery masks to. this gray matter mask was created using empirically thresholded rCbV 
values that were formed using the area under the Δr2
* profile. Skull stripping was performed 
on both small artery masks and the gray matter mask based on an image of the maximum 
difference of the contrast agent passage that was smoothed and subsequently eroded. 
From all Δr2
* profiles selected by the small artery masks and the gray matter mask severe 
partial-volume shape errors were excluded using the SS:AUC1st ratio criterion (29). Additional 
exclusions of profiles were based on the ttP (larger than the mean value +2*SD), tA (larger than 
the mean value +2*SD) and relative (r)CbV (smaller than lower-threshold of the gray matter 
mask). to evaluate the shape-characteristics of the local AIF candidates and the gray matter 






data were calculated. First, the metric-histograms of the small arteries masks and gray matter 
mask were compared. In addition, the average for each metric was computed. the metrics of 
the local AIF candidates were compared to the metrics of the gray matter profiles and to each 
other using a paired t-test over the five DSC-MrI scans using α = 0.05 corrected for multiple 
comparison using bonferroni correction (3 variables) leading to pbonf < 0.0167 (one-sided) and 
pbonf < 0.0083 (two-sided). 
results 
the results of the shape-characteristics of the local AIFs in the numerical simulations are pre-
sented in table 1 and Figures 1-4. Figure 1 shows the histograms of the different metrics for the 
simulated PrEStO data with tissue passage and crushing. the three metrics have approximately 
a gaussian distribution. Figure 2 shows the mean value and SD of the three timing metrics tA, 
rttP, FWHM for the ground truth AIF, the simulated tissue passage, and the different simula-
tions of EPI and PrEStO. As shown in table 1 and Figure 2, the tA of all simulations are closer 
to the tA of the ground truth AIF than the tA of the ground truth tissue response. Furthermore, 
including the tissue response (wt) in the simulations did not significantly delay tA for the two 
investigated sequences. the addition of the tissue response in the local AIF voxel does, how-
ever, increase the rttP for both sequences. Whereas, the rttP of the simulations without the 
tissue response in the surrounding are similar to the rttP of the ground truth AIF, the rttP of 
the simulations with tissue response is delayed and even close to the rttP of the ground truth 
of the tissue response. the FWHM of the simulations is larger than the FWHM of the ground 
truth AIF and close to the FWHM of the ground truth of the tissue response, except for PrEStO 
without the tissue response (wot). the addition of the tissue response has a small effect on the 
FWHM for single shot EPI and a relatively large effect for PrEStO. In PrEStO without the tissue 
response, the intravascular signal is crushed and therefore only the susceptibility effects in the 
table 1: Shape-characteristic metrics used for evaluating the simulations of single shot EPI and PrEStO. 
Simulations were performed with the tissue response (wt) and without the tissue response (wot). In 
addition, the PrEStO simulations were performed with crushing (wot, wt) and without crushing of the 
intravascular signal due to the large gradients employed for echo shifting (wt woC). the ground truths (gt) 
of the AIF and the tissue response are presented as well. the timing metrics are in seconds and SD is the 
standard deviation over the group of local AIFs.
gt epi presto
AiF tissue wot wt wot wt
wt 
woC
mean sd mean sd mean sd mean sd mean sd
tA 9,5 11,1 9,8 0,2 9,8 0,2 9,9 0,3 9,9 0,3 9,9 0,3
rttP 8,1 9,7 7,6 0,3 8,9 0,5 7,5 0,4 8,5 0,6 8,7 0,6
FWHM 9,8 12,5 12,7 1,8 13,3 1,6 11,2 1,8 12,5 1,7 12,8 1,8
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surrounding of the small artery can explain the increase in FWHM. the effect of crushing the 
intravascular signal in PrEStO on the tA and rttP compared to PrEStO without crushing (wt 
woC) is minimal. 
Subdividing the group of local AIF profiles (of PrEStO (wt)) by artery size shows that smaller 
arteries have a larger rttP compared to the rttP of the larger arteries, although the effect is 
small (see Figure 3). Note that the ground truth AIF of these simulations were the same for small 
and large arteries, that is the diameter of the simulated arteries was the only difference. the 
small arteries also have a broader profile compared to the larger arteries (see Figure 3). Figure 
4 shows the histograms of the correlation of the Δr2
* profiles with the ground truth for the 
different simulations. this figure shows that the distribution of the correlation with the ground 
truth is shifted to higher correlation values for the simulations without the tissue passage. the 
correlation of the ground truth tissue response with the ground truth AIF is 0.81.
Figure 1: the histograms of the time-of-arrival (tA), relative time-to-peak (rttP) and full-width-at-half-
maximum (FWHM) of the simulated local AIFs. All distributions are close to gaussian distributions.
Figure 2: three timing characteristics (time-of-arrival (tA), relative time-to-peak (rttP) and full-width-at-
half-maximum (FWHM)) in seconds to compare the simulated local arterial input functions (AIFs) (of single 
shot EPI and PrEStO) with the ground truth AIF (white bar) and ground truth tissue response (black bar). 






table 2 and Figure 5 show the in vivo metrics of gray matter (gM) and the local AIF candi-
dates based on the two angiograms. gM has the latest tA but the value is very close to the tA of 
the t1-based local AIF candidates. the tA of the tOF-based local AIF candidates are significantly 
lower than gM and significantly lower than the t1-based local AIF candidates. the average 
rttP of the tOF-based local AIF candidates is larger than the rttP of gray matter although not 
Figure 3: Division of the simulated local arterial input functions (AIFs) of PrEStO by artery radius with 
tissue response and crushing (wt). Shown are the ground truth AIF (white bar), the ground truth tissue 
response (black bar), the three radii and the group average for each timing characteristics (time-of-arrival 
(tA), relative time-to-peak (rttP) and full-width-at-half-maximum (FWHM)).  
Figure 4: Histograms of the correlation with the ground truth arterial input function (AIF) for the different 
simulations. the correlation of the ground truth tissue response with the ground truth AIF is 0.81.
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significantly, whereas the average rttP of the t1-based local AIF candidates is significantly larger 
than the average rttP of gray matter. the tOF-based local AIF candidates have Δr2
* profiles as 
broad as gM, as measured with the average FWHM. the t1-based local AIF candidates have a 
significantly larger FWHM than the average FWHM of gM. the distributions of the in vivo met-
rics are shown in Figure 6; all show a distribution close to a gaussian distribution. Furthermore, 
there is much overlap between the distributions of the shape-characteristics of gM and the 
local AIF candidates. Moreover, the distribution in the lower tails for the three timing metrics 
differ little in absolute numbers between gM and the local AIF candidates.
disCussion And ConClusions
the aim of this study was to investigate whether automatic local AIF measurements would 
reflect the true concentration-time curve of small brain-feeding arteries, since partial-volume 
effects in the local AIF measurement can lead to broadening of the measured Δr2
* profile (14). 
For this purpose, a 3D numerical model was created that simulates local AIF measurements 
with single shot EPI and PrEStO acquisition at different orientations and with different artery 
sizes. In addition, in vivo data were used to identify true local AIF candidates using two different 
 table 2: Shape-characteristic metrics used for evaluating the in vivo local AIF candidates based on two 
angiograms (tOF and t1). the metric values are compared to gray matter (gM), since the ground truth is 
unknown. 
  gm toF t1 gm vs toF gm vs t1 t1 vs toF
  mean sd mean sd mean sd diff p-value diff p-value diff p-value
tA 25,4 1,0 24,8 1,0 25,3 1,0 -0,6 0,0075 -0,1 0,5529 -0,5 0,0008
rttP 4,9 0,2 5,2 0,4 5,4 0,4 0,3 0,0343 0,5 0,0050 -0,2 0,0028
FWHM 6,3 0,6 6,3 0,5 6,8 0,7 0,0 0,8605 0,5 0,0039 -0,5 0,0109
Figure 5: Shown are three timing characteristics (time-of-arrival (tA), relative time-to-peak (rttP) and full-
width-at-half-maximum (FWHM)) of the in vivo local arterial input function candidates (tOF-based and 






angiograms and the shape-characteristics from these candidates were compared to gray mat-
ter CtC shape-characteristics. the findings of this study are two-fold. First, the simulations show 
that partial-volume effects in local AIF measurements lead to erroneously broader measured 
AIFs. the broadening is both caused by the tissue response and the extravascular local field 
changes. Second, in vivo data shows (based on shape-characteristics of the measured Δr2
* pro-
files) that local AIF selection do not have a higher number of AIF-like profiles than gM profiles. 
therefore, local AIF measurements using shape-criteria cannot reliably measure the CtC in 
small arteries, since the overlap in the distributions of gM and local AIF candidates is too high.
the simulations show that partial-volume effects lead to broader local AIF profiles. For single 
shot EPI the FWHM was even larger than the FWHM of the ground truth of the tissue response. 
For single shot EPI, the broadening is caused by extravascular susceptibility effects and 
intravascular relaxation changes, because the simulations with and without tissue response 
show little difference in FWHM. For PrEStO, separation between extravascular susceptibility 
effects and intravascular relaxation changes was made by simulating the sequence with and 
Figure 6: Histograms of the shape-characteristic metrics for gray matter (a) for t1-based local arterial input 
function (AIF) candidates (b) and tOF-based local AIF candidates (c). the distributions are close to gaussian 
distributions and the lower tail of the timing metrics shows a large degree of overlap. Note that the number 
of voxels in the gray matter (gM) mask is much larger than the two small artery masks.
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without crushing of the intravascular signal. these simulations showed that the influence of 
the intravascular signal on the broadening of the simulated local AIF is small. the simulations 
of PrEStO (with crushing) with and without tissue response show that the tissue response 
causes, on average, broadening of the simulated local AIFs as do the extravascular susceptibil-
ity effects. the fraction between the effect of tissue response and extravascular susceptibility 
effects on the broadening is likely to change for different orientations, but on average, both 
effects lead to comparable broadening. the tA of the simulated local AIFs are close to the tA of 
the ground truth AIF. the rttP is sensitive to the tissue response and for the simulation without 
the tissue response, the rttP is close to the rttP of the ground truth AIF. For the simulations 
with the tissue response, the rttP is close to the rttP of the ground truth of the tissue response. 
Subdividing the simulated local AIF profiles by vessel radius showed that smaller arteries result 
in more erroneous broadening of the local AIF measurement compared to the larger arteries. 
the largest studied arteries with a radius of 1.5 mm, however, result in local AIF measurements 
still broader than the ground truth AIF. the simulations show that these smaller arteries show 
later tA (note that the ground truth AIF is the same) and longer FWHM.
the in vivo data were used to investigate local AIF candidates based on angiogram infor-
mation and, because the ground truth is unknown, the shape-characteristics of the local AIF 
candidates are compared to gray matter CtCs. For this purpose, two different angiograms were 
used (tOF angiogram and t1 pre- and post-contrast angiogram). the properties of angiogram-
based local AIF candidates should differ from the properties of the gM profiles, with a much 
higher number of AIF-like curves in the first group to justify a local AIF approach. the results 
show that the tA is significantly lower for the tOF-based local AIFs compared to gM and com-
pared to t1-based local AIFs (one sided t-test was used since larger tA were not expected). this 
suggests that the tOF-based local AIF candidates are likely to be more upstream than the local 
AIF candidates determined with the t1 pre- and post-contrast images. the local AIF candidates 
of the tOF angiogram have an average FWHM equal to the FWHM value of gM. the t1-based 
local AIF candidates have a significantly larger FWHM than the FWHM of gM. Note that these 
findings confirm the observation of the simulations where FWHM were observed equal or 
larger than the ground truth of the tissue response FWHM value. the distributions of the shape 
metrics angiogram local AIF candidates and gM overlap. One should take in account that the 
number of voxels in the gM mask is much larger than the small artery masks. therefore, the 
absolute number of voxels in the lower tail of the shape-characteristics plays a role in determin-
ing whether the chance of selecting a local AIF candidate is higher for the angiogram-based 
local AIFs compared to gM profiles. Since there is a large overlap, differentiation between gM 
profiles and local AIF candidates will be difficult. this is supported by the simulations that show 
that the rttP and FWHM of the simulated local AIF (with tissue response) are close to the rttP 
and FWHM of the ground truth of the tissue response. 
In the tOF-based artery mask large arteries were removed and small arteries selected. the 






the large arteries are subtracted due to fresh inflow) and possibly small veins. therefore, it is 
possible that the t1-based small arteries mask is contaminated with small veins and this would 
result in longer tA, rttP and FWHM. However, the distribution of the t1-based small artery mask 
is approximately gaussian and does not show two peaks. In summary, the tOF-based small 
artery mask reflects more the arterial side of the vasculature, but does not show the smallest 
vessels, whereas the t1-based angiogram selects smaller vessels but at risk of including veins. 
the current study simulated PVEs in local AIF measurements for a large range of orientations 
and for different vessel radii. A previous simulation study reported that the broadening of the 
measured AIF profile in local AIF measurements is caused by the tissue response (14). this study 
shows that the broadening is not only caused by the tissue response in the surrounding but 
also by extravascular susceptibility effects and to a smaller extent by intravascular relaxation 
changes.
A broader AIF than the true AIF corrupts the perfusion estimates, and is likely to result in 
an overestimation of CbF. When comparing the CtCs of global AIFs to local AIFs, local AIFs are 
more delayed and more dispersed. the observed broadening is, however, much larger than one 
would expect based on the dispersion resulting from the transport properties of the vascular 
network. 
the numerical model used in this study models the small brain-feeding artery as an infi-
nite straight cylinder. the infinite cylinder is valid for a straight section at least four times the 
diameter of the vessel (30). Small arteries, however, often curve and can have branches. the 
orientation of the cylinder affects the extravascular susceptibility effects the most. because 
the orientation is often unknown a full range of orientations were simulated and subsequently 
analyzed as a single group. because the cylinder was simulated at different orientations, only 
the central voxels (that encompassed the middle of the vessel axis) of the volume were selected 
for local AIF measurements. this implies that voxels completely outside the small brain-feeding 
artery were not selected, because Δr2
* changes are too small in such voxels, since the extravas-
cular effect drops off with distance. 
In conclusion, partial-volume effects in local AIF measurements lead to broader Dr2
*-curves. 
these broader local AIFs will lead to errors in the perfusion estimates. Furthermore, automatic 
local AIF selections will not be able to select local AIF candidates without including gray matter 
profiles.
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ABstrACt 
the increased cerebro- and cardiovascular risk in migraineurs may be the consequence of a basal 
systemic vascular susceptibility, reflected by the presence of interictal global or regional cere-
bral perfusion abnormalities. Whether focal perfusion changes occur during interictal migraine 
has not been convincingly demonstrated. In this study, we measured brain perfusion with 
dynamic susceptibility-contrast magnetic resonance imaging (DSC-MrI) in 30 interictal female 
migraineurs (13 migraine with aura (MA), 17 migraine without aura (MO)) and 17 female controls 
to improve our understanding of migraine pathophysiology and its potential cerebrovascular 
consequences. In voxelwise analyses (p<0.001, uncorrected, minimum cluster size 20 voxels), 
interictal hyperperfusion was observed in the left medial frontal gyrus in migraineurs and in the 
inferior and middle temporal gyrus in MO patients, in comparison to controls. Hypoperfusion 
was seen in the postcentral gyrus and in the inferior temporal gyrus in MA patients and in the 
inferior frontal gyrus in MO patients. region-of-interest analyses of the pons, hypothalamus, 
occipital lobe and cerebellum did not show significant interictal perfusion differences between 
migraineurs and controls. We conclude that interictal migraine is characterized by discrete areas 
of hyper- and hypoperfusion unspecific for migraine pathophysiology and not explaining the 








Migraine is a prevalent neurovascular disorder, characterized by recurrent attacks of disabling 
headache accompanied by dysfunction of the autonomic nervous system. In up to a third of 
the patients, neurological (mostly visual) aura symptoms precede or accompany the headache 
phase of migraine attacks (1). Migraine, especially migraine with aura (MA), has been identified 
as an independent risk factor for clinical and subclinical brain infarction.(2, 3) the posterior 
circulation territory, notably the cerebellum, seems to be specifically vulnerable.(2, 4, 5) Further, 
female migraineurs both with and without aura are at increased risk of deep white matter and 
hyperintense brainstem lesions (2, 5, 6). repetitive physiological and biochemical changes 
during migraine attacks, including changes in brain perfusion, are amongst the mechanisms 
proposed to explain or contribute to the increased risk of ischemic brain lesions (7).
besides the increased risk of cerebrovascular complications in migraineurs, there is increas-
ing evidence that migraine is also independently associated with other (ischemic) vascular 
disorders, including angina pectoris, myocardial infarction, claudication and retinopathy (7, 8). 
A direct relationship with migraine attacks is not plausible for these types of vascular disease, 
and therefore these associations seem to be better explained by a basal systemic susceptibility 
of the vasculature in migraine patients. Several lines of evidence support this concept, includ-
ing interictal evidence of endothelium (dependent) dysfunction, impaired cerebrovascular 
reactivity, reports on ictal and interictal generalized or coronary artery vasospasm, impaired 
brachial artery compliance, increased aortic stiffness and hypercoagulability, which all seem to 
be independent of the coincidence of established cardiovascular risk factors (9).
Consequences of such basal vascular susceptibility may be reflected by the presence of 
interictal global or regional perfusion abnormalities in the brains of migraineurs. Earlier single 
photon emission computed tomography (SPECt) reported such gross differences in cerebral 
hemodynamics between interictal migraineurs and control subjects, but results were con-
tradictory (10-15). More recent perfusion studies, using positron emission tomography (PEt) 
(16-20) and dynamic susceptibility contrast magnetic resonance imaging (DSC-MrI) (21-23), 
concentrated on the ictal phenomena, so it has still not been convincingly proven whether in 
the interictal stage of migraine, differences in cerebral hemodynamics are present or absent in 
comparison with headache-free control subjects. 
knowledge of patterns of interictal brain perfusion will improve our understanding of the 
migraine pathophysiology and its potential consequences that could make certain brain areas 
in migraineurs more susceptible to temporary or permanent brain changes. Further, it serves as 
baseline measure for future analyses of brain perfusion changes during and around migraine 
attacks. In the current study, we investigated interictal groups of MA and migraine without aura 
(MO) patients vs. controls, using DSC-MrI. DSC-MrI has several advantages compared to earlier 
performed PEt and SPECt studies, including a better spatial resolution with whole-brain cover-
age and a higher signal-to-noise ratio (SNr), allowing for voxelwise detection of small perfusion 
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differences (24). We performed unbiased whole brain voxelwise analyses of cerebral blood flow 
(CbF), cerebral blood volume (CbV), mean transit time (Mtt) and time-to-peak (ttP) maps, but 
also performed region-of-interest analyses in predefined regions that have been reported to 
show perfusion changes during the different stages of migraine, or that have been reported to 
be specifically at risk for ischemic lesion development, such as the cerebellum. 
methods
subject population
thirty female migraine patients (13 MA: mean age 42.9, range 28-52; 17 MO: mean age 47.6, 
range 38-57) and seventeen female control subjects (mean age 39.9, range 21-55) participated 
in this study. Migraine patients were enrolled through advertisements in newspapers and 
magazines. Migraineurs were diagnosed with MA or MO according to the criteria of the Head-
ache Classification Committee of the International Headache Society (1) at the Department 
of Neurology (ggS); headache-free control subjects were recruited by local advertisement 
and enrolled in the study. None of the migraine patients were taking prophylactic medication 
and all were headache-free for 7 days or more at time of scanning (interictally). the study was 
approved by the local ethics committee and all subjects gave written and informed consent.
neuroimaging protocol
t2-weighted turbo spin echo images (tr/tE 4741/80 msec, echo train length 16, acquisition 
matrix 448x392 mm, FOV 224x180 mm2, 48 slices of 3 mm thickness) and fluid-attenuated 
inversion recovery (FlAIr) (tr/tE 10128/120 msec, echo train length 36, acquisition matrix 
224x224, FOV 224x180 mm2, 48 slices of 3 mm thickness) were acquired and evaluated by an 
experienced neuroradiologist (MCk). two cases showing structural brain abnormalities that 
could have impeded or confounded perfusion image post processing were excluded from 
further analyses: one control subject with a frontal cortical infarct, and one MA patient with 
confluent white matter lesions (WMls). Small, punctuate deep white matter lesions were not 
considered an exclusion criterion. 
DSC-Mr imaging was performed on a 3.0 tesla MrI system (Achieva, Philips Medical Sys-
tems, best, the Netherlands), using an 8-channel receive array head coil; 0.2 ml/kg-bodyweight 
gd-DtPA (Magnevist®, Schering) was injected intravenously at 5 ml/sec followed by a saline 
chaser of 25 ml (injected at 5 ml/sec (20 ml) and 2 ml/sec (5 ml)). PrEStO (Principles of Echo-
Shifting with a train of Observations, a 3D ultrafast gradient echo sequence combining whole 
brain coverage with t2
*-weighted imaging (25)) was used for the acquisition with the following 
parameters: data matrix 64x53 mm (zerofilled to 128x108 mm), echo time (tE)/repetition time 






3 mm thickness, number of echoes in a echo train 21, and 60 segments per volume resulting in 
a dynamic scan time of 1.1 sec. 
post-processing
the perfusion maps of CbF, CbV, Mtt and ttP were generated using validated software devel-
oped at the Massachusetts general Hospital using block-circulant singular value decomposition 
(26). this program requires a manual selection of the arterial input function (AIF, the passage 
of contrast agent through a major brain-feeding artery). At least eight voxels near the middle 
cerebral artery were selected to form the global AIF used in the deconvolution. 
the signal drop in the t2
*-weighted images resulting from the contrast agent passage was 
converted to the concentration contrast agent (C(t)) using
 114
least eight voxels near the middle cerebral artery were selected to form the global AIF 
used in the deconvolution.  
The signal drop in the T2*-weighted images resulting from the contrast agent passage was 
converted to the concentration contrast agent (C(t)) using 











The deconvolution was performed over the first and second passage of the gadolinium 
concentration passage with a noise threshold of 0.4 and an oscillation threshold of 0.095.  
The CBF maps were used to coregister all perfusion maps spatially to the PET template 
in SPM5 (Wellcome Trust Centre for Neuroimaging, Institute of Neurology, UCL, 
London UK – http://www.fil.ion.ucl.ac.uk/spm). To improve the spatial normalization 
further, an average CBF map was constructed over all subjects and the individual CBF 
maps were coregistered to that average CBF template together with all other perfusion 
maps. The relative CBF and relative CBV maps were converted to quantitative CBF and 
CBV maps by setting the white matter CBF to 22 ml/100g/min (27). The white matter 
segmentation for this quantification step was performed in SPM5 on the CBF map, since 
gray matter has a higher CBF than white matter; the segmentation mask consisted of all 
voxels with a 95% or higher certainty that the voxel is white matter. 
Statistical analyses 
All perfusion maps were smoothed using an isotropic Gaussian kernel (full width at half 
maximum of 8 mm). Whole brain voxelwise comparison was performed, comparing 
interictal scans of patients with migraine, MA, MO and controls using one-way analyses 
of variance implemented in SPM5, correcting for age. For statistical tests, the height 
threshold was set at p<0.001, uncorrected for multiple comparisons, with a cluster extent 
of minimal 20 neighbouring voxels.  
Next to voxel-based comparison, regions-of-interest (ROIs) for the occipital lobe and 
cerebellum (constructed from the corresponding regions from the automated anatomical 
labeling (AAL) template for SPM5) (28), the pons and the hypothalamus (drawn 
manually and incorporated into the AAL template) were created to study the average 
distribution of perfusion parameters in these areas in the normalized, non-smoothed 
 [1]
the deconvolution was performed over the first and second passage of the gadolinium 
concentration passage with a noise threshold of 0.4 and an oscillation threshold of 0.095. 
the CbF maps were used to coregister all perfusion maps spatially to the PEt template in 
SPM5 (Wellcome trust Centre for Neuroimaging, Institute of Neurology, UCl, london Uk – 
http://www.fil.ion.ucl.ac.uk spm). to improve the spatial normalization further, n average CbF 
map was constructed over all subjects and the individual CbF maps were coregistered to that 
average CbF template together with all other perfusion maps. the relative CbF and relative CbV 
maps were converted to quantitative CbF and CbV maps by setting the white matter CbF to 22 
ml/100g/min (27). the white matter segmentation for this quantification step was performed in 
SPM5 on the CbF map, since gray matter has a higher CbF than white matter; the segmentation 
mask consisted of all voxels with a 95% or higher certainty that the voxel is white matter.
statistical analyses
All perfusion maps were smoothed using an isotropic gaussian kernel (full width at half 
maximum of 8 mm). Whole brain voxelwise comparison was performed, comparing interictal 
scans of patients with migraine, MA, MO and controls using one-way analyses of variance 
implemented in SPM5, correcting for age. For statistical tests, the height threshold was set at 
p<0.001, uncorrected for multiple comparisons, with a cluster extent of minimal 20 neighbour-
ing voxels. 
Next to voxel-based comparison, regions-of-interest (rOIs) for the occipital lobe and 
cerebellum (constructed from the corresponding regions from the automated anatomical 
labeling (AAl) templat  for SPM5) (28), the pons and the hypothalamus (drawn manually and 
incorporated into the AAl template) were created to study the average distribution of perfu-
sion parameters in these areas in the normalized, non-smoothed images. the choice of rOIs 
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for pons, hypothalamus and occipital lobe was based on previous reports of hemodynamic 
changes during migraine (16, 18-20). the cerebellum was analyzed specifically because of 
its suggested increased vulnerability for cerebellar infarction in migraineurs. Distributions of 
mean CbF, CbV, Mtt and ttP were compared between migraine patients and control subjects 
using multivariate general linear models adjusted for age in SPSS for Windows, release 16.0.2 
(Chicago, USA). 
results
After exclusion of the two participants with larger brain lesions, 45 female subjects remained 
for analysis: 12 MA patients, 17 MO patients, and 16 control subjects for further analysis. Mean 
age (MA 42.9±8.2 years, MO 47.6±5.3 years, controls (39.9±12.3), p>0.05, one-way ANOVA) was 
not different across the groups. the results of the voxelwise whole brain comparison between 
interictal migraineurs and controls are shown in table 1 and Figures 1 and 2. We found a higher 
CbF in a part of the left medial frontal gyrus when analyzing the whole group of migraineurs 
vs. controls (Figure 1A). 
table 1 Significant differences in cerebral blood flow (CbF), cerebral blood volume (CbV), mean transit time 
(Mtt) and time-to-peak (ttP) at interictal stage





Migraine vs. controls l Medial frontal gyrus -6 28 38 48 4.21
MA vs. controls l Medial frontal gyrus -8 26 40 34 3.82
MO vs. controls l Medial frontal gyrus -6 28 38 20 3.76
Decreased
MA vs. controls r Inferior temporal gyrus 36 0 -50 49 4.47
l Postcentral gyrus -48 -24 32 24 3.41
MO vs. controls l Inferior frontal gyrus -54 20 32 26 3.82
CBv
Increased
MO vs. controls r Middle temporal gyrus 48 -16 -12 26 3.51
r Inferior temporal gyrus 38 -2 -48 30 3.41
58 -30 -22 22 3.34
No decreases
mtt
No increases or decreases
ttp
No increases or decreases
MA=migraine with aura, MO=migraine without aura, MNI=Montreal Neurological Institute; p<0.001, 






this difference remained, also when assessing MA and MO groups separately vs. controls 
(not shown in figure). A lower CbF was present in a zone of the right inferior temporal gyrus 
(figure. 1b) and the left postcentral gyrus (figure. 1C) in MA patients and in a part of the inferior 
frontal gyrus in MO patients (figure. 1D). CbV was increased in a zone of the right inferior and 
middle temporal gyrus in MO (Figure 2). CbV reductions were not identified. In addition, no 
Figure 1: Statistical parametric maps demonstrating increases (yellow) and decreases (blue) in DSC-MrI 
measured cerebral blood flow (CbF). Increases in CbF between migraineurs and controls in the medial 
frontal gyrus (A) and decreases in CbF between MA patients and controls in the inferior temporal gyrus 
(B) and postcentral gyrus (C) and between MO patients and controls in the inferior frontal gyrus (d) are 
superimposed on a t1-weighted template in MNI standard space. Color bars represent Z-values. the left 
side of each picture is the right side of the brain.
Figure 2: Statistical parametric maps demonstrating increases in DSC-MrI measured cerebral blood volume 
(CbV) in MO patients compared to headache-free control subjects in the inferior temporal gyrus (A,C) and 
middle temporal gyrus (B), superimposed on a t1-weighted template in MNI standard space. Colour bars 
represent Z-values. the left side of each picture is the right side of the brain.
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voxelwise increases or decreases in Mtt and ttP were observed between migraineurs and 
control subjects.
the results of the rOI-analyses in interictal migraineurs and controls are shown in table 2. 
the CbF, CbV, Mtt and ttP in pons, hypothalamus, occipital lobe and cerebellum did not differ 
significantly between migraine and controls, or between migraine subgroups and controls 
(table 2).
disCussion And ConClusions
to the best of our knowledge, this is the first explorative DSC-MrI study assessing brain perfu-
sion characteristics and patterns in female migraine patients in an interictal state vs. headache-
free control subjects. In this relatively large sample of migraineurs (MA and MO) and control 
subjects, our voxelwise comparison of perfusion maps identified some small areas of perfusion 
differences between migraineurs and controls, including both hyper- and hypoperfusion in 
frontal, parietal, and temporal regions in the interictal migraine brain. regional analyses assess-
ing perfusion differences in the pons, hypothalamus, occipital lobe and cerebellum between 
table 2 region-of-interest analyses cerebral blood flow (CbF), cerebral blood volume (CbV), mean transit 
time (Mtt) and time-to-peak (ttP) for the pons, hypothalamus, occipital lobe and cerebellum at baseline, 
migraine and its subgroups vs. controls
pons hypothalamus occipital lobe Cerebellum
p-value p-value p-value p-value
CBF (ml/100g/min)
Controls (n=16) 64.8 (9.9) 46.1 (6.0) 60.9 (8.4) 67.5 (9.6)
Migraine (n=29) 64.1 (8.6) 0.312 44.2 (6.6) 0.362 59.1 (4.5) 0.504 64.7 (6.5) 0.888
MA (n=12) 63.8 (7.2) 0.683 41.1 (8.0) 0.089 61.0 (5.2) 0.389 66.4 (7.1) 0.846
MO (n=17) 64.4 (9.6) 0.172 46.3 (4.5) 0.777 57.9 (3.5) 0.736 63.5 (5.9) 0.915
CBv (ml/100g)
Controls (n=16) 3.3 (0.6) 3.7 (0.7) 3.9 (0.7) 4.6 (1.0) 
Migraine (n=29) 3.3 (0.7) 0.526 3.8 (0.8) 0.197 4.0 (0.8) 0.184 4.7 (0.9) 0.316
MA (n=12) 3.4 (0.6) 0.520 3.6 (0.6) 0.676 4.0 (0.6) 0.432 4.6 (0.6) 0.657
MO (n=17) 3.3 (0.8) 0.694 3.9 (0.9) 0.091 4.1 (0.9) 0.121 4.7 (1.0) 0.191
mtt (s)
Controls (n=16) 4.2 (0.5) 4.1 (0.7) 3.9 (0.5) 3.6 (0.4)
Migraine (n=29) 4.5 (0.7) 0.273 4.4 (1.0) 0.232 4.1 (0.8) 0.250 3.8 (0.7) 0.283
MA (n=12) 4.3 (0.7) 0.678 4.1 (0.7) 0.955 3.9 (0.5) 0.774 3.7 (0.5) 0.629
MO (n=17) 4.6 (0.7) 0.127 4.6 (1.1) 0.061 4.3 (0.9) 0.111 3.9 (0.8) 0.161
ttp (s)
Controls (n=16) 1.3 (0.5) 1.1 (0.5) 1.7 (0.5) 1.6 (0.5)
Migraine (n=29) 1.5 (0.6) 0.316 1.4 (1.0) 0.197 1.9 (0.7) 0.566 1.8 (0.6) 0.718
MA (n=12) 1.4 (0.6) 0.499 1.4 (1.0) 0.253 1.8 (0.6) 0.847 1.7 (0.5) 0.935
MO (n=17) 1.6 (0.6) 0.192 1.4 (0.9) 0.141 2.0 (0.7) 0.357 1.9 (0.7) 0.448
MA=migraine with aura, MO=migraine without aura; denotation is mean (SD); p-values from linear 






interictal migraineurs and controls did not show significant differences. In general, areas with 
altered interictal perfusion may reflect local interictal differences in neuronal activity or density, 
or may point at some degree of interictal cerebrovascular dysregulation, that both might be 
the consequence of repetitive migraine attacks, or might be attributed to systemic vascular 
processes, or both. 
the area of higher CbF that we identified in the left medial frontal gyrus in both MA and 
MO patients, seems to co-localize with a reported area of gray matter reductions in migraine 
patients (29). gray matter changes in the medial frontal gyrus have been reported to correlate 
with pain scores in another chronic pain condition, fibromyalgia (30), suggesting a correlation 
between morphology and function. In MA patients, we found lower CbF in the postcentral 
gyrus, part of the somatosensory cortex. One earlier morphometric study described thickening 
of the somatosensory cortex in migraineurs, that was suggested to be an adaptation to repeti-
tive migraine attacks (31). In MO patients, we found areas of lower CbF in the inferior frontal 
gyrus and higher CbV in the middle temporal gyrus. Decreases in regional CbF in these areas 
were seen in MO patients after administration of sumatriptan in a recently published PEt study 
(19), and an earlier voxel based morphometry (VbM) study in migraineurs also identified gray 
matter reductions in these gyri (32).
Although thus seemingly altered interictal perfusion in certain brain areas in migraineurs 
can be co-localized with earlier reported structural or hemodynamic changes in the brains of 
patients with migraine and other pain conditions, we want to stress that the changes measured 
by DSC-MrI are small and not necessarily specific for migraine. Further, higher or lower perfu-
sion did not consistently relate to specific structural changes; e.g. hypoperfusion seems to be 
related in some areas with cortical thickening, and in other areas with gray matter reduction. 
this makes interpretation of these changes difficult. 
We found no interictal differences in CbF, CbV, Mtt or ttP in the regional maps of the pons, 
hypothalamus and occipital lobe, although perfusion changes have previously been identified 
in these areas during migraine attacks (16, 18-20). Similarly, we found no interictal perfusion 
abnormalities in the cerebellum. these negative interictal findings may be explained e.g. by 
high inter- and intra-individual variance in cerebral hemodynamics, and of course do not 
exclude the possibility of ictal perfusion changes in these areas.
We are not aware of any PEt or DSC-MrI studies that report perfusion differences in 
migraineurs during interictal stage in comparison with control subjects. there are however 
several reports on interictal CbF changes in regular migraine compared to controls, measured 
with SPECt, but results are contradicting. lauritzen et al. did not find interictal CbF changes 
when comparing 11 migraineurs to 20 controls (14). levine et al. reported general hypoperfu-
sion in 15 MA and 12 MO patients in the posterior circulation territory, compared to 20 controls 
(15). Other studies reported single or multiple foci of interictal hypoperfusion in 43-67% of 
migraineurs (10, 11). However, yet another SPECt study reported interictal global hyperper-
fusion in 50 MO patients (mainly located in frontal regions) and global hypoperfusion in 20 
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MA patients (mainly located in posterior regions), compared to control subjects (12). these 
contradicting results may be due to the insufficiency of visual evaluation of SPECt-derived 
CbF images to pick up abnormalities in interictal migraineurs (13). the small focal areas of 
hyper- and hypoperfusion we observed in frontal, temporal, and parietal regions in migraine 
patients compared to controls seem to show overlap with some of the regions found in the 
aforementioned SPECt studies, but comparison between these different techniques remains 
complicated because of differences in post-processing, which is discussed further below.
Up till now, DSC-MrI has been performed in only a few occasions in regular migraine (21-
23); DSC-MrI has most often been used for studying perfusion changes during attacks of rare 
subforms of migraine, such as familial hemiplegic migraine or persistent migraine aura, most 
often only in a single case (33-40). the DSC-MrI acquisition and analysis in the current study 
was applied with more advanced acquisition and post-processing techniques than previously 
used in DSC-MrI studies in regular migraine (23). First, the 3D PrEStO acquisition in combina-
tion with parallel imaging covered the entire brain at a temporal resolution of 1.1 seconds. A 
low dynamic scan time is important because the concentration contrast agent is monitored 
dynamically, and a simulation study by knutsson et al. showed that the dynamic scan time 
should be below 1.5 sec (41). Second, delay-insensitive deconvolution was used. this improves 
the quality of the perfusion estimates, since delay effects are more present when a global AIF is 
used for the deconvolution (26, 42). In our analysis, a global AIF was selected close but outside 
the middle cerebral arteries (43). these two brain-feeding arteries supply the majority of but 
not the entire cortex. However, the use of a delay insensitive deconvolution technique reduced 
the error for tissue that is not supplied by the MCA. third, spatial normalization was performed 
in two steps, first to the PEt template and second to an average CbF map. this improves the 
accuracy of the voxelwise comparison analysis. 
Next to an increased spatial resolution allowing for voxelwise comparisons, DSC-MrI has 
several advantages compared to other techniques used for measuring perfusion in migraine. 
DSC-MrI does not expose the subjects to ionizing radiation and is therefore better suited for 
measuring cerebral perfusion in large samples of both migraineurs as well as controls than 
PEt or SPECt. Further, DSC-MrI is more widely available and less time consuming. SPECt only 
measures CbF and some SPECt techniques provide only relative values, whereas PEt and DSC-
MrI measure values of CbF, CbV and Mtt. Furthermore, the spatial resolution of PEt and SPECt 
is lower than DSC-MrI making it harder to detect local perfusion changes. In the SPECt studies 
that compared interictal migraineurs to controls, images were acquired with varying SPECt-
contrast agents and were often evaluated visually or semiquantitatively leading to a substantial 
degree of subjectivity. to overcome this problem, our results of local hyper- and hypoperfused 
areas between migraine attacks were generated by an unbiased whole brain voxelwise com-
parison of DSC-MrI images. besides aforementioned advantages, DSC-MrI also has a major 






patients with renal failure increases the risk for attaining nephrogenic systemic fibrosis (NSF) 
(44, 45). 
Arterial spin-labeling (ASl) likely is a good alternative technique for both DSC-MrI and PEt. 
ASl, a relatively new Mr technique, is better for perfusion estimation and has the possibility for 
repeated measurements to increase the sensitivity (46). Although this technique only allows 
for absolute quantification of CbF (and not CbV or Mtt), intravenous administration of contrast 
agents or radioactive tracers is not necessary. the first results of ASl during migraine attacks 
show results comparable to those in PEt studies (47, 48). 
In summary, our study shows in an unbiased whole brain voxelwise approach that interictal 
migraineurs have discrete areas of cerebral hyper- and hypoperfusion, measured with DSC-
MrI. their specifity for migraine pathophysiology is thought to be small, and we did not find 
changes in hemodynamics of interictal migraineurs that likely account for subclinical cerebellar 
lesions found previously.
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Chapter 8 general discussion
the purpose of dynamic susceptibility contrast (DSC-) MrI is to provide hemodynamic 
parameters describing the microvascular blood supply to brain tissue. Quantification of the 
hemodynamic parameters has different aspects ranging from tracer kinetic theory to overcom-
ing practical issues. For example, DSC-MrI uses a mathematical process (called deconvolution) 
for obtaining hemodynamic parameters from the tissue response (the passage of contrast 
agent through the microvasculature) and the AIF (the passage of contrast agent through the 
brain-feeding artery). In this mathematical process, the impulse response is calculated from the 
AIF and the tissue response. the impulse response only reflects properties of the capillaries, 
whereas the tissue response incorporates the total transport properties between the injection 
site and the capillaries. the hemodynamic properties of the capillaries are relevant for assessing 
brain diseases and pathologies.
In this chapter, the different aspects for perfusion quantification will be discussed, with a 
special focus on the AIF measurement. the first aspect is the tracer kinetic theory; this theory 
describes the physiological model for obtaining cerebral blood flow (CbF), cerebral blood 
volume (CbV) and mean transit time (Mtt) from bolus passage measurements in tissue and 
a calibration measurement in the brain-feeding artery directly draining into the capillaries. 
Second, the influence of AIF measurements more upstream from the capillaries on the perfu-
sion measurements is discussed. because, in practice AIF measurements in DSC-MrI are most 
often performed near large brain-feeding arteries (e.g. middle cerebral artery) and not in the 
very small brain-feeding arteries that directly feed into the microvasculature. third, a correct 
relation between the measured Mr-signal and the concentration contrast agent is required 
for obtaining the perfusion parameters. Fourth, the sampling rate of the Mr-signal changes 
is important as well as the effects of different sampling schemes. Fifth, different acquisition 
settings and their influence on the measured signal are described. Sixth, partial volume effects 
occur in DSC-MrI since the voxels are relatively large compared to the brain-feeding arteries 
supplying the microvasculature, and these partial volume effects can corrupt the AIF measure-
ment. the seventh aspect is automatic AIF measurements for DSC-MrI: these are faster and 
user-independent. In this paragraph, the pros and cons of automatic AIF measurements are 
briefly discussed. After discussion of the different aspects in DSC-MrI, the limitations of the 






the theory For perFusion meAsurements 
the tracer kinetic theory developed by Zierler is used for determining the hemodynamic 
parameters CbF, CbV and Mtt as measured with DSC-MrI (1). this theory is described in more 
detail in chapter 2. below follows a summary of the theory.
A bolus of paramagnetic contrast agent is injected in the arm vein and flows through the 
heart, lungs and again through the heart before entering the oxygen rich arterial stream. brain-
feeding arteries feed the bolus contrast agent into the brain-tissue microvasculature. therefore, 
the concentration of contrast agent of a voxel in tissue is dependent on the concentration of 
contrast agent in the feeding artery as can be seen in the following relation (see chapter 2 eq. 
11): 
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where f / Vvoxel equals the CBF except for some conversion factors,  (t) is the residue 
function (the impulse response scaled to unity),   stands for a convolution and cAIF(t) is 
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microvasculature in the voxel. 
Therefore, the CBF can be obtained by means of a deconvolution from the tissue passage 
curves with the AIF (keep in mind that  (0)=1): 
     tctctCBF AIFt 1
The CBV can be calculated from the product of the blood flow and the transport time 






Finally, the MTT of the blood through the capillary network can be calculated by using 
the central volume theorem, which describes the relation between CBF, CBV and the 
mean transit time (2, 3): 
 
[1]
where f / Vvoxel equals the CbF except for some conversion factors, ℜ(t) is the residue function 
(the impulse response scaled to unity), 
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Finally, the MTT of the blood through the capillary network can be calculated by using 
the central volume theorem, which describes the relation between CBF, CBV and the 
mean transit time (2, 3): 
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independent. In this paragraph, the pros and cons of automatic AIF measurements are 
briefly discussed. After discussion of the different aspects in DSC-MRI, the limitations of 
the numerical models used in this thesis are discussed. 
The theory for perfusion measurements  
Th  trac r kinetic theory developed by Zierler is u ed for determining the hemodynamic 
parameters CBF, CBV and MTT as measured with DSC-MRI (1). This theory is 
described in more detail in chapter 2. Below follows a summary of the theory. 
A bolus of paramagnetic contrast agent is injected in the arm vein and flows through the 
heart, lungs and again through the heart before entering the oxygen rich arterial stream. 
Brain-feeding arteries feed the bolus contrast agent into the brain-tissue 
microvasculatur . Therefore, the concentrat on of contrast agent of a voxel in tissue is 
dependent on the concentration of contrast agent in the feeding artery as can be seen in 
the following relation (see chapter 2 eq. 11):  





where f / Vvoxel equals the CBF except for some conversion factors,  (t) is the residue 
function (the impuls  response scaled to unity),   stands for a convolution and cAIF(t) is 
the concentration of contrast agent in the brain-feeding artery that supplies the tissue-
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Therefore, the CBF can be obtained by means of a deconvolution from the tissue passage 
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Finally, the MTT of the blood through the capillary network can be calculated by using 
the central volume theorem, which describes the relation between CBF, CBV and the 
mean transit time (2, 3): 
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the CbV can b  calculated from the product of the blood flow and the transport time func-
tion (see Chapter 2 eq. 14):
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Finally, the MTT of the blood through the capillary network can be calculated by using 
the central volume theorem, which describes the relation between CBF, CBV and the 
mean transit time (2, 3): 
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Finally, the Mt  of the blood through the capillary network can be calculated by using the 





As can be seen from eq. 3, the MTT can also be calculated by taking the area-under-the-
curve of the residue function. 
In theory, the CBV can also be calculated from the ratio of the areas-under-the-curve of 
the tissue passage curve and the AIF, although this results in slightly worse quantification 
than the product of the blood flow and the area under the hemodynamic response function 
due to difficulties in differentiating between the first passage and the recirculation (4).  
If for some reason the cAIF(t) is over- or underestimated by a unknown factor then the 
CBV and CBF still would have correct relative values and because both parameters scale 
equally the MTT has a correct quantitative value. In this case, absolute quantification of 
CBV and CBF can be obtained by performing an additional absolute CBV measurement, 
for example by the steady state concentration (bookend method (5)) or by an additional 
absolute CBF measurement, such as arterial spin labeling (ASL) (6). However, both 
additional quantifications have their problems in absolute quantification. In ASL, the 
main problems are assessing the labeling efficiency and correction for transit delays and 
in the bookend method it is the estimation of the arterial MR-signal and the conversion 
from longitudinal (or transverse) relaxation rates to the concentration.  
In the case that the shape of cAIF(t) is distorted then the deconvolution results in an 
erroneous estimation of all three hemodynamic parameters. A simulation study by 
Calamante et al. showed that perfusion errors are especially severe for distorted AIFs that 
exhibit a steeper upslope than the true cAIF(t) (7). 
The theory for computing CBF, CBV and MTT assumes an intact blood-brain barrier 
(BBB), meaning that the vasculature from the calibration measurement to the tissue 
microvasculature must be intact. BBB breakdown occurs especially in high-grade tumors 
and stroke, and results in local increases in the concentration of the contrast agent in the 
measured tissue response and T1-effects. Attempts have been made to overcome the 
problem of a broken BBB and Vonken et al. proposed a method to measure the 
extravasation of the contrast agent together with the hemodynamic parameters using 
model driven analysis of dual echo T2*-weighted images (8). 
 
[4]
As can be seen from eq. 3, the Mtt can also be calculated by taking the area-under-the-
curve of the residue function.
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In theory, the CbV can also be calculated from the ratio of the areas-under-the-curve of the 
tissue passage curve and the AIF, although this results in slightly worse quantification than 
the product of the blood flow and the area under the hemodynamic response function due to 
difficulties in differentiating between the first passage and the recirculation (4). 
If for some reason the cAIF(t) is over- or underestimated by a unknown factor then the CbV 
and CbF still would have correct relative values and because both parameters scale equally 
the Mtt has a correct quantitative value. In this case, absolute quantification of CbV and CbF 
can be obtained by performing an additional absolute CbV measurement, for example by the 
steady state concentration (bookend method (5)) or by an additional absolute CbF measure-
ment, such as arterial spin labeling (ASl) (6). However, both additional quantifications have 
their problems in absolute quantification. In ASl, the main problems are assessing the labeling 
efficiency and correction for transit delays and in the bookend method it is the estimation of 
the arterial Mr-signal and the conversion from longitudinal (or transverse) relaxation rates to 
the concentration. 
In the case that the shape of cAIF(t) is distorted then the deconvolution results in an erro-
neous estimation of all three hemodynamic parameters. A simulation study by Calamante et 
al. showed that perfusion errors are especially severe for distorted AIFs that exhibit a steeper 
upslope than the true cAIF(t) (7).
the theory for computing CbF, CbV and Mtt assumes an intact blood-brain barrier (bbb), 
meaning that the vasculature from the calibration measurement to the tissue microvasculature 
must be intact. bbb breakdown occurs especially in high-grade tumors and stroke, and results in 
local increases in the concentration of the contrast agent in the measured tissue response and 
t1-effects. Attempts have been made to overcome the problem of a broken bbb and Vonken 
et al. proposed a method to measure the extravasation of the contrast agent together with the 
hemodynamic parameters using model driven analysis of dual echo t2
*-weighted images (8).
delAy And dispersion
As explained above the AIF should be measured in the small arteries directly supplying the 
capillaries. However, AIFs are commonly measured in arteries upstream from this ideal location. 
the cAIF(t) in the smaller brain-feeding artery is more delayed and dispersed than the cAIF(t) in 
the major brain feeding artery supplying that small artery (a result of the transport properties of 
the vascular tree). Deconvolution of the tissue response and an upstream AIF gives an impulse 
response that reflects the combined effect of the microvasculature and the vascular network 
from the location of the AIF measurement to the beginning of the capillaries. Correction for 
the induced error is not yet possible, because this would require extensive knowledge of the 
vascular network from the location of the AIF measurement up to the true AIF that feeds the 






Calamante et al. performed a finite elements model to estimate the dispersion effect in the 
internal carotid artery of patients with an occlusion in that segment (9). With these kind of 
calculations, one could predict the dispersion effect from the major brain-feeding artery (e.g. 
the internal carotid artery or the middle cerebral artery) to the true AIF, but it requires the 
geometric properties of the vascular tree and its vascular elastic properties. blind deconvolu-
tion as proposed by grüner et al. determines voxel-specific AIF and residue function using an 
iterative model-based blind deconvolution technique and thereby corrects the dispersion that 
would occur when a global AIF (e.g. near the middle cerebral artery) was used (10). A major 
disadvantage of obtaining the voxel-specific AIF and the impulse response from a single tissue 
response is that dispersion in the tissue response can be a result of a dispersed AIF as well 
as a broader impulse response, thereby making the blind deconvolution perfusion estimates 
sensitive to errors in the discrimination between AIF and impulse response. 
Perfusion estimation with a global AIF and voxel-specific local or regional AIFs could provide 
insight into the vascular network between the two measurements, for example to asses an 
occlusion or stenosis in that part of the vascular network. this however requires two correct 
AIF measurements and an error in either will lead to incorrect assessment of the occlusion or 
stenosis.
determining the ConCentrAtion oF ContrAst Agent 
In DSC-MrI, the concentration of contrast agent in tissue and in the brain-feeding artery is 
determined using t2
*-weighted images and sometimes using t2-weighted images. this is 
possible because increasing the concentration of paramagnetic contrast agent shortens the 
t2 relaxation time and induces local field disturbances in the surrounding of the vasculature. 
the net effect is signal dephasing and therefore a signal decrease in the t2
(*)-weighted images. 
the t2
(*)-weighted profiles are normally transformed to Δr2
(*) via: 
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where T2(*) is the transverse relaxation time that changes in time due to the bolus passage, 
TE is the echo time and S is the magnitude of the MR-signal in time.  
The ΔR2* profile of tissue is heavily weighted by the local field disturbances caused by 
the susceptibility effects (11). The simulations of Kjølby and coworkers showed a linear 
relation between ΔR2* and ct(t). However, the results of chapter 5 provide some evidence 
that this does not hold true in vivo. In chapter 5, we found that the ratio of the area-under-
the-curve of the first passage to the steady state was different for white matter and gray 
matter ΔR2* profiles, suggesting a non-linearity in the relation between the concentration 
of contrast agent and the ΔR2*. The non-linearity could be caused by a different 
organization of the microvasculature of gray matter and white matter. In cortical gray 
matter, the small feeding arteries entering gray matter run perpendicular to the surface of 
gray matter and then within the gray matter layers spread out parallel to the surface of 
gray matter. The arterioles and capillaries have a more random organization. In white 
matter, the organization of the small feeding arteries is more random making the overall 
organization of the vasculature more random. The model of Kjølby and coworkers 
assumed a random organization of the small arteries, arterioles and capillaries, which is 
valid for white matter but not for gray matter. An alternative reason for the non-linearity 
could be the fact that the static dephasing regime does not hold for low concentrations 
(12), since in white matter the concentrations of contrast agent are much lower than in 
gray matter due to the lower vascular density. Finally, it could be due to the fact that 
dephasing is expected to level off at higher concentrations in the more dense vascular 
 [5]
where t2
(*) is the transverse relaxation time that changes in time due to the bolus passage, tE is 
the echo time and S is the magnitude of the Mr-signal in time. 
the Δr2
* profile of tissue is heavily weighted by the local field disturbances caused by the 
susceptibility effects (11). the simulations of kjølby and coworkers sho ed a linear relation 
betwe n Δr2
* and ct(t). However, the results of chapt r 5 provide some evidence that this does 
not hold true in vivo. In chapter 5, we found that the ratio of the area-under-the-curve of the 
first passage to the steady state was different for white matter and gray matter Δr2
* profiles, 
suggesting a non-linearity in the relation between the concentration of contrast agent and the 
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Δr2
*. the non-linearity could be caused by a different organization of the microvasculature of 
gray matter and white matter. In cortical gray matter, the small feeding arteries entering gray 
matter run perpendicular to the surface of gray matter and then within the gray matter layers 
spread out parallel to the surface of gray matter. the arterioles and capillaries have a more 
random organization. In white matter, the organization of the small feeding arteries is more 
random making the overall organization of the vasculature more random. the model of kjølby 
and coworkers assumed a random organization of the small arteries, arterioles and capillaries, 
which is valid for white matter but not for gray matter. An alternative reason for the non-linearity 
could be the fact that the static dephasing regime does not hold for low concentrations (12), 
since in white matter the concentrations of contrast agent are much lower than in gray matter 
due to the lower vascular density. Finally, it could be due to the fact that dephasing is expected 
to level off at higher concentrations in the more dense vascular network of gray matter, since 
the simulations of kjølby et al. only modeled a single capillary and not the overlapping local 
field changes of multiple capillaries. For instance, the space between two parallel capillaries in 
the plane perpendicular to the main magnetic field can be less inhomogeneous because the 
local field changes in between the two capillaries add up, leading to a reduced gradient. the 
reduction in local field gradients leads to reduced dephasing much larger than two capillaries. 
this of course applies for the space between any set of capillaries with non-parallel orientations 
to the main magnetic field. 
the difference in phase of the Mr-signal (with respect to the phase before contrast adminis-
tration (Δφ)) of a tissue-voxel is close to zero for randomly oriented capillaries. However, there 
can be a net phase effect when the microvasculature is not randomly oriented, but determining 
the relation is very difficult because this requires detailed information of the organization of the 
microvasculature. A possible experiment could be to measure the Δφ of a capillary phantom 
such as proposed by Anderson et al. at ISMrM 2010 (13). that phantom used parallel capillaries; 
however, it would be necessary to use a (more) randomly oriented capillary phantom. local Δφ 
changes in the brain can be observed in the DSC-MrI scan, due to the susceptibility effects of 
larger, less random oriented vessels. Alternatively, gyrus and sulcus structures of cortical gray 
matter or the shapes of other brain structures can lead to susceptibility effects in and around 
these structures resulting in phase effects dependent on the concentration of contrast agent. 
However, the overall Δφ change in time is expected to be close to zero, since the cortex has a 
more or less spherical shape and the internal net phase effect of a sphere is zero and averaged 
over the entire cortex the vessels are more randomly oriented.
the Δr2
* profile in blood is quadratically related to the concentration of contrast agent 
and depends on the hematocrit level (14, 15). this quadratic relationship was determined for 
gd-DtPA in whole blood at 1.5 t (15). It would be interesting to know how this quadratic rela-
tion scales with the field strength. We attempted such an experiment where we tried to mimic 
blood with a mixture of yeast and water, since yeast cells have a similar diameter to a red blood 






experiments at 7 t showed also a much smaller quadratic relation for gd-DtPA than expected. 
A possible explanation is that red blood cells have more of a donut shape whereas yeast cells 
are spherical, thereby changing the susceptibility effects outside the cell. Alternatively, the 
difference in the water exchange rate in the cells could be an explanation for the absence of 
a quadratic relation. Furthermore, the temperature was different from the blood experiments 
because we used regular tap water, in future experiments this can easily be controlled. the 
two measurements did however show a linear scaling with field strength for the linear relation 
between the Δr2
* and the concentration of contrast agent. this finding encouraged us to use a 
linear scaling with field strength for the simulations of the local AIF measurements in chapter 6. 
the Δφ can also be used to determine the concentration of contrast agent inside a brain-
feeding artery. the susceptibility effect of the contrast agent induces local field changes in and 
around the vasculature (except for parallel arteries and arteries oriented at the magic angle). 
Inside the artery, the local field change is homogenous and can be positive (θ<magic angle), 
zero (magic angle) or negative (θ>magic angle) for increasing concentrations of contrast agent. 
these local field changes can be measured by the phase of the gradient echo Mr-signal. A 
potential benefit of measuring the phase is that it is independent of changes in t1 and t2 
relaxivity. Another benefit is that the phase change inside the artery is linearly related to the 
concentration of contrast agent. 
because the susceptibility difference inside the artery induces local field changes outside 
the non-parallel arteries, the concentration of contrast agent inside the arteries can also be 
measured outside large (non-parallel) arteries via the magnitude or the phase of the Mr-signal 
of t2
*-weighted images (see chapter 3 and 4). both signal parts are influences by the local field 
changes outside the artery, which are the strongest for a perpendicular orientation with respect 
to the main magnetic field and absent for arteries oriented parallel to b0. Simulations showed 
that the correlation with the ground truth for phase-based extravascular AIF measurement 
was high (ρ>0.99) superior, inferior, anterior and posterior to perpendicular oriented arteries. 
However, whether this relation is truly linear is still a question. In the simulation of chapter 4, we 
observed that the relation is not exactly linear but that the peak was slightly underestimated. 
An analytical determination of the relation between the phase and the dephasing (due to the 
local field changes) in a voxel outside non-parallel arteries would be interesting. because the 
tissue response often hamper the AIF measurement, the very small tissue response is beneficial 
for phase-based extravascular AIF measurements. In magnitude-based extravascular AIF mea-
surements, the concentration determination is hampered by the larger tissue response (see 
chapter 3).
In t2-weighted images, the 180º pulse of such spin echo sequences refocuses the local 
field changes and the t2 signal is only sensitive to the relaxivity and diffusion over the local 
field changes. because the local field changes are refocused, extravascular AIF measurements 
are not well understood at the moment. However, in practice the AIF in t2-weighted images 
is determined outside large arteries, such as the middle cerebral artery. Phase-based AIF 
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measured are in theory not possible. boxerman et al. showed that the sensitivity of the Δr2 
drops off for vessels larger than 30-50 μm (16). Whether this is true for much larger arteries is up 
to now unanswered. therefore, AIF measurements in or near brain-feeding arteries such as the 
middle cerebral artery or the internal carotid artery measured with spin echo acquisition could 
be the topic for future studies.
disCrete sAmpling 
the concentration profile cannot be determined continuously, it has to be sampled in time. A 
simulation study by knutsson et al. showed that the temporal resolution should be below 1.5 
seconds because otherwise the CbF will be underestimated (17). For such temporal resolutions, 
fast imaging acquisitions such as single shot EPI, segmented EPI or spiral readouts are required. 
Single shot EPI has a relatively long echo-train length (Etl). the effect of a long Etl in the 
readout is image distortion especially when susceptibility differences are present (e.g. near air 
cavities). Segmented EPI measures k-space in multiple shots, with each shot having a shorter 
Etl, resulting in fewer distortions. However, head motion between shots can result in artifacts. 
because for real objects the upper half of k-space is the complex conjugate of the lower 
half, one half can be reconstructed from the other half without actually acquiring the data. 
Acquisition of (a bit more than) half of k-space and reconstructing the other half is called partial 
Fourier. the benefit of partial Fourier is a reduction in Etl in single shot EPI with an equal imag-
ing matrix. A disadvantage is a reduction in baseline signal-to-noise.
Finally, DSC-MrI can benefit from the advantages of parallel imaging (e.g. SENSE or grAPPA 
(18, 19)). Parallel imaging requires additional hardware (multichannel receive coils) and software 
but it can accelerate the acquisition. One of the possibilities with the accelerated acquisition is 
increasing the temporal resolution thereby decreasing the distortion artifacts (because the Etl 
is reduced). the accelerated acquisition can also be used to increase the spatial resolution or 
increase coverage, since these three measurement parameters are all interrelated.
eFFeCts oF ACQuisition settings in dsC-mri
As for every measurement, DSC-MrI measurements are subject to noise. A huge benefit is 
that the induced Δr2
* signal is large compared to the noise level and signal averaging need 
not to be performed. the noise is gaussian in k-space (the raw data of the MrI scanner) and 
after reconstruction (via inverse Fourier transformation) gaussian in image space (the real and 
imaginary images). the noise in the magnitude is rician and for high signal to noise ratios (SNr) 






at very low signal magnitudes the phase is difficult to determine and so called “salt and pepper” 
noise is observed.
the baseline SNr (of a single image) depends on the hardware, field strength, the voxel 
size, the tE and for gradient echo acquisition also on the flip angle (FA). Increasing the voxel 
size increases the baseline SNr and lowers the spatial resolution. lowering the tE increases the 
baseline SNr in t2
(*)-weighted images but influences the signal-to-noise of the bolus passage 
measurement. In addition, an FA at the Ernst angle has the highest SNr. 
An increase in concentration of contrast agent results in a magnitude decrease in t2
*-
weighted images. the decrease in magnitude depends on the tE, the concentration contrast 
agent and the field strength. the concentration of contrast agent is higher in the larger brain-
feeding arteries than in the capillaries therefore signal dropout occurs quicker in the larger 
arteries. At 3 tesla the baseline SNr is nearly double the baseline SNr of 1.5 tesla. However, the 
magnitude decrease is linear with field strength and therefore the magnitude drops faster for 
increasing concentration contrast agent. For this reason in the lUMC, a single dose contrast 
agent (0.1 mmol/kg-bodyweight gd-DtPA) is injected into the arm vein when the patient is 
scanned at 3 tesla and a double dose (0.2 mmol/kg-bodyweight gd-DtPA) is injected when 
the patient is scanned at 1.5 tesla. lowering the echo time could prevent signal depletion but 
a disadvantage is that the much lower concentrations of contrast agent in tissue are difficult 
to measure with a short tE. therefore, dual echo acquisition can be used with an optimal tE 
for both the AIF and the tissue response, although this can lower spatial resolution, SNr or 
coverage. 
Single shot EPI has a repetition time (tr) exactly the same as the dynamic scan time or 
temporal resolution. In segmented EPI, the tr is lower than the temporal resolution because a 
single image is acquired with several shots. PrEStO a segmented EPI technique with echo shift-
ing has a tr shorter than the echo time (tE). because the contrast agent not only affects the 
transverse relaxivity but also the longitudinal relaxivity, a shorter tr increases the contrast agent 
t1 relaxivity effect in the t2
*-weighted images. the influence of t1-effects on the concentration 
of contrast agent estimation is shown in chapter 5, figure 3. the initial dip is characteristic as 
well as the lower steady state. Dual echo acquisition is not only beneficial for optimal echo time 
for AIF and tissue but makes correction for t1-effects in tissue possible (20, 21). Alternatively, the 
flip angle can be lowered to reduce the t1-effects but this is at the cost of baseline SNr.
pArtiAl volume eFFeCts
larger voxels are beneficial for baseline SNr but also have a downside. Not only does this result 
in decreased spatial resolution of the perfusion maps, but also results in partial volume effects 
of the AIF since, the size of the voxels used in DSC-MrI will be larger than the brain-feeding 
arteries. therefore, pure intravascular AIF measurements are not possible and so-called partial 
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volume effects hamper the Δr2
*, Δr2 and Δφ AIF measurements. the partial volume effects not 
only lead to scaling errors in gradient echo magnitude-based AIF measurements but also shape 
errors, which lead to erroneous perfusion estimates. In this section, the partial volume effects 
in gradient echo acquisition will be discussed. Partial volume effects can be corrected for when 
the artery is oriented parallel to the main magnetic field (22). However, measuring the AIF in 
the internal carotid artery (ICA, which is approximately parallel to b0) requires an extra slice in 
the neck leading to reduced brain coverage. Furthermore, the ICA is a large brain-feeding artery 
and therefore signal saturation occurs sooner. 
Partial volume effects alter the complex trajectory of the bolus passage and therefore affect 
the magnitude and phase-based AIF measurements. Partial volume effects originating from 
voxels encompassing non-parallel brain-feeding arteries can and often will severely corrupt 
the shape of the measured AIF. An alternative is to measure the AIF outside the brain-feeding 
artery in homogeneous tissue where there are no partial volume effects of tissue with arterial 
signal. However, this requires strong induced local field changes in the surrounding. the local 
field changes are the strongest for perpendicular oriented arteries. the middle cerebral artery 
(MCA) is oriented approximately perpendicular to the main magnetic field and therefore ideal 
for extravascular AIF measurements. Extravascular AIF measurements are best performed using 
the phase of the Mr-signal (as shown in chapter 4)
Partial volume effects also corrupt AIF measurements in small brain-feeding arteries, which 
are closer to the microvasculature (thereby reducing the delay and more importantly the disper-
sion effects). local AIF measurements completely outside small brain-feeding arteries are not 
feasible because the induced local field changes are low (since the local field change depends 
on the radius of the artery). therefore, local or regional AIF measurements are performed with 
voxels encompassing the small brain-feeding artery. these voxels are always hampered by 
partial volume effects but the partial volume shape error varies. If the shape error is minimal 
than the tissue response in the voxel can still lead to additional broadening, since the signal 
fraction of the tissue response is much larger in the local AIF measurements. 
For future studies, it could be interesting to investigate the extent of the scaling and shape 
error in spin echo magnitude based global and local AIF measurements. 
AutomAtiC seleCtion
Instead of using anatomical information to select the AIF, automatic selection criteria can 
select AIF candidates based on the shape of the bolus passage. Up to now automatic selection 
programs only focus on magnitude-based AIF measurements and not on phase-based AIF 
measurements. Different approaches have been employed such as independent component 






An advantage of automatic AIF selection is that it provides fast, user independent and 
reproducible results. the disadvantage is that the automatic AIF selection can determine Δr2
* 
profiles to be correct when in fact the profile is corrupted by partial volume effects. Our pro-
posed criterion (described in chapter 5) can help in preventing part of the selection bias. this 
criterion is especially advantageous for detecting PVEs that have a smaller width and higher 
peak than the true arterial response, since these are not excluded by the current automatic AIF 
selection criteria.
Automatic AIF measurements focus on local AIF measurements and use specific selection 
criteria. However, as discussed in chapter 6 partial volume effects in voxels encompassing a 
small brain-feeding artery lead to broader curves. therefore, automatic methods are likely to 
select broader curves, which do not reflect the concentration-time curve of small brain-feeding 
arteries. 
limitAtions oF the numeriCAl models
the numerical models of this thesis are focused on gradient echo arterial input function 
measurements in DSC-MrI. One numerical model (Model 1) (discussed in chapter 3, 4 and 5) 
simulated AIF measurements near a perpendicular oriented artery for different fast imaging 
sequences (single shot EPI, segmented EPI and PrEStO). Another numerical model (Model 2) 
simulated local AIF measurements at various orientations without incorporating the effects of 
fast imaging sequences (chapter 6).
both models assumed an infinitely long straight vessel without arterial branches. Model 1 
simulated an artery such as the MCA, which is oriented approximately perpendicular to the 
main magnetic field. this model is valid for a straight artery at least four times the diameter (26). 
the M1 segment of the MCA is often a straight part and, in the middle of the M1 segment, the 
assumption does hold. there are, however, often branches corrupting the local field surround-
ing the artery. Model 2 simulated smaller arteries than the MCA. these arteries are more likely 
to curve and have branches.
the surroundings of the artery were modeled as homogeneous tissue. However, arteries 
in the brain are surrounded by muscle, CSF, gray matter tissue and white matter tissue. the 
structures close to the vessel wall give additional partial volume effects. this thesis showed that 
two compartment partial volume effects can cause huge shape errors. because partial volume 
effects of two compartments already produce a huge variation of shape errors, more compart-
ments will not produce more shape errors. 
the model assumed no phase effect in tissue, but as discussed above there could be a small 
tissue phase effect. Such a tissue phase response would hamper the extravascular phase-based 
AIF measurements. Magnitude-based extravascular AIF measurements are susceptible to 
relaxation changes and to the passage of contrast agent through tissue. the tissue response 
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was incorporated in the model using a linear relation. the relation could differ from in vivo as 
explained above.
Model 1 was created with the option to rotate the slices around the vessel axis. tilting the 
slices around the vessel axis results in the same (rotated) locations for AIF measurements (data 
not shown). the effect of other rotations of the vessel axis was not investigated but since the 
optimal AIF measurements are outside the artery we would expect this criteria to hold for small 
angulations of the vessel axis. the numerical model was validated using phantom experiments. 
this comparison supported the idea that the most important effects were included in the 
model. the effect of diffusion was, for example, not included. In a numerical model for t2-based 
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the main topic of this thesis is to improve quantification of brain-perfusion measured with 
dynamic susceptibility contrast (DSC-) MrI. the improvements were primarily made on the 
arterial input function (AIF) measurement, which calibrates the hemodynamic parameters. 
Manual and automatic AIF selection were investigated as well global and local or regional AIF 
selection.
Chapter 1 is a short introduction that introduces the magnetic resonance imaging tech-
nique dynamic susceptibility contrast MrI. this chapter introduces also the term arterial input 
function and the relevance of a correct arterial input function in dynamic susceptibility contrast 
MrI.
Chapter 2 is a review about two MrI techniques for measuring brain-perfusion. Perfusion 
MrI techniques can be categorized in two different groups based on tracer type. First, DSC-MrI 
is a method based on the injection of an exogenous tracer, a gadolinium-based contrast agent, 
in the arm vein. by means of fast t2 or t2
*-weighted imaging the first passage of the contrast 
agent through the brain tissue is monitored. the second technique, arterial spin labeling (ASl), 
is a completely non-invasive technique that employs water protons as an endogenous tracer. 
In this chapter, the crucial elements for correct perfusion measurements by DSC-MrI and ASl 
are discussed. In DSC-MrI, the conversion from signal changes to concentration contrast agent, 
the arterial input function measurement and the deconvolution method are the most impor-
tant elements. Whereas in ASl, the efficiency of the labeling method, correction for relaxation 
processes, and M0-calibration methods can be considered the most essential components of 
blood flow quantification. 
Chapter 3 provides insight in magnitude-based manual AIF selection near the middle cerebral 
artery (MCA) using numerical modeling. One of the main difficulties in obtaining quantitative 
perfusion values from DSC-MrI is a correct AIF measurement, as partial volume effects can lead 
to an erroneous shape and amplitude of the AIF. Cerebral blood flow and volume scale linearly 
with the area under the AIF, but shape changes of the AIF can lead to large, nonlinear errors. 
A numerical model, validated by phantom experiments, was used for predicting the optimal 
location for AIF measurements in the vicinity of the middle cerebral artery. the findings are 
fourfold: AIF measurements should be performed in voxels completely outside the artery, here 
a linear relation should be assumed between Dr2







exact optimal location differs per acquisition type, and voxels including a small middle cerebral 
artery yield also correct AIF measurements for segmented EPI when a short echo time is used.
Chapter 4 provides insight in phase-based manual AIF selection near the middle cerebral 
artery using the numerical model of chapter 3. In dynamic susceptibility contrast perfusion 
MrI arterial input function measurements using the phase of the Mr signal are commonly 
performed inside an artery. However, phase-based AIF selection is also feasible in tissue sur-
rounding an artery such as the MCA, which runs approximately perpendicular to b0, since 
contrast agents also induce local field changes in tissue surrounding the artery. the aim of this 
study was to investigate whether phase-based AIF selection is better performed in tissue just 
outside the MCA than inside the artery. Additionally, phase-based AIF selection was compared 
to magnitude-based AIF selection. three main findings are presented: first, phase-based AIF 
selections are better made in tissue outside the MCA rather than within the MCA, since in the 
latter approach partial volume effects affect the shape of the estimated AIF. Second, optimal 
locations for phase-based AIF selection are similar for different clinical DSC-MrI sequences. 
third, phase-based AIF selection allows more locations in tissue to be chosen which show the 
correct AIF than does magnitude-based AIF selection.
Current selection criteria of automatic AIF-selection algorithms discriminate venous, capil-
lary and arterial profiles based on shape- and timing-characteristics of the first passage. Unfor-
tunately, partial volume effects (PVEs) can lead to shape errors in the bolus passage, including 
a narrower and higher peak, which might be selected as a “correct” AIF. Chapter 5 introduces 
a new criterion for AIF selection to exclude partial volume effects, which are normally not 
excluded by the current selection criteria. this criterion is based on tracer kinetic principles for 
computing CbV and employs the ratio of the steady-state value to the area-under-the-curve 
of the first passage, which should result in an equal value for tissue and arterial responses. by 
employing a reference value from tissue, PVEs-induced shape errors of the AIF measurement 
can be detected. In vivo data were used to evaluate the proposed approach. the data showed 
that the new criterion enables detection of shape errors, although false positives do occur, 
which could be easily avoided when combined with current AIF selection criteria. 
Chapter 6 evaluated signal formation in local AIF measurements of DSC-MrI. Often a single 
global AIF is selected near a large brain-feeding artery. Alternatively, local AIFs could be used, 
which are measured closer to the capillaries, thereby resulting in better perfusion estimates, 
because DSC-MrI theory assumes that the employed AIF reflects the input of the microvascu-
lature. However, do the measured local AIFs reflect the true concentration-time curves (CtC) 
of small arteries? to answer this question we created a 3D numerical model that simulated 
PVEs in local AIF measurements and compared these to the ground truth. In addition, in vivo 
data was used to evaluate local AIF candidates selected using two different angiograms. the 
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findings are two-fold. First, the simulations show that PVEs in the local AIF measurements lead 
to broader CtCs than the ground truth AIF (caused by the extravascular susceptibility effect 
and the tissue response). Second, the in vivo data showed that the shape-characteristics of 
local AIF candidates largely overlap with the shape-characteristics of gray matter CtCs. these 
findings suggest that local AIF measurements do not reflect the true CtC in the small arteries.
Chapter 7 employs some of the developed techniques in a clinical DSC-MrI study of 
migraine patients. Whether focal changes in cerebral perfusion are present during the interictal 
stage of migraine, compared to headache-free control subjects, has not been convincingly 
demonstrated. In this study, brain perfusion measured with DSC-MrI was compared between 
30 interictal female migraineurs (13 migraine with aura, 17 migraine without aura) and 17 
female controls to investigate the occurrence of perfusion changes. We conclude that interictal 
migraine is characterized by discrete areas of hyper- and hypoperfusion that are unspecific 
for migraine pathophysiology and that do not give an explanation for migraine-associated 
subclinical cerebellar infarction.
Chapter 8 is a general discussion in which the different aspects for perfusion quantification 
are discussed with a special focus on the AIF measurement. these aspects are the tracer kinetic 
theory, the influence of AIF measurements more upstream, correct transformation from the 
measured Mr-signal to the concentration contrast agent, effects of different sampling schemes, 
different acquisition settings and their influence on the measured signal and partial volume 
effects. In addition, the pros and cons of automatic AIF measurements are briefly discussed. 




Dit proefschrift behandelt het verbeteren van de kwantificatie van hersenperfusie gemeten 
met dynamic susceptibility contrast (DSC-) MrI. De onderzochte verbeteringen zijn voornamelijk 
toegespitst op de arteriële input functie (AIF) meting. Deze passage van het contrastmiddel 
door een arterie is nodig voor de kalibratie van de hemodynamische parameters. Naast de 
handmatige en automatische AIF selectie zijn ook de globale en lokale (of regionale) AIF-
metingen onderzocht.
Hoofdstuk 1 is een korte introductie van de onderzochte DSC-MrI-techniek. Dit hoofdstuk 
introduceert de term AIF en het belang van een correcte AIF voor DSC-MrI.
Hoofdstuk 2 is een overzichtsartikel van twee MrI-technieken voor het meten van hersen-
perfusie. De technieken verschillen van elkaar door de gebruikte tracer. De eerste techniek 
is DSC-MrI, een methode die gebaseerd is op de injectie van een exogeen contrastmiddel 
(een gadolinium derivaat) in een ader van de arm. Door middel van snelle t2- of t2
*-gewogen 
beelden is de eerste passage van het contrastmiddel door het hersenweefsel af te beelden. 
De tweede techniek is arterial spin labeling (ASl), een niet-invasieve techniek die waterstofpro-
tonen in het bloed gebruikt als een endogene tracer. In hoofdstuk 2 worden de belangrijkste 
elementen voor correcte perfusiemetingen door DSC-MrI en ASl besproken. In DSC-MrI zijn 
de conversie van signaalverandering naar contrastmiddelconcentratie, de AIF meting en de 
deconvolutie, de belangrijkste elementen. In ASl zijn de bepaling van de labelingefficiëntie, de 
correctie voor relaxatie processen en de M0-calibratie methode de belangrijkste voorwaarden 
voor een correcte doorbloedingskwantificatie.
Hoofdstuk 3 geeft inzicht in de handmatige AIF-selectie, die gebaseerd is op de magni-
tude van het Mr-signaal nabij de arteria cerebri media (MCA), door middel van numerieke 
modelering. Een van de moeilijkheden bij het kwantificeren van de perfusie zoals gemeten 
met DSC-MrI is de juiste bepaling van de AIF, omdat partiële volume-effecten kunnen leiden 
tot vorm- en amplitudeveranderingen van de AIF. Hersendoorbloeding (cerebral blood flow 
(CbF)) en cerebrale bloedvolume schalen lineair met de oppervlakte onder de AIF, maar vorm-
veranderingen van de AIF kunnen leiden tot grote niet-lineaire fouten. Een numeriek model, 
gevalideerd door middel van fantoomexperimenten, is gebruikt voor het voorspellen van de 
optimale lokatie voor AIF metingen in de buurt van de MCA. Uit de experimenten blijkt dat 









gebruikt te worden tussen Dr2
* en contrastmiddelconcentratie. Ook tonen de experimenten 
aan dat de exacte locatie van de correcte AIF meting verschilt per acquisitie type. Voor een 
kleine MCA (diameter ≈ 2 mm) geven voxels die het vat omvatten ook een correcte AIF wan-
neer segmented EPI met een korte echo tijd wordt gebruikt.
In hoofdstuk 4 wordt de beste locatie onderzocht voor de handmatige AIF-selectie geba-
seerd op de fase van het Mr-signaal bij de MCA. In DSC-MrI literatuur is voorgesteld om de 
AIF-meting middels de fase uit te voeren binnen de arterie. Echter, AIF-selectie gebaseerd op 
de fase is ook mogelijk in weefsel buiten een arterie zoals de MCA, omdat deze loodrecht op het 
magneetveld staat en daarbij lokale veldveranderingen induceert in het omliggende weefsel. 
Het doel van deze studie was om te onderzoeken of AIF-selectie gebaseerd op de fase van het 
Mr-signaal beter uitgevoerd kan worden in het omliggende weefsel dan binnenin de arterie. 
Daarnaast zijn AIF fase-metingen vergeleken met de AIF gemeten met de magnitude van het 
Mr-signaal. Uit deze studie blijkt ten eerste dat AIF-metingen, gemeten met de fase van het 
Mr-signaal, beter buiten de arterie gemeten kunnen worden, omdat bij AIF metingen in het 
vat partiële volume effecten de vorm van de gemeten AIF veranderen. ten tweede, de optimale 
lokaties voor het meten van de AIF met de fase zijn nagenoeg gelijk voor verschillende klinische 
DSC-MrI-sequenties. ten derde, AIF-metingen met de fase kunnen op meer lokaties rondom 
het vat gedaan worden in vergelijking met de AIF-metingen met de magnitude.
Hoofdstuk 5 beschrijft een nieuw criterium voor (automatische) AIF-metingen. De huidige 
AIF voxelselectie criteria onderscheiden de curves van de vene, de capillairen en de arterie 
op basis van vorm en temporele karakteristieken van de eerste passage. Helaas kunnen par-
tiële volume-effecten ook leiden tot vormveranderingen van de bolus passage, zoals smallere 
hogere pieken, die daardoor juist geselecteerd kunnen worden als correcte AIF. Wij stellen een 
nieuw criterium voor dat gebaseerd is op tracer kinetiek voor het bepalen van cerebrale bloed-
volume. Dit criterium gebruikt de verhouding tussen de evenwichtstoestandswaarde en de 
oppervlakte onder de eerste passage, welke gelijk moet zijn voor weefsel en arteriële passages. 
Door middel van een referentiemeting in weefsel kunnen de door partiële volume-effecten 
geïnduceerde vormveranderingen van de AIF meting gedetecteerd worden. In vivo data is 
gebruikt om de methode te evalueren. De data laat zien dat het nieuwe criterium het mogelijk 
maakt om vormveranderingen waar te nemen. Fout positieve waarden treden eveneens op, 
maar deze kunnen voorkomen worden door gebruik te maken van additionele selectiecirteria 
die al beschreven staan in de literatuur.
Hoofdstuk 6 evalueert de signaalvorming in lokale AIF-metingen gemeten met DSC-MrI. 
Normalitair wordt er een enkele globale AIF geselecteerd bij een toevoerende arterie. lokale 
AIFs, die dichter bij de capillairen gemeten worden, leiden tot betere perfusiebepalingen 
omdat de DSC-MrI theorie aanneemt dat de gebruikte AIF de werkelijke invoer van de 
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microvasculatuur reflecteert. Echter, komen de gemeten lokale AIFs overeen met de werkelijke 
concentratie-tijd curves (CtC) van smalle arteriën? Om dit te beantwoorden hebben we een 
3D-numeriek model gemaakt dat partiële volume-effecten in lokale AIF-metingen simuleert. 
Dit hebben we vergeleken met de werkelijke invoer door in vivo data te gebruiken voor de 
evaluatie van lokale AIF-kandidaten die geselecteerd zijn door twee verschillende angiogram-
men. De simulaties tonen aan dat partiële volume-effecten in de lokale AIF-metingen leiden tot 
bredere CtCs dan de werkelijke invoer (veroorzaakt door de extravasculaire susceptibiliteitsef-
fecten en de tissue passage). ten tweede, de in vivo data laat zien dat de vormkarakteristieken 
van de lokale AIF-kandidaten grotendeels overlappen met de vormkarakteristieken van grijze 
stof CtCs. Uit deze bevindingen blijkt dan ook dat de lokale AIF-meting waarschijnlijk niet de 
werkelijke CtC van kleine arteriën weergeeft.
In hoofdstuk 7 worden de beschreven technieken toegepast in een DSC-MrI-studie om het 
verband tussen migraine en hersendoorbloeding aan te tonen. Er is nog geen overtuigend 
bewijs voor de aanname dat focale veranderingen in de hersendoorbloeding voorkomen in 
de interictale fase van migraine in vergelijking met gezonde proefpersonen. In deze studie is 
de hersendoorbloeding gemeten met DSC-MrI in 30 interictale vrouwelijke migraineurs (13 
migraine met aura, 17 migraine zonder aura) en 17 vrouwelijke controles. Onze bevinding is dat 
interictale migraine wordt gekarakteriseerd door discrete gebieden van hyper- en hypoperfu-
sie die niet specifiek zijn voor migraine pathofysiologie of geen verklaring kunnen geven voor 
het op treden van subklinische infracten in de kleine hersenen.
In de algemene discussie (hoofdstuk 8) worden verschillende aspecten voor perfusiekwan-
tificatie en AIF-metingen in het bijzonder beschreven. Deze aspecten zijn onder andere 
tracer kinetiek, de invloed van het meten van de AIF dichterbij de microvasculatuur, de juiste 
transformatie van het Mr-signaal naar de contrastmiddelconcentratie, effecten van verschil-
lende samplingmethodes, verschillende acquisitieinstellingen en hun invloed op het gemeten 
signaal en partiële volume-effecten. Daarbij worden de voor- en nadelen van automatische 
AIF-metingen besproken. De discussie sluit af met het bespreken van de beperkingen van de 
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